<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Vaccines for preventing influenza in the elderly - Demicheli, V - 2018 | Cochrane Library</title> <meta content="Vaccines for preventing influenza in the elderly - Demicheli, V - 2018 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004876.pub4/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Vaccines for preventing influenza in the elderly - Demicheli, V - 2018 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004876.pub4/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD004876.pub4" name="dc.identifier" scheme="DOI"/> <meta content="Vaccines for preventing influenza in the elderly" name="citation_title"/> <meta content="Vittorio Demicheli" name="citation_author"/> <meta content="vittorio.demicheli@libero.it" name="citation_author_email"/> <meta content="Tom Jefferson" name="citation_author"/> <meta content="University of Oxford" name="citation_author_institution"/> <meta content="Carlo Di Pietrantonj" name="citation_author"/> <meta content="Local Health Unit Alessandria- ASL AL" name="citation_author_institution"/> <meta content="Eliana Ferroni" name="citation_author"/> <meta content="Regional Center for Epidemiology, Veneto Region" name="citation_author_institution"/> <meta content="Sarah Thorning" name="citation_author"/> <meta content="Gold Coast Hospital and Health Service" name="citation_author_institution"/> <meta content="Roger E Thomas" name="citation_author"/> <meta content="University of Calgary" name="citation_author_institution"/> <meta content="Alessandro Rivetti" name="citation_author"/> <meta content="ASL CN2 Alba Bra" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="2" name="citation_issue"/> <meta content="10.1002/14651858.CD004876.pub4" name="citation_doi"/> <meta content="2018" name="citation_date"/> <meta content="2018/02/01" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004876.pub4/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004876.pub4/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004876.pub4/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Influenza Vaccines [*administration &amp; dosage, adverse effects]; Influenza, Human [*prevention &amp; control]; Randomized Controlled Trials as Topic; Vaccines, Inactivated [administration &amp; dosage]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004876.pub4&amp;doi=10.1002/14651858.CD004876.pub4&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004876.pub4&amp;doi=10.1002/14651858.CD004876.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004876.pub4&amp;doi=10.1002/14651858.CD004876.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004876.pub4&amp;doi=10.1002/14651858.CD004876.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004876.pub4&amp;doi=10.1002/14651858.CD004876.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004876.pub4&amp;doi=10.1002/14651858.CD004876.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004876.pub4&amp;doi=10.1002/14651858.CD004876.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004876.pub4&amp;doi=10.1002/14651858.CD004876.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004876.pub4&amp;doi=10.1002/14651858.CD004876.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004876.pub4&amp;doi=10.1002/14651858.CD004876.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004876.pub4&amp;doi=10.1002/14651858.CD004876.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004876.pub4&amp;doi=10.1002/14651858.CD004876.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004876.pub4&amp;doi=10.1002/14651858.CD004876.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004876.pub4&amp;doi=10.1002/14651858.CD004876.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004876.pub4&amp;doi=10.1002/14651858.CD004876.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004876.pub4&amp;doi=10.1002/14651858.CD004876.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004876.pub4&amp;doi=10.1002/14651858.CD004876.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004876.pub4&amp;doi=10.1002/14651858.CD004876.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004876.pub4&amp;doi=10.1002/14651858.CD004876.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004876.pub4&amp;doi=10.1002/14651858.CD004876.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004876.pub4&amp;doi=10.1002/14651858.CD004876.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004876.pub4&amp;doi=10.1002/14651858.CD004876.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004876.pub4&amp;doi=10.1002/14651858.CD004876.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774054000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774081000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000"}};Liferay.authToken="1pyM3CVc";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD004876\x2epub4\x26doi\x3d10\x2e1002\x2f14651858\x2eCD004876\x2epub4\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004876\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004876\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1559916434000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","ru","pt","ms","hr","fr","zh_HANS","zh_HANT","th","ja","fa","pl"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD004876.pub4",title:"Vaccines for preventing influenza in the elderly",firstPublishedDate:"Feb 1, 2018 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Acute Respiratory Infections Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738735355000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=1pyM3CVc&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004876.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD004876.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD004876.pub4/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD004876.pub4/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004876.pub4%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD004876.PUB4" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;บทคัดย่อ&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Zusammenfassung in einfacher Sprache&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo para leigos&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;ข้้อสรุปภาษาธรรมดา&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]},{&quot;param&quot;: &quot;comments&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Comments&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD004876.pub4/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD004876.PUB4" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD004876.pub4/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD004876.pub4/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>33604 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD004876.pub4" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004876.pub4/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004876.pub4/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004876.pub4/full#CD004876-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004876.pub4/full#CD004876-sec-0085"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004876.pub4/full#CD004876-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004876.pub4/full#CD004876-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004876.pub4/full#CD004876-sec-0014"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004876.pub4/full#CD004876-sec-0015"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004876.pub4/full#CD004876-sec-0048"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004876.pub4/full#CD004876-sec-0079"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004876.pub4/appendices#CD004876-sec-0090"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/table_n/CD004876StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/table_n/CD004876StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004876.pub4/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004876.pub4/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004876.pub4/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD004876.pub4/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD004876.pub4/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD004876.pub4/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2018 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Vaccines for preventing influenza in the elderly</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004876.pub4/information#CD004876-cr-0004"><i class="icon corresponding-author fa fa-envelope"></i>Vittorio Demicheli</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004876.pub4/information#CD004876-cr-0005">Tom Jefferson</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004876.pub4/information#CD004876-cr-0006">Carlo Di Pietrantonj</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004876.pub4/information#CD004876-cr-0007">Eliana Ferroni</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004876.pub4/information#CD004876-cr-0008">Sarah Thorning</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004876.pub4/information#CD004876-cr-0009">Roger E Thomas</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004876.pub4/information#CD004876-cr-0010">Alessandro Rivetti</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/information/en#CD004876-sec-0130">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 01 February 2018 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD004876.pub4">https://doi.org/10.1002/14651858.CD004876.pub4</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD004876-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD004876-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD004876-abs-0011">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD004876-abs-0019">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD004876-abs-0009">Français</a> </li> <li class="section-language"> <a class="" href="full/pt#CD004876-abs-0005">Português</a> </li> <li class="section-language"> <a class="" href="full/th#CD004876-abs-0016">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD004876-abs-0013">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD004876-abs-0001" lang="en"> <section id="CD004876-sec-0001"> <h3 class="title" id="CD004876-sec-0001">Background</h3> <p>The consequences of influenza in the elderly (those age 65 years or older) are complications, hospitalisations, and death. The primary goal of influenza vaccination in the elderly is to reduce the risk of death among people who are most vulnerable. This is an update of a review published in 2010. Future updates of this review will be made only when new trials or vaccines become available. Observational data included in previous versions of the review have been retained for historical reasons but have not been updated because of their lack of influence on the review conclusions. </p> </section> <section id="CD004876-sec-0002"> <h3 class="title" id="CD004876-sec-0002">Objectives</h3> <p>To assess the effects (efficacy, effectiveness, and harm) of vaccines against influenza in the elderly. </p> </section> <section id="CD004876-sec-0003"> <h3 class="title" id="CD004876-sec-0003">Search methods</h3> <p>We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (the Cochrane Library 2016, Issue 11), which includes the Cochrane Acute Respiratory Infections Group's Specialised Register; MEDLINE (1966 to 31 December 2016); Embase (1974 to 31 December 2016); Web of Science (1974 to 31 December 2016); CINAHL (1981 to 31 December 2016); LILACS (1982 to 31 December 2016); WHO International Clinical Trials Registry Platform (ICTRP; 1 July 2017); and ClinicalTrials.gov (1 July 2017). </p> </section> <section id="CD004876-sec-0004"> <h3 class="title" id="CD004876-sec-0004">Selection criteria</h3> <p>Randomised controlled trials (RCTs) and quasi‐RCTs assessing efficacy against influenza (laboratory‐confirmed cases) or effectiveness against influenza‐like illness (ILI) or safety. We considered any influenza vaccine given independently, in any dose, preparation, or time schedule, compared with placebo or with no intervention. Previous versions of this review included 67 cohort and case‐control studies. The searches for these trial designs are no longer updated. </p> </section> <section id="CD004876-sec-0005"> <h3 class="title" id="CD004876-sec-0005">Data collection and analysis</h3> <p>Review authors independently assessed risk of bias and extracted data. We rated the certainty of evidence with GRADE for the key outcomes of influenza, ILI, complications (hospitalisation, pneumonia), and adverse events. We have presented aggregate control group risks to illustrate the effect in absolute terms. We used them as the basis for calculating the number needed to vaccinate to prevent one case of each event for influenza and ILI outcomes. </p> </section> <section id="CD004876-sec-0006"> <h3 class="title" id="CD004876-sec-0006">Main results</h3> <p>We identified eight RCTs (over 5000 participants), of which four assessed harms. The studies were conducted in community and residential care settings in Europe and the USA between 1965 and 2000. Risk of bias reduced our certainty in the findings for influenza and ILI, but not for other outcomes. </p> <p>Older adults receiving the influenza vaccine may experience less influenza over a single season compared with placebo, from 6% to 2.4% (risk ratio (RR) 0.42, 95% confidence interval (CI) 0.27 to 0.66; low‐certainty evidence). We rated the evidence as low certainty due to uncertainty over how influenza was diagnosed. Older adults probably experience less ILI compared with those who do not receive a vaccination over the course of a single influenza season (3.5% versus 6%; RR 0.59, 95% CI 0.47 to 0.73; moderate‐certainty evidence). These results indicate that 30 people would need to be vaccinated to prevent one person experiencing influenza, and 42 would need to be vaccinated to prevent one person having an ILI. </p> <p>The study providing data for mortality and pneumonia was underpowered to detect differences in these outcomes. There were 3 deaths from 522 participants in the vaccination arm and 1 death from 177 participants in the placebo arm, providing very low‐certainty evidence for the effect on mortality (RR 1.02, 95% CI 0.11 to 9.72). No cases of pneumonia occurred in one study that reported this outcome (very low‐certainty evidence). No data on hospitalisations were reported. Confidence intervaIs around the effect of vaccines on fever and nausea were wide, and we do not have enough information about these harms in older people (fever: 1.6% with placebo compared with 2.5% after vaccination (RR 1.57, 0.92 to 2.71; moderate‐certainty evidence)); nausea (2.4% with placebo compared with 4.2% after vaccination (RR 1.75, 95% CI 0.74 to 4.12; low‐certainty evidence)). </p> </section> <section id="CD004876-sec-0007"> <h3 class="title" id="CD004876-sec-0007">Authors' conclusions</h3> <p>Older adults receiving the influenza vaccine may have a lower risk of influenza (from 6% to 2.4%), and probably have a lower risk of ILI compared with those who do not receive a vaccination over the course of a single influenza season (from 6% to 3.5%). We are uncertain how big a difference these vaccines will make across different seasons. Very few deaths occurred, and no data on hospitalisation were reported. No cases of pneumonia occurred in one study that reported this outcome. We do not have enough information to assess harms relating to fever and nausea in this population. </p> <p>The evidence for a lower risk of influenza and ILI with vaccination is limited by biases in the design or conduct of the studies. Lack of detail regarding the methods used to confirm the diagnosis of influenza limits the applicability of this result. The available evidence relating to complications is of poor quality, insufficient, or old and provides no clear guidance for public health regarding the safety, efficacy, or effectiveness of influenza vaccines for people aged 65 years or older. Society should invest in research on a new generation of influenza vaccines for the elderly. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD004876-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD004876-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD004876-abs-0003">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD004876-abs-0012">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD004876-abs-0020">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD004876-abs-0010">Français</a> </li> <li class="section-language"> <a class="" href="full/hr#CD004876-abs-0008">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ja#CD004876-abs-0018">日本語</a> </li> <li class="section-language"> <a class="" href="full/ms#CD004876-abs-0007">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#CD004876-abs-0021">Polski</a> </li> <li class="section-language"> <a class="" href="full/pt#CD004876-abs-0006">Português</a> </li> <li class="section-language"> <a class="" href="full/ru#CD004876-abs-0004">Русский</a> </li> <li class="section-language"> <a class="" href="full/th#CD004876-abs-0017">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD004876-abs-0014">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD004876-abs-0015">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD004876-abs-0002" lang="en"> <h3>Vaccines for preventing seasonal influenza and its complications in people aged 65 or older </h3> <p><b>Review aim</b> </p> <p>The aim of this Cochrane Review, first published in 2006, was to summarise research that looks at the effects of immunising the elderly (those aged 65 years or older) with influenza vaccine during influenza seasons. We used information from randomised trials comparing influenza vaccine with dummy vaccine or with nothing. The influenza vaccines were prepared by treating influenza viruses with a chemical that kills the virus (inactivated virus), and the vaccination was given by injection through the skin. We were interested in showing the effects of vaccines on reducing the number of elderly with confirmed influenza, the number who had influenza‐like symptoms such as headache, high temperature, cough, and muscle pain (influenza‐like illness, of ILI), and harms from vaccination. We looked for evidence of the impact of influenza or ILI such as hospital admission, complications, and death. We will update this review in the future only when new trials or vaccines become available. </p> <p>Observational data from 67 studies included in previous versions of the review have been retained for historical reasons but have not been updated because of their lack of influence on the review conclusions. </p> <p><b>What was studied in this review?</b> </p> <p>Over 200 viruses cause ILI, producing the same symptoms (fever, headache, aches, pains, cough, and runny nose). Without laboratory tests, doctors cannot distinguish between viruses, as they last for days and rarely lead to serious illness. At best, vaccines are only effective against influenza A and B, which represent about 5% of all circulating viruses. Inactivated vaccine is prepared by treating influenza viruses with a specific chemical agent that 'kills' the virus. Final preparations may contain either the complete viruses (whole‐virion vaccine) or the active part of them (split or subunit vaccines). These vaccines are typically administered by injection through the skin. The virus strains contained in the vaccine are usually those that are expected to circulate in the following epidemic seasons (two type A and one or two B strains), which are recommended by the World Health Organization (seasonal vaccine). Pandemic vaccine contains only the virus strain that is responsible for the pandemic (e.g. the type A H1N1 for the 2009 to 2010 pandemic). </p> <p><b>Key messages</b> </p> <p>Inactivated vaccines can reduce the proportion of elderly who have influenza and ILI. Data on deaths were sparse, and we found no data on hospitalisations due to complications. However, variation in the results of studies means we cannot be certain about how big a difference these vaccines will make across different seasons. </p> <p><b>Main results</b> </p> <p>We found eight randomised controlled trials (over 5000 people), of which four assessed harms. The studies were conducted in community and residential care settings in Europe and the USA between 1965 and 2000. </p> <p>Older adults receiving the influenza vaccine may experience less influenza over a single season, from 6% to 2.4%, meaning that 30 people would need to be vaccinated with inactivated influenza vaccines to avoid one case of influenza. Older adults also probably experience less ILI, from 6% to 3.5%, meaning that 42 people would need to be vaccinated to prevent one case of ILI. The amount of information on pneumonia and mortality was limited. Data were insufficient to be certain about the effect of vaccines on mortality. No cases of pneumonia occurred in one study that reported this outcome, and no data on hospitalisations were reported. We do not have enough information to assess harms relating to fever and nausea in this population. </p> <p>The impact of influenza vaccines in older people is modest, irrespective of setting, outcome, population, and study design.<br/><b>How up to date is this review?</b> </p> <p>The evidence is current to 31 December 2016.</p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD004876-sec-0085" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD004876-sec-0085"></div> <h3 class="title" id="CD004876-sec-0086">Implications for practice</h3> <section id="CD004876-sec-0086"> <p>Healthy older adults receiving the influenza vaccine may be at lower risk of influenza (from 6% to 2.4%, low‐certainty evidence) and are probably at lower risk of influenza‐like illness (ILI) (from 6% to 3.5%, moderate‐certainty evidence) compared with those who do not receive a vaccination over the course of a single influenza season. Our uncertainty in the effect on influenza reflects a lack of information about how the diagnosis was confirmed in the studies and judgements of high or unclear risk of bias. </p> <p>The findings of our review indicate that implementing vaccination programmes for elderly people may lead to reductions in influenza and ILI, but randomised studies to date have provided insufficient data on complications. Very few deaths occurred in the trials, and no data on hospitalisation were reported. No cases of pneumonia occurred in one study that reported this outcome. The sparse nature of the data overall may reflect the low risk of developing complications in the healthy population of interest and low rates of ILI and influenza in the trials. Vaccination probably increases fever from 1.6% to 2.5% (moderate‐certainty evidence) and may increase nausea from 2.4% to 4.2%, but for both of these harms the confidence interval is wide. Similar effects were observed for headache, general malaise, and upper respiratory tract symptoms. Sore arm and swelling occurred more frequently with vaccination. </p> <p>Policymakers considering funding vaccine programmes and individuals contemplating vaccination should take into account the likely benefits in terms of the reductions in the risk of influenza and ILI (3.5% and 2.5%, respectively), uncertainty over complications, and possible increases in harms. </p> </section> <h3 class="title" id="CD004876-sec-0087">Implications for research</h3> <section id="CD004876-sec-0087"> <p>Investment in the development of better vaccines than are currently available should be linked to better knowledge of the causes and patterns of ILI in different communities. The additional effects of vaccinating carers in reducing transmission in nursing homes should be assessed. The effect of vaccination of high‐risk groups should also be further assessed. </p> <p>Until such time as the role of vaccines for preventing complications of influenza in the elderly is clarified, more comprehensive and effective strategies for the control of acute respiratory infections should be investigated. These should include several preventive interventions that take into account the multi‐agent nature of ILI and its context (such as personal hygiene and adequate food, water, and sanitation). </p> <p>When a new vaccination or preventive technology becomes available, an adequately powered, publicly funded, high‐quality placebo‐controlled trial run over several seasons should be undertaken. New insights on the role of viruses and other agents in the genesis of influenza and ILI are also needed. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD004876-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD004876-sec-0008"></div> <div class="table" id="CD004876-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Influenza vaccine compared to placebo for preventing influenza in the elderly</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Influenza vaccine compared to placebo for preventing influenza in the elderly</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people aged over 65 years<br/><b>Setting:</b> community and residential care institutions in the USA and Europe during influenza seasons between 1965 and 2000<br/><b>Intervention:</b> influenza vaccine<br/><b>Comparison:</b> placebo </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with placebo</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with influenza vaccine</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Influenza assessed with: laboratory confirmation</b> </p> <p>Follow‐up was conducted over an influenza season.</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.42<br/>(0.27 to 0.66) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2217<br/>(3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>LOW <sup>2 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>57 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>24 per 1000<br/>(15 to 38) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Influenza‐like illness<br/>assessed with: subjective report</b> </p> <p>Follow‐up was conducted over an influenza season.</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.59<br/>(0.47 to 0.73) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>6894<br/>(4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/>MODERATE <sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>59 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>35 per 1000<br/>(28 to 43) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pneumonia</b> </p> <p>Follow‐up was conducted over an influenza season.</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>No events occurred in 1 study of 699 people.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>699<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>4 5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Hospitalisations</b> ‐ not reported </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>All deaths</b> </p> <p>Follow‐up was conducted over an influenza season.</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.02<br/>(0.11 to 9.72) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>699<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>4 5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>6 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>6 per 1000<br/>(1 to 55) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Fever</b> </p> <p>Follow‐up was conducted over an influenza season.</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.57<br/>(0.92 to 2.71) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2519<br/>(3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/>MODERATE <sup>6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>16 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>25 per 1000<br/>(15 to 43) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Nausea</b> </p> <p>Follow‐up was conducted over an influenza season.</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.75<br/>(0.74 to 4.12) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>672<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>LOW <sup>6 7</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>24 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>42 per 1000<br/>(18 to 98) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> confidence interval; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate quality:</b> We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low quality:</b> Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low quality:</b> We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Control group risk taken as aggregate of the study control group risks.<br/><sup>2</sup>Downgraded one level due to serious risk of bias. Most of the evidence summarised in the meta‐analysis comes from studies with high or unclear risk of bias for more than one 'Risk of bias' domain.<br/><sup>3</sup>Downgraded due to indirectness. Uncertainty over the definition, testing, and surveillance of influenza in older trials.<br/><sup>4</sup>Downgraded two levels due to very serious imprecision. No events occurred in one study of nearly 700 people. The study was likely underpowered to detect effects on either pneumonia or mortality.<br/><sup>5</sup>Downgraded one level due to serious risk of bias. One study contributing data to this outcome had high risk of selection bias.<br/><sup>6</sup>Downgraded one level due to serious imprecision. Confidence intervals for nausea and fever were wide and include reduction and increase in risk of adverse events.<br/><sup>7</sup>Downgraded one level due to serious risk of bias. One study contributing data to this outcome had unclear risk of selection bias. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD004876-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD004876-sec-0009"></div> <section id="CD004876-sec-0010"> <h3 class="title" id="CD004876-sec-0010">Description of the condition</h3> <p>Viral respiratory disease imposes a heavy burden on society. The majority of viral respiratory disease (influenza‐like illness (ILI)) is caused by many different agents that are not clinically distinguishable from one another. A variable proportion of ILI (7% to 15% on average) is caused by influenza viruses and is known as influenza (<a href="./references#CD004876-bbs2-0396" title="JeffersonTO . Mistaken identity: seasonal influenza versus influenza-like illness. Clinical Evidence2009;329:1-4.">Jefferson 2009a</a>). </p> <p>Influenza is an acute respiratory infection caused by a virus of the <i>Orthomyxoviridae</i> family. Three serotypes are known (A, B, and C). Influenza causes an acute febrile illness with muscle ache, headache, and cough. Although the median duration of the acute illness is three days, cough and malaise can persist for weeks. Complications of influenza include otitis media, pneumonia, secondary bacterial pneumonia, exacerbations of chronic respiratory disease, and bronchiolitis in children. Additionally, influenza can cause a range of non‐respiratory complications including febrile convulsions, Reye's syndrome, and myocarditis (<a href="./references#CD004876-bbs2-0409" title="TreanorJ . Influenza vaccination. New England Journal of Medicine2016;375(13):1261-8. [DOI: 10.1056/NEJMcp1512870]">Treanor 2016</a>; <a href="./references#CD004876-bbs2-0413" title="WiselkaM . Influenza: diagnosis, management and prophylaxis. BMJ1994;308(6940):1341-5.">Wiselka 1994</a>). Efforts to prevent or minimise the impact of seasonal influenza in the second part of the 20th century centred on the use of vaccines. Due to the yearly changes in viral antigenic configuration and the lack of carry‐over protection from year to year, a new vaccination campaign needs to be organised annually, with a huge scientific and logistic effort to ensure production and delivery of the vaccines. </p> </section> <section id="CD004876-sec-0011"> <h3 class="title" id="CD004876-sec-0011">Description of the intervention</h3> <p>Currently there are three types of influenza vaccines:</p> <p> <ol id="CD004876-list-0001"> <li> <p>whole‐virion vaccines, which consist of complete viruses that have been 'killed' or inactivated, so that they are not infectious but retain their strain‐specific antigenic properties; </p> </li> <li> <p>subunit virion vaccines, which are made of surface antigens (H and N) only; and</p> </li> <li> <p>split‐virion vaccines, in which the viral structure is broken up by a disrupting agent.</p> </li> </ol> </p> <p>These vaccines contain both surface and internal antigens. In addition, a variety of non‐European manufacturers produce live attenuated vaccines. Traditionally, whole‐virion vaccines are thought to be less well tolerated due to the presence of a lipid stratum on the surface of the viral particles (a remnant of the host cell membrane coating the virion, when budding from the host cell). </p> <p>Influenza vaccines are produced worldwide. Periodic antigenic drifts and shifts pose problems for vaccine production and procurement, as a new vaccine closely matching the circulating antigenic configuration must be produced and procured for the beginning of each new influenza 'season'. To achieve this, the World Health Organization (WHO) has established a worldwide surveillance system, allowing for the identification and isolation of viral strains circulating the different parts of the globe. Sentinel practices (designated primary care points) recover viral particles from the nasopharynx of people with influenza‐like symptoms, and the samples are swiftly sent to the laboratories of the national influenza centres (110 laboratories in 79 countries). When new strains are detected, the samples are sent to one of the four WHO reference centres (London, Atlanta, Tokyo, and Melbourne) for antigenic analysis. Information on the circulating strain is then sent to the WHO, which in February of each year recommends, through a committee, the strains to be included in the vaccine for the forthcoming 'season'. Individual governments may or may not follow the WHO recommendations. Surveillance and early identification thus play a central part in the composition of the vaccine. </p> <p>The global influenza spread and burden can be assessed by consulting the WHO Global Influenza Surveillance and Response System (GISRS) web page, which provides an overview and country comparison options (www.who.int/influenza/resources/charts/en/). </p> </section> <section id="CD004876-sec-0012"> <h3 class="title" id="CD004876-sec-0012">How the intervention might work</h3> <p>Vaccines work by simulating an infection and stimulating the body to produce antibodies against the threat and activate other defence mechanisms. </p> <p>Vaccines have been the main global weapon to minimise the impact of influenza in the elderly for the last four decades, as people aged 65 and older are at higher risk of complications, hospitalisations, and death from influenza. According to the Centers for Disease Control and Prevention, the primary goal of influenza vaccination in the elderly is to reduce the risk of complications among people who are most vulnerable (<a href="./references#CD004876-bbs2-0364" title="Advisory Committee on Immunization Practices. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). Morbidity and Mortality Weekly Report2005;54(RR-8):1-40.">ACIP 2005</a>; <a href="./references#CD004876-bbs2-0368" title="Centers for Disease Control and Prevention. Updated interim influenza vaccination recommendations: 2004-2005 influenza season. www.cdc.gov/flu (accessed 31 December 2004).">CDC 2004</a>). Vaccines containing yearly WHO recommended influenza strains are used worldwide (<a href="./references#CD004876-bbs2-0385" title="GrohskopfLA , SokolowLZ , BroderKR , OlsenSJ , KarronRA , JerniganDB , et al. Prevention and control of seasonal influenza with vaccines. Morbidity and Mortality Weekly Report2016;65(5):1-54. [DOI: 10.15585/mmwr.rr6505a1]">Grohskopf 2016</a>; <a href="./references#CD004876-bbs2-0409" title="TreanorJ . Influenza vaccination. New England Journal of Medicine2016;375(13):1261-8. [DOI: 10.1056/NEJMcp1512870]">Treanor 2016</a>; <a href="./references#CD004876-bbs2-0411" title="World Health Organization. Recommended composition of influenza virus vaccines for use in the 2016-2017 Northern Hemisphere influenza season. Weekly Epidemiological Record2016;91(10):121-32.">WHO 2016</a>). </p> <p>The European Medicines Agency (EMA) recently made changes to the registration of seasonal, pre‐pandemic, and pandemic influenza vaccines (<a href="./references#CD004876-bbs2-0376" title="European Medicine Agency. Guideline on influenza vaccines. Non-clinical and clinical module. European Medicines Agency (www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2014/07/WC500170300.pdf) 2014 (last accessed on May 18, 2017);(EMA/CHMP/VWP/457259/2014).">EMA 2014</a>; <a href="./references#CD004876-bbs2-0412" title="WijnansL , VoordouwB . A review of the changes to the licensing of influenza vaccines in Europe. Influenza and Other Respiratory Viruses2016;10(1):2-8.">Wijnans 2016</a>). Changes were introduced in 2014, triggered by the realisation that antibody responses are not sufficient predictors of field protection, as our reviews have consistently shown over the years. Most of the data for influenza vaccines included in our reviews are from registered vaccines, and yet the field protection afforded is modest or negligible. In addition, the methods of standardisation of antibody titres were lacking. The new rules for adults and elderly require demonstration of non‐inferiority of antibody response (immunogenicity) by a candidate seasonal influenza vaccine compared to an established one. In addition, whenever a demonstration of clinical efficacy is necessary, EMA encourages minimal use of placebo and encourages the use of active controls (such as non‐influenza vaccines) with ILI (and relevant polymerase chain reaction (PCR) results) as a primary endpoint. Clinical effectiveness should be tested by carrying out (preferably prospective) cohort studies or nested so‐called test negative case‐control studies following the European Centre for Disease Prevention and Control protocol (<a href="./references#CD004876-bbs2-0374" title="KisslingE , MorenA , ValencianoM . Protocol for case-control studies to measure pandemic and seasonal influenza vaccine effectiveness in the European Union and European Economic Area Member States. ECDC Technical Document (accessed on 18 May 2017)2009. [WEB: ecdc.europa.eu/en/publications/Publications/0907_TED_Influenza_AH1N1_Measuring_Influenza_Vaccine_Effectiveness_Protocol_Case_Control_Studies.pdf]">ECDC 2009a</a>; <a href="./references#CD004876-bbs2-0375" title="KisslingE , MorenA , ValencianoM . Protocol for cohort database studies to measure pandemic and seasonal influenza vaccine effectiveness in the European Union and European Economic Area Member States. ECDC Technical Document (accessed on 18 May 2017)2009. [WEB: ecdc.europa.eu/en/publications/Publications/0907_TER_Influenza_AH1N1_Measuring_Influenza_Vaccine_Effectiveness_Protocol_Cohort_Database_Studies.pdf]">ECDC 2009b</a>). </p> <p>Harms surveillance is now required with a follow‐up of at least 6 months’ duration and in the general elderly population a database of at least 3000 people exposed to the vaccine. Enhanced vaccine vigilance data should be collected as soon as possible at the beginning of the vaccination campaign each year. </p> </section> <section id="CD004876-sec-0013"> <h3 class="title" id="CD004876-sec-0013">Why it is important to do this review</h3> <p>Due to the unique production cycle of influenza vaccines (they are tested using surrogate outcomes ‐ antibody stimulation ‐ ahead of each influenza 'season'), past performance is probably the only reliable way to predict future performance. </p> <p>An accurate assessment of the effects (efficacy, effectiveness, and safety profile) of influenza vaccines is essential to allow for rational choice between alternative strategies. This review, with its two companion reviews (<a href="./references#CD004876-bbs2-0371" title="DemicheliV , JeffersonT , Al-AnsaryLA , FerroniE , RivettiA , Di PietrantonjC . Vaccines for preventing influenza in healthy adults. Cochrane Database of Systematic Reviews2014, Issue 3. Art. No: CD001269. [DOI: 10.1002/14651858.CD001269.pub5]">Demicheli 2014</a>; <a href="./references#CD004876-bbs2-0398" title="JeffersonT , RivettiA , Di PietrantonjC , DemicheliV , FerroniE . Vaccines for preventing influenza in healthy children. Cochrane Database of Systematic Reviews2012, Issue 8. Art. No: CD004879. [DOI: 10.1002/14651858.CD004879.pub4]">Jefferson 2012</a>), are long‐running reviews. They are among the most consistently accessed in the whole <i>Cochrane Database of Systematic Reviews</i>, confirming the importance of the topic and interest in it. Periodic updates, some stretching back almost two decades, have allowed us to include an increasing number of studies on the effects of influenza vaccines and monitor their impact on our reviews (<a href="#CD004876-tbl-0002">Table 1</a>). </p> <div class="table" id="CD004876-tbl-0002"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Studies included in the various versions of this review and their impact on our conclusions</span></div> <tbody> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Review version (searches date)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Number of included trials (RCTs/CCTs)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Number of included observational studies</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Estimates of effect (RCTs/CCTs only)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Conclusions (1 to 2 lines from abstract)</b> </p> </th> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Version 1</p> <p>(24 May 2006)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>62<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Influenza‐like illness</b> </p> <p>LAIV = no data</p> <p>TIV = 41% (95% CI 27% to 53%)</p> <p>IAV = n.s.</p> <p><b>Influenza</b> </p> <p>LAIV = n.s.</p> <p>TIV = 58% (95% CI 34% to 73%)</p> <p>IAV = n.s.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>In long‐term care facilities, where vaccination is most effective against complications, the aims of the vaccination campaign are fulfilled, at least in part. However, according to reliable evidence the usefulness of vaccines in the community is modest. </p> <p>The apparent high effectiveness of the vaccines in preventing death from all causes may reflect a baseline imbalance in health status and other systematic differences in the 2 groups of participants. </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Version 2</p> <p>(20 January 2010)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>66<sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Influenza‐like illness</b> </p> <p>LAIV = no data</p> <p>TIV = 41% (95% CI 27% to 53%)</p> <p>IAV = n.s.</p> <p><b>Influenza</b> </p> <p>LAIV = n.s.</p> <p>TIV = 58% (95% CI 34% to 73%)</p> <p>IAV = n.s.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The available evidence is of poor quality and provides no guidance regarding the safety, efficacy, or effectiveness of influenza vaccines for people aged 65 years or older. To resolve the uncertainty, an adequately powered publicly‐funded randomised, placebo‐controlled trial run over several seasons should be undertaken. </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><sup>1</sup>These include 49 cohort studies for efficacy/effectiveness (79 data sets); 10 case‐control studies for efficacy/effectiveness (12 data sets); 3 studies (cohorts) for Guillain‐Barré syndrome.<br/><sup>2</sup>For this update, two cohort studies and two case‐control studies were added to the review (all assessing efficacy/effectiveness). </p> <p>Key: CCT = controlled clinical trial; CI = confidence interval; IAV = inactivated aerosol vaccines; LAIV = live attenuated vaccines; n.s. = not significant; RCT = randomised controlled trial; TIV = trivalent inactivated vaccines </p> </div> </div> <p>The reviews are not methodologically homogeneous, as their methods reflect the history and development of Cochrane Reviews. In particular, the inclusion of observational studies, which was initially favoured for the assessment of harms, has been a source of discussion. In the elderly, randomised evidence represents 11% of included studies because no eligible trials have been completed in the past three decades, while numerous observational studies are completed each year. </p> <p>Historically, observational studies have been of poor methodological quality, often reporting conflicting or paradoxical results, preventing the drawing of firm conclusions. However, inclusion of particular study types and increasing size of the data sets has not led to a change in the conclusion of the reviews, while leading to a greatly increased workload. This is the main reason why the authors, the review group, and the Cochrane editors have decided to stabilise all three reviews, that is to not carry out routine updates of the observational data set and to update the randomised data set if certain conditions are fulfilled in the future. </p> <p>For the same reason, the observational content of this review and its companions have been retained as historical evidence of the life cycle of the reviews. </p> <p>We plan to update the randomised evidence in this review if any or all of the following conditions are fulfilled in the future: </p> <p> <ul id="CD004876-list-0002"> <li> <p>a trial assessing the clinical effects of the evolution of current technologies becomes available; </p> </li> <li> <p>a new type of vaccine is developed; or</p> </li> <li> <p>a new credible causal paradigm for influenza is put forward.</p> </li> </ul> </p> <p>For an overview of the three reviews, see the covering editorial at <a href="https://community.cochrane.org/news/why-have-three-long-running-cochrane-reviews-influenza-vaccines-been-stabilised" target="_blank">https://community.cochrane.org/news/why-have-three-long-running-cochrane-reviews-influenza-vaccines-been-stabilised</a>. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD004876-sec-0014" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD004876-sec-0014"></div> <p>To assess the effects (efficacy, effectiveness, and harm) of vaccines against influenza in the elderly. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD004876-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD004876-sec-0015"></div> <section id="CD004876-sec-0016"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD004876-sec-0017"> <h4 class="title">Types of studies</h4> <p>We considered randomised controlled trials (RCTs) or quasi‐RCTs. We have not sought new cohort and case‐control studies for the update of this review, but we have retained the data from previous versions for historical reasons. For study design definitions, see <a href="./appendices#CD004876-sec-0091">Appendix 1</a>. </p> </section> <section id="CD004876-sec-0018"> <h4 class="title">Types of participants</h4> <p>Elderly participants aged 65 years or older, irrespective of setting. We excluded studies assessing efficacy in selected groups affected by a specific chronic pathology (i.e. diabetes or cardiac disease), as we were interested in the whole population. The question of whether these vaccines are effective in specific at‐risk populations is the topic of other reviews. </p> </section> <section id="CD004876-sec-0019"> <h4 class="title">Types of interventions</h4> <p> <ol id="CD004876-list-0003"> <li> <p>Vaccination with any influenza vaccine given independently, in any dose, preparation, or time schedule, compared with placebo or with no intervention. </p> </li> <li> <p>We also considered new, as yet unlicensed vaccine types (e.g. live attenuated and DNA vaccines). </p> </li> <li> <p>Vaccination of staff in order to protect patients and residents admitted into hospitals, nursing homes, and long‐term care facilities has been assessed by a separate review (<a href="./references#CD004876-bbs2-0408" title="ThomasRE , JeffersonT , LassersonTJ . Influenza vaccination for healthcare workers who work with the elderly. Cochrane Database of Systematic Reviews2010, Issue 2. Art. No: CD005187. [DOI: 10.1002/14651858.CD005187.pub2]">Thomas 2010</a>). </p> </li> <li> <p>We excluded studies in which a vaccine was administered after the beginning of the epidemic period. </p> </li> <li> <p>We excluded old oil adjuvant vaccine or vaccines with a content greater than 15 µg of haemagglutinin/strain/dose from the safety assessment. </p> </li> </ol> </p> </section> <section id="CD004876-sec-0020"> <h4 class="title">Types of outcome measures</h4> <section id="CD004876-sec-0021"> <h5 class="title">Primary outcomes</h5> <section id="CD004876-sec-0022"> <h6 class="title">For treatment efficacy and effectiveness</h6> <p>We included outcomes occurring within the epidemic period (the six‐month winter period, if not better specified). When trial authors presented data according to different levels of viral circulation, we only included data restricted to higher viral circulation. </p> <p> <ol id="CD004876-list-0004"> <li> <p>Cases of influenza, laboratory‐confirmed (by means of viral isolation, serological supporting evidence), or both. </p> </li> <li> <p>Cases of influenza, clinically defined from a list of likely respiratory and systemic signs and symptoms. We accepted the trial authors' definition of clinical illness because some countries have their own official definition. </p> </li> <li> <p>Cases of influenza (as defined above) admitted to hospital.</p> </li> <li> <p>Deaths (total).</p> </li> <li> <p>Deaths due to influenza (as defined above) or to its complications.</p> </li> <li> <p>Other direct or indirect indicator of disease impact: pneumonia; hospitalisation due to any respiratory disease, and hospitalisation due to heart disease. </p> </li> </ol> </p> <p>We excluded studies with generic outcomes (e.g. deaths from all causes) and long‐term (one‐year) follow‐up, as most illnesses were most likely due to causes other than influenza. We excluded studies reporting only serological outcomes. </p> </section> </section> <section id="CD004876-sec-0023"> <h5 class="title">Secondary outcomes</h5> <section id="CD004876-sec-0024"> <h6 class="title">For adverse events</h6> <p> <ol id="CD004876-list-0005"> <li> <p>Local events for aerosol vaccines (upper respiratory tract infection symptoms such as cough, coryza, sore throat, and hoarseness) within seven days of vaccination. </p> </li> <li> <p>Local events for parenteral vaccines (tenderness/soreness, erythema, induration, and arm stiffness) within seven days from vaccination. </p> </li> <li> <p>Systemic events (myalgia, fever, headache, fatigue, indisposition, rash, angioedema, and asthma) within seven days from vaccination. </p> </li> <li> <p>Rare events (thrombocytopenia, neurological disorders, and Guillain‐Barré syndrome.</p> </li> </ol> </p> </section> </section> </section> </section> <section id="CD004876-sec-0025"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD004876-sec-0026"> <h4 class="title">Electronic searches</h4> <p>For this 2016 update we searched the Cochrane Central Register of Controlled Trials (CENTRAL; 2016, Issue 11, searched 31 December 2016 via the Cochrane Library), which contains the Cochrane Acute Respiratory Infections Group's Specialised Register; MEDLINE (Ovid) (1966 to 31 December 2016); Embase (Elsevier) (1974 to 31 December 2016); Web of Science (Thomson Reuters) (1974 to 31 December 2016); Cumulative Index to Nursing and Allied Health Literature (CINAHL) (EBSCO) (1981 to 31 December 2016); Latin American and Caribbean Health Sciences Information Database (LILACS) (Bireme) (1982 to 31 December 2016); World Health Organization International Clinical Trials Registry Platform (WHO ICTRP; <a href="http://www.who.int/ictrp/en" target="_blank">www.who.int/ictrp/en</a>, 1 July 2017); and ClinicalTrials.gov (<a href="http://www.clinicaltrials.gov" target="_blank">www.clinicaltrials.gov</a>, 1 July 2017). </p> <p>The MEDLINE search (<a href="./appendices#CD004876-sec-0092">Appendix 2</a>) was combined with the Cochrane Highly Sensitive Search Strategy for identifying randomised trials in MEDLINE: sensitivity‐ and precision‐maximising version (2008) revision; Ovid format (<a href="./references#CD004876-bbs2-0400" title="LefebvreC , ManheimerE , GlanvilleJ . Chapter 6: Searching for studies. In: HigginsJP , GreenS , editors(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.">Lefebvre 2011</a>), and these search terms were adapted to search Embase (<a href="./appendices#CD004876-sec-0093">Appendix 3</a>), Web of Science (<a href="./appendices#CD004876-sec-0094">Appendix 4</a>), CINAHL (<a href="./appendices#CD004876-sec-0095">Appendix 5</a>), LILACS (<a href="./appendices#CD004876-sec-0096">Appendix 6</a>), WHO ICTRP (<a href="./appendices#CD004876-sec-0097">Appendix 7</a>), and ClinicalTrials.gov (<a href="./appendices#CD004876-sec-0097">Appendix 7</a>). </p> <p>There were no language or publication restrictions.</p> </section> <section id="CD004876-sec-0027"> <h4 class="title">Searching other resources</h4> <p>The 2016 update included searches of the databases just listed to identify trials only. For details of other resources searched for previous versions of the review, see <a href="./appendices#CD004876-sec-0098">Appendix 8</a>. </p> </section> </section> <section id="CD004876-sec-0028"> <h3 class="title" id="CD004876-sec-0028">Data collection and analysis</h3> <section id="CD004876-sec-0029"> <h4 class="title">Selection of studies</h4> <p>Two review authors (TOJ, EF) independently applied inclusion criteria to all identified and retrieved articles. </p> </section> <section id="CD004876-sec-0030"> <h4 class="title">Data extraction and management</h4> <p>Two review authors (EF and LAA) independently performed data extraction using a data extraction form (<a href="./appendices#CD004876-sec-0100">Appendix 9</a>). Two review authors (TOJ, CDP) checked data and entered the data into Review Manager 5 (<a href="./references#CD004876-bbs2-0406" title="Nordic Cochrane Centre, The Cochrane CollaborationReview Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.">RevMan 2014</a>). </p> <p>We extracted data on the following.</p> <p> <ol id="CD004876-list-0006"> <li> <p>Methodological quality of studies</p> </li> <li> <p>Study design (<a href="./appendices#CD004876-sec-0091">Appendix 1</a>) </p> </li> <li> <p>Description of setting</p> </li> <li> <p>Characteristics of participants</p> </li> <li> <p>Description of vaccines (content and antigenic match)</p> </li> <li> <p>Description of viral circulation degree</p> </li> <li> <p>Description of outcomes</p> </li> <li> <p>Length of follow‐up</p> </li> <li> <p>Publication status</p> </li> <li> <p>Date of study</p> </li> <li> <p>Location of study</p> </li> </ol> </p> </section> <section id="CD004876-sec-0031"> <h4 class="title">Assessment of risk of bias in included studies</h4> <section id="CD004876-sec-0032"> <h5 class="title">Experimental studies</h5> <p>All review authors independently assessed the methodological quality of the included studies using criteria from the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD004876-bbs2-0389" title="HigginsJP , Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.">Higgins 2011</a>), and results were introduced into the sensitivity analysis. </p> <p>We classified studies according to the following criteria.</p> <section id="CD004876-sec-0033"> <h6 class="title">Randomisation</h6> <p>A = individual participants allocated to vaccine or control group.<br/>B = groups of participants allocated to vaccine or control group. </p> </section> <section id="CD004876-sec-0034"> <h6 class="title">Generation of the allocation sequence</h6> <p>A = adequate, e.g. table of random numbers or computer‐generated random numbers.<br/>B = inadequate, e.g. alternation, date of birth, day of the week, or case record number.<br/>C = not described. </p> </section> <section id="CD004876-sec-0035"> <h6 class="title">Allocation concealment</h6> <p>A = adequate, e.g. numbered or coded identical containers administered sequentially, on‐site computer system that can only be accessed after entering the characteristics of an enrolled participant, or serially numbered, opaque, sealed envelopes.<br/>B = possibly adequate, e.g. sealed envelopes that are not sequentially numbered or opaque.<br/>C = inadequate, e.g. open table of random numbers.<br/>D = not described. </p> </section> <section id="CD004876-sec-0036"> <h6 class="title">Blinding</h6> <p>A = adequate double‐blinding, e.g. placebo vaccine.<br/>B = single‐blind, e.g. blinded outcome assessment.<br/>C = no blinding. </p> </section> <section id="CD004876-sec-0037"> <h6 class="title">Follow‐up</h6> <p>Average duration of follow‐up and number of losses to follow‐up.</p> </section> </section> <section id="CD004876-sec-0038"> <h5 class="title">Non‐experimental studies</h5> <p>In previous versions of this review we carried out quality assessment of non‐RCTs in relation to the presence of potential confounders that could make interpretation of the results difficult. We evaluated the quality of case‐control and cohort studies (prospective and retrospective) using the appropriate Newcastle‐Ottawa Scales (NOS) (<a href="./appendices#CD004876-sec-0110">Appendix 10</a>). Due to the lack of empirical evidence on the impact that the methodological quality has on the results of non‐RCTs, this evaluation was only used at the analysis stage as a mean of interpretation of the results, and a set of sensitivity analyses was performed for this scope. We classified studies as at low risk of bias (up to one inadequate item in the NOS), medium risk of bias (up to three inadequate items), high risk of bias (more than three inadequate items), and very high risk of bias (when there was no description of methods). </p> <p>In case of disagreement between the review authors, TOJ arbitrated.</p> </section> </section> <section id="CD004876-sec-0039"> <h4 class="title">Measures of treatment effect</h4> <p>We summarised efficacy (against influenza) and effectiveness (against influenza‐like illness) estimates as risk ratio (RR) (using a 95% confidence interval (CI)) or odds ratio (OR) (using a 95% CI). Absolute vaccine efficacy (VE) is expressed as a proportion, using the formula VE = 1 ‐ RR or VE = 1 ‐ OR whenever significant. When not significant, we reported the relevant RR or OR. </p> <p>We have calculated the number needed to vaccinate (NNV) as the reciprocal of the risk difference. Rather than use the pooled risk difference, we have multiplied an illustrative control group risk by the RR to generate a difference in risk. </p> </section> <section id="CD004876-sec-0040"> <h4 class="title">Unit of analysis issues</h4> <p>We identified no studies with a cluster design, and no studies contributed more than one treatment comparison to the analyses. </p> </section> <section id="CD004876-sec-0041"> <h4 class="title">Dealing with missing data</h4> <p>In earlier versions of the review, we considered contacting the first or corresponding author of the study to request missing data whenever we identified non‐reporting or partial reporting of data. This proved to be a major task with few returns. It was not carried out for this update as we are stabilising this review, that is we will update the randomised data set if certain conditions are fulfilled in the future. </p> </section> <section id="CD004876-sec-0042"> <h4 class="title">Assessment of heterogeneity</h4> <p>We calculated the I<sup>2</sup> statistic for every pooled estimate to assess the effect on statistical heterogeneity. The I<sup>2</sup> statistic can be interpreted as the proportion of total variation among effect estimates that is due to heterogeneity rather than sampling error, and it is intrinsically independent of the number of studies. When the I<sup>2</sup> statistic is less than 30%, there is little concern about statistical heterogeneity (<a href="./references#CD004876-bbs2-0387" title="HigginsJP , ThompsonSG . Quantifying heterogeneity in a meta-analysis. Statistics in Medicine2002;21(11):1539-58.">Higgins 2002</a>; <a href="./references#CD004876-bbs2-0388" title="HigginsJP , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta-analyses. BMJ2003;327(7414):557-60.">Higgins 2003</a>). </p> </section> <section id="CD004876-sec-0043"> <h4 class="title">Assessment of reporting biases</h4> <p>Prior to the 2010 update, we carried out a complete re‐extraction of all studies and reassessed their methodological quality. We also assessed concordance between data presented and conclusions and direction of conclusions (in favour or not of the performance of influenza vaccines). We also looked at the relationship between these variables and study funding and journal of publication (see 'Potential biases in the review process' in the <a href="#CD004876-sec-0079">Discussion</a> and <a href="./references#CD004876-bbs2-0397" title="JeffersonT , Di PietrantonjC , DebaliniMG , RivettiA , DemicheliV . Study  quality, concordance, take home message, funding and impact: their relationship in influenza vaccines studies. BMJ2009;338:b354. [DOI: 10.1136/bmj.b354 ]">Jefferson 2009b</a>). </p> </section> <section id="CD004876-sec-0044"> <h4 class="title">Data synthesis</h4> <p>Aggregation of data was dependent on the sensitivity and homogeneity of definitions of exposure, populations, and outcomes used. Where we found studies to be homogenous, we carried out a meta‐analysis of these studies within each design category. We pooled whole, split, and subunit vaccines, as in community studies this information was not reported. When a study reported data for more than one influenza season or for more than one setting, we considered these separately, creating separate data sets. Within the data sets, we used the term 'observation' to describe an occurrence (i.e. a particular outcome such as fever) and not number of participants, as multiple outcomes were sometimes recorded for the same participant. We used random‐effects models throughout to take account of the between‐study variance in our findings (<a href="./references#CD004876-bbs2-0372" title="DerSimonianR , LairdN . Meta-analysis in clinical trials. Controlled Clinical Trials1986;7(3):177-88.">DerSimonian 1986</a>). </p> <p>We analysed non‐RCT separately from RCT evidence.</p> <p>We grouped reports first according to the setting of the study (community or long‐term care facilities) and then by level of viral circulation and vaccine matching (when trial authors presented data according to different levels of viral circulation, we included only data relating to higher viral circulation). We considered a period 'epidemic' when the weekly incidence rate exceeded the seasonal threshold. A vaccine was defined as 'matching' when the vaccine strains were antigenically similar to the wild circulating strains. We further stratified by co‐administration of pneumococcal polysaccharide vaccine (PPV) and by different types of influenza vaccines (live, inactivated, with adjuvant). </p> <p>Wherever possible, we performed a quantitative analysis adjusted for confounders if the cohort or case‐control studies used the same methods of adjustment (logistic regression) for the same confounders (sex, age, smoking, and comorbidities). We constructed a comparison with effect sizes adjusted for the effects of possible known confounders and their standard error, which we derived from the reported confidence intervals (<a href="./references#CD004876-bbs2-0382" title="GreenlandS . Quantitative methods in the review of epidemiologic literature. Epidemiologic Reviews1987;9:1-30.">Greenland 1987</a>), and performed quantitative analysis with the inverse of the variance (<a href="./references#CD004876-bbs2-0389" title="HigginsJP , Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.">Higgins 2011</a>). </p> <p>We included the findings of one case‐control study reporting data stratified by risk factors for influenza by use of the inverse variance combining stratum‐specific effect size and overall effect size (<a href="./references#CD004876-bbs2-0074" title="MulloolyJP , BennettMD , HornbrookMC , BarkerWH , WilliamsWW , PatriarcaPA , et al. Influenza vaccination programs for elderly persons: cost-effectiveness in a health maintenance organization. Annals of Internal Medicine1994;121(12):947-52. ">Mullooly 1994</a>). </p> </section> <section id="CD004876-sec-0045"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We did a further analysis to investigate the causes of heterogeneity. To assess the effect of viral circulation and vaccine matching on overall heterogeneity, we calculated heterogeneity within each grouping and compared its sum with the overall heterogeneity (<a href="./references#CD004876-bbs2-0382" title="GreenlandS . Quantitative methods in the review of epidemiologic literature. Epidemiologic Reviews1987;9:1-30.">Greenland 1987</a>). </p> </section> <section id="CD004876-sec-0046"> <h4 class="title">Sensitivity analysis</h4> <p>We performed a subanalysis of studies describing a better defined epidemic period for most significant comparisons. We then tested effect size from cohort studies conducted in long‐term care facilities (where data are more plentiful), stratified by methodological quality of the studies. </p> </section> <section id="CD004876-sec-0047"> <h4 class="title">Summary of findings and assessment of the certainty of the evidence</h4> <p>We created a <a href="./full#CD004876-tbl-0001">summary of findings Table 1</a> using the following outcomes: influenza, ILI, pneumonia, hospitalisation, all deaths, fever, and nausea<i>.</i> We used the five GRADE considerations (study limitations, consistency of effect, imprecision, indirectness, and publication bias) to assess the quality of a body of evidence as it relates to the studies that contributed data to the meta‐analyses for the prespecified outcomes (<a href="./references#CD004876-bbs2-0365" title="AtkinsD , BestD , BrissPA , EcclesM , Falck-YtterY , FlottorpS , et al, GRADE Working Group. Grading quality of evidence and strength of recommendations. BMJ2004;328(7454):1490.">Atkins 2004</a>). We used methods and recommendations described in Section 8.5 and Chapter 12 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD004876-bbs2-0389" title="HigginsJP , Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.">Higgins 2011</a>), employing GRADEpro GDT software (<a href="./references#CD004876-bbs2-0381" title="GRADE Working Group, McMaster UniversityGRADEpro GDT. Hamilton (ON): GRADE Working Group, McMaster University, 2014.">GRADEpro GDT 2014</a>). We justified all decisions to down‐ or upgrade the quality of studies using footnotes, and made comments to aid readers’ understanding of the review where necessary. We have restricted our focus in the 'Summary of findings' table to evidence from randomised studies comparing influenza vaccine with placebo, which was the most commonly adopted strategy. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD004876-sec-0048" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD004876-sec-0048"></div> <section id="CD004876-sec-0049"> <h3 class="title">Description of studies</h3> <section id="CD004876-sec-0050"> <h4 class="title">Results of the search</h4> <p>In the first publication of this review (<a href="./references#CD004876-bbs2-0415" title="RivettiD , JeffersonT , ThomasR , RudinM , RivettiA , Di PietrantonjC , et al. Vaccines for preventing influenza in the elderly. Cochrane Database of Systematic Reviews2006, Issue 3. Art. No: CD004876. [DOI: 10.1002/14651858.CD004876.pub2]">Rivetti 2006</a>), we identified 4400 titles of reports of potentially relevant studies and screened these for retrieval. We excluded 4088 reports by screening titles and abstracts and retrieved 312 reports for detailed assessment; 241 reports did not fulfil our inclusion criteria. </p> <p>In the 2010 review update (<a href="./references#CD004876-bbs2-0416" title="JeffersonT , Di PietrantonjC , Al-AnsaryLA , Ferroni, ThorningS , ThomasRE . Vaccines for preventing influenza in the elderly. Cochrane Database of Systematic Reviews2010, Issue 2. Art. No: CD004876. [DOI: 10.1002/14651858.CD004876.pub2]">Rivetti 2010</a>), we identified 1435 reports of potentially relevant studies. We retrieved 18 studies for further evaluation; we included four and excluded 14 for various reasons. We identified two case‐control studies, <a href="./references#CD004876-bbs2-0052" title="JordanRE , HawkerJI , AyresJG , TunnicliffeW , AdabP , OlowokureB , et al. A case-control study of elderly patients with acute respiratory illness: effect of influenza vaccination on admission to hospital in winter 2003-2004. Vaccine2007;25(46):7909-13. ">Jordan 2007</a> and <a href="./references#CD004876-bbs2-0094" title="Puig-BarberàJ , Díez-DomingoJ , VareaAB , ChavarriGS , RodrigoJA , Hoyos SP et al. Effectiveness of MF59-adjuvanted subunit influenza vaccine in preventing hospitalisations for cardiovascular disease, cerebrovascular disease and pneumonia in the elderly. Vaccine2007;25(42):7313-21. ">Puig‐Barbera 2007</a>, and two cohort studies, <a href="./references#CD004876-bbs2-0044" title="HaraM , SakamotoT , TanakaK . Effectiveness of influenza vaccination in preventing influenza-like illness among community-dwelling elderly: population-based cohort study in Japan. Vaccine2006;24(27-8):5546-51. ">Hara 2006</a> and <a href="./references#CD004876-bbs2-0057" title="LeungJCK . Effectiveness of influenza vaccination among elderly home residents in Hong Kong: a retrospective cohort study. Hong Kong Practitioner2007;29(4):123-33. ">Leung 2007</a>, fulfilling the inclusion criteria. </p> <p>For this 2016 update we did not identify new randomised evidence.</p> </section> <section id="CD004876-sec-0051"> <h4 class="title">Included studies</h4> <p>We included 75 studies in previous versions of the review: 68 studies were used to assess efficacy/effectiveness, and 8 were included in the safety assessment (one RCT was included in both assessments). See <a href="#CD004876-fig-0001">Figure 1</a> for study flow. </p> <div class="figure" id="CD004876-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow. We identified no new randomised controlled trials for the 2016 update and stabilisation." data-id="CD004876-fig-0001" src="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-FIG-01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow. We identified no new randomised controlled trials for the 2016 update and stabilisation. </p> </div> </div> </div> <p>The 65 studies included in the efficacy/effectiveness assessment were split into subsets by influenza season or setting or vaccine type, resulting in 100 data sets. </p> <p>We identified eight published RCTs published over four decades involving just over 5000 participants (<a href="./references#CD004876-bbs2-0003" title="AllsupS , HaycoxA , ReganM , GosneyM . Is influenza vaccination cost effective for healthy people between ages 65 and 74 years? A randomised controlled trial. Vaccine2004;23(5):639-45. ">Allsup 2004</a>; <a href="./references#CD004876-bbs2-0028" title="Edmondson WP Jr, RothenbergR , WhitePW , Gwaltney JM Jr. A comparison of subcutaneous, nasal, and combined influenza vaccination. II. Protection against natural challenge. American Journal of Epidemiology1971;93(6):480-6. ">Edmondson 1971</a>; <a href="./references#CD004876-bbs2-0039" title="GovaertTM , DinantGJ , AretzK , MasurelN , SprengerMJ , KnottnerusJA . Adverse reactions to influenza vaccine in elderly people: randomised double blind placebo controlled trial. BMJ1993;307(6910):988-90. ">Govaert 1993</a>; <a href="./references#CD004876-bbs2-0040" title="GovaertTM , ThijsCT , MasurelN , SprengerMJ , DinantGJ , KnottnerusJA . The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial. JAMA1994;272(21):1661-5. ">Govaert 1994a</a>; <a href="./references#CD004876-bbs2-0055" title="KeitelWA , CateTR , AtmarRL , TurnerCS , NinoD , DukesCM , et al. Increasing doses of purified influenza virus hemagglutinin and subvirion vaccines enhance antibody responses in the elderly. Clinical and Diagnostic Laboratory Immunology1996;3(5):507-10. ">Keitel 1996</a>; <a href="./references#CD004876-bbs2-0069" title="MargolisKL , NicholKL , PolandGA , PluharRE . Frequency of adverse reactions to influenza vaccine in the elderly. A randomized, placebo-controlled trial. JAMA1990;264(9):1139-41. ">Margolis 1990a</a>; <a href="./references#CD004876-bbs2-0096" title="RudenkoLG , ArdenNH , GrigorievaE , NaychinA , RekstinA , KlimovAI , et al. Immunogenicity and efficacy of Russian live attenuated and US inactivated influenza vaccines used alone and in combination in nursing home residents. Vaccine2000;19(2-3):308-18. ">Rudenko 2001</a>; <a href="./references#CD004876-bbs2-0105" title="StuartWH , DullHB , NewtonLH , McQueenJL , SchiffER . Evaluation of monovalent influenza vaccine in a retirement community during the epidemic of 1965-66. JAMA1969;209(2):232-8. ">Stuart 1969</a>; <a href="./references#CD004876-bbs2-0107" title="TreanorJ , DumyatiG , O'BrienD , RileyMA , RileyG , ErbS , et al. Evaluation of cold-adapted, reassortant influenza B virus vaccines in elderly and chronically ill adults. Journal of Infectious Diseases1994;169(2):402-7. ">Treanor 1994</a>). Four of these RCTs only reported safety outcomes (<a href="./references#CD004876-bbs2-0039" title="GovaertTM , DinantGJ , AretzK , MasurelN , SprengerMJ , KnottnerusJA . Adverse reactions to influenza vaccine in elderly people: randomised double blind placebo controlled trial. BMJ1993;307(6910):988-90. ">Govaert 1993</a>; <a href="./references#CD004876-bbs2-0055" title="KeitelWA , CateTR , AtmarRL , TurnerCS , NinoD , DukesCM , et al. Increasing doses of purified influenza virus hemagglutinin and subvirion vaccines enhance antibody responses in the elderly. Clinical and Diagnostic Laboratory Immunology1996;3(5):507-10. ">Keitel 1996</a>; <a href="./references#CD004876-bbs2-0069" title="MargolisKL , NicholKL , PolandGA , PluharRE . Frequency of adverse reactions to influenza vaccine in the elderly. A randomized, placebo-controlled trial. JAMA1990;264(9):1139-41. ">Margolis 1990a</a>; <a href="./references#CD004876-bbs2-0107" title="TreanorJ , DumyatiG , O'BrienD , RileyMA , RileyG , ErbS , et al. Evaluation of cold-adapted, reassortant influenza B virus vaccines in elderly and chronically ill adults. Journal of Infectious Diseases1994;169(2):402-7. ">Treanor 1994</a>). </p> <p>Fifty‐one cohort studies resulted in 80 data sets (<a href="./references#CD004876-bbs2-0004" title="ArdenNH , PatriarcaPA , FasanoMB , LuiKJ , HarmonMW , KendalAP , et al. The roles of vaccination and amantadine prophylaxis in controlling an outbreak of influenza A (H3N2) in a nursing home. Archives of Internal Medicine1988;148(4):865-8. ">Arden 1988</a>; <a href="./references#CD004876-bbs2-0005" title="ArroyoJC , PosticB , BrownA , HarrisonK , BirgenheierR , DowdaH . Influenza A/Philippines/2/82 outbreak in a nursing home: limitations of influenza vaccination in the aged. American Journal of Infection Control1984;12(6):329-34. ">Arroyo 1984</a>; <a href="./references#CD004876-bbs2-0006" title="AymardM , BentejacMC , LarbaigtG , MichautD , TriauR . Efficacy of the antiinfluenza A vaccination during epidemics due to A/VIC/3/75 and A/Texas/1/77 viruses. Developments in Biological Standardization1979;43:231-9. ">Aymard 1979a</a>; <a href="./references#CD004876-bbs2-0007" title="AymardM , BentejacMC , LarbaigtG , MichautD , TriauR . Efficacy of the antiinfluenza A vaccination during epidemics due to A/VIC/3/75 and A/Texas/1/77 viruses. Developments in Biological Standardization1979;43:231-9. ">Aymard 1979b</a>; <a href="./references#CD004876-bbs2-0008" title="CaminitiC , RiccoD , TanziML , BorriniB , CorselloA , BiasioLR , et al. Field evaluation of influenza vaccine efficacy in a population of institutionalized elderly. L’igiene Moderna1994;101(2):163-75. ">Caminiti 1994</a>; <a href="./references#CD004876-bbs2-0009" title="CartterML , RenzulloPO , HelgersonSD , MartinSM , JekelJF . Influenza outbreaks in nursing homes: how effective is influenza vaccine in the institutionalized elderly?Infection Control and Hospital Epidemiology1990;11(9):473-8. ">Cartter 1990a</a>; <a href="./references#CD004876-bbs2-0010" title="CartterML , RenzulloPO , HelgersonSD , MartinSM , JekelJF . Influenza outbreaks in nursing homes: how effective is influenza vaccine in the institutionalized elderly?Infection Control and Hospital Epidemiology1990;11(9):473-8. ">Cartter 1990b</a>; <a href="./references#CD004876-bbs2-0011" title="CartterML , RenzulloPO , HelgersonSD , MartinSM , JekelJF . Influenza outbreaks in nursing homes: how effective is influenza vaccine in the institutionalized elderly?Infection Control and Hospital Epidemiology1990;11(9):473-8. ">Cartter 1990c</a>; <a href="./references#CD004876-bbs2-0012" title="ChristensonB , LundberghP , HedlundJ , OrtqvistA . Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in adults aged 65 years or older: a prospective study. Lancet2001;357(9261):1008-11. ">Christenson 2001a</a>; <a href="./references#CD004876-bbs2-0013" title="ChristensonB , LundberghP , HedlundJ , OrtqvistA . Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in adults aged 65 years or older: a prospective study. Lancet2001;357(9261):1008-11. ">Christenson 2001b</a>; <a href="./references#CD004876-bbs2-0014" title="ChristensonB , HedlundJ , LundberghP , OrtqvistA . Additive preventive effect of influenza and pneumococcal vaccines in elderly persons. European Respiratory Journal2004;23(3):363-8. ">Christenson 2004a</a>; <a href="./references#CD004876-bbs2-0015" title="ChristensonB , HedlundJ , LundberghP , OrtqvistA . Additive preventive effect of influenza and pneumococcal vaccines in elderly persons. European Respiratory Journal2004;23(3):363-8. ">Christenson 2004b</a>; <a href="./references#CD004876-bbs2-0016" title="ColesFB , BalzanoGJ , MorseDL . An outbreak of influenza A (H3N2) in a well immunized nursing home population. Journal of the American Geriatrics Society1992;40(6):589-92. ">Coles 1992</a>; <a href="./references#CD004876-bbs2-0017" title="ComeriL , TinellaM , CroceE , ArzeseM . Protective efficacy of antiinfluenza vaccination in the elderly. L’igiene Moderna1995;103(6):651-6. ">Comeri 1995</a>; <a href="./references#CD004876-bbs2-0018" title="ConsonniS , SandriniC , SegatoE , PerruchiniE , BergamaschiniL , VerganiC . Tolerability and efficacy of anti-influenza vaccination alone and associated with antipneumococcal vaccination in an elderly ambulatory population and adherence to the vaccination campaign. Journal of Preventive Medicine and Hygiene2004;45:45-50. ">Consonni 2004a</a>; <a href="./references#CD004876-bbs2-0019" title="ConsonniS , SandriniC , SegatoE , PerruchiniE , BergamaschiniL , VerganiC . Tolerability and efficacy of anti-influenza vaccination alone and associated with antipneumococcal vaccination in an elderly ambulatory population and adherence to the vaccination campaign. Journal of Preventive Medicine and Hygiene2004;45:45-50. ">Consonni 2004b</a>; <a href="./references#CD004876-bbs2-0021" title="Cuneo CrovariP , GaspariniR , CrovariP . Efficacy of influenza vaccination: results in a community controlled for 2 years. Bollettino dell’Istituto Sieroterapico Milanese1980;59(4):306-13. ">Cuneo Crovari 1980</a>; <a href="./references#CD004876-bbs2-0022" title="CurrierM , CoffmanT , BoydP , FremdB , IsraelE . Influenza vaccine efficacy in a Maryland nursing home. Maryland Medical Journal1988;37(10):781-3. ">Currier 1988</a>; <a href="./references#CD004876-bbs2-0023" title="D'AlessioDJ , Cox PM Jr, DickEC . Failure of inactivated influenza vaccine to protect an aged population. JAMA1969;210(3):485-9. ">D'Alessio 1969</a>; <a href="./references#CD004876-bbs2-0024" title="DavisJW , LeeE , TairaDA , ChungRS . Influenza vaccination, hospitalizations, and costs among members of a Medicare managed care plan. Medical Care2001;39(12):1273-80. ">Davis 2001a</a>; <a href="./references#CD004876-bbs2-0025" title="DavisJW , LeeE , TairaDA , ChungRS . Influenza vaccination, hospitalizations, and costs among members of a Medicare managed care plan. Medical Care2001;39(12):1273-80. ">Davis 2001b</a>; <a href="./references#CD004876-bbs2-0027" title="DeguchiY , NishimuraK . Efficacy of influenza vaccine in elderly persons in welfare nursing homes: reduction in risks of mortality and morbidity during an influenza A (H3N2) epidemic. Journals of Gerontology. Series A, Biological Sciences and Medical Sciences2001;56(6):M391-4. ">Deguchi 2001</a>; <a href="./references#CD004876-bbs2-0031" title="FeeryBJ , EveredMG , MorrisonEI . Different protection rates in various groups of volunteers given subunit influenza virus vaccine in 1976. Journal of Infectious Diseases1979;139(2):237-41. ">Feery 1976</a>; <a href="./references#CD004876-bbs2-0032" title="FlemingDM , WatsonJM , NicholasS , SmithGE , SwanAV . Study of the effectiveness of influenza vaccination in the elderly in the epidemic of 1989-90 using a general practice database. Epidemiology and Infection1995;115(3):581-9. ">Fleming 1995</a>; <a href="./references#CD004876-bbs2-0034" title="FysonRE . Influenza outbreaks in two institutions for the elderly - Ontario. Canadian Diseases Weekly Report1983;9:37. ">Fyson 1983a</a>; <a href="./references#CD004876-bbs2-0035" title="FysonRE . Influenza outbreaks in two institutions for the elderly - Ontario. Canadian Diseases Weekly Report1983;9:37. ">Fyson 1983b</a>; <a href="./references#CD004876-bbs2-0036" title="Gavira IglesiasFJ , Rodriguez LopezFC , Berni MaestreRM . Analysis of an influenza vaccination campaign in rural environment. Revista de Sanidad e Higiene Publica1987;61(7-8):759-81. ">Gavira Iglesias 1987</a>; <a href="./references#CD004876-bbs2-0037" title="Gene BadiaJ , Calero MunozS , Castanera RibeC , Gran RoviretaA . Effectiveness of an anti-influenza vaccination program in 4 primary care centers. Gaceta Sanitaria1991;5(26):203-8. ">Gené Badia 1991</a>; <a href="./references#CD004876-bbs2-0038" title="GoodmanRA , OrensteinWA , MunroTF , SmithSC , SikesRK . Impact of influenza A in a nursing home. JAMA1982;247(10):1451-3. ">Goodman 1982</a>; <a href="./references#CD004876-bbs2-0041" title="GrossPA , QuinnanGV , RodsteinM , LaMontagneJR , KaslowRA , SaahAJ , et al. Association of influenza immunization with reduction in mortality in an elderly population. A prospective study. Archives of Internal Medicine1988;148(3):562-5. ">Gross 1988</a>; <a href="./references#CD004876-bbs2-0042" title="HakE , NordinJ , WeiF , MulloolyJ , PobleteS , StrikasR , et al. Influence of high-risk medical conditions on the effectiveness of influenza vaccination among elderly members of 3 large managed-care organizations. Clinical Infectious Diseases2002;35(4):370-7. ">Hak 2002a</a>; <a href="./references#CD004876-bbs2-0043" title="HakE , NordinJ , WeiF , MulloolyJ , PobleteS , StrikasR , et al. Influence of high-risk medical conditions on the effectiveness of influenza vaccination among elderly members of 3 large managed-care organizations. Clinical Infectious Diseases2002;35(4):370-7. ">Hak 2002b</a>; <a href="./references#CD004876-bbs2-0044" title="HaraM , SakamotoT , TanakaK . Effectiveness of influenza vaccination in preventing influenza-like illness among community-dwelling elderly: population-based cohort study in Japan. Vaccine2006;24(27-8):5546-51. ">Hara 2006</a>; <a href="./references#CD004876-bbs2-0045" title="HormanJT , StetlerHC , IsraelE , SorleyD , SchipperMT , JosephJM . An outbreak of influenza A in a nursing home. American Journal of Public Health1986;76(5):501-4. ">Horman 1986</a>; <a href="./references#CD004876-bbs2-0046" title="HowarthDM , ChastonTM , LickissK , WeekesJR , O'DohertyC , FosterRE , et al. Age-related responses to influenza vaccination in the Newcastle region during 1983 and 1984. Medical Journal of Australia1987;146(10):514-7. ">Howarth 1987a</a>; <a href="./references#CD004876-bbs2-0047" title="HowarthDM , ChastonTM , LickissK , WeekesJR , O'DohertyC , FosterRE , et al. Age-related responses to influenza vaccination in the Newcastle region during 1983 and 1984. Medical Journal of Australia1987;146(10):514-7. ">Howarth 1987b</a>; <a href="./references#CD004876-bbs2-0048" title="HowellsCH , Vesselinova-JenkinsCK , EvansAD , JamesJ . Influenza vaccination and mortality from bronchopneumonia in the elderly. Lancet1975;1(7903):381-3. ">Howells 1975a</a>; <a href="./references#CD004876-bbs2-0049" title="HowellsCH , Vesselinova-JenkinsCK , EvansAD , JamesJ . Influenza vaccination and mortality from bronchopneumonia in the elderly. Lancet1975;1(7903):381-3. ">Howells 1975b</a>; <a href="./references#CD004876-bbs2-0050" title="HowellsCH , Vesselinova-JenkinsCK , EvansAD , JamesJ . Influenza vaccination and mortality from bronchopneumonia in the elderly. Lancet1975;1(7903):381-3. ">Howells 1975c</a>; <a href="./references#CD004876-bbs2-0051" title="IsaacsS , DickinsonC , BrimmerG . Outbreak of influenza A in an Ontario nursing home - January 1997. Canada Communicable Disease Report1997;23(14):105-8. ">Isaacs 1997</a>; <a href="./references#CD004876-bbs2-0054" title="KawaiN , IkematsuH , IwakiN , SatohI , KawashimaT , TsuchimotoT , et al. A prospective, internet-based study of the effectiveness and safety of influenza vaccination in the 2001-2002 influenza season. Vaccine2003;21(31):4507-13. ">Kawai 2003</a>; <a href="./references#CD004876-bbs2-0057" title="LeungJCK . Effectiveness of influenza vaccination among elderly home residents in Hong Kong: a retrospective cohort study. Hong Kong Practitioner2007;29(4):123-33. ">Leung 2007</a>; <a href="./references#CD004876-bbs2-0058" title="Lopez HernandezB , VazquezJ , FernandezE , MartinezB , RomeroJ , ArribasL . Effectiveness of anti-flu vaccine in the elderly. Atencion Primaria1994;14(1):532-6. ">Lopez Hernandez 1994</a>; <a href="./references#CD004876-bbs2-0060" title="MangtaniP , CumberlandP , HodgsonCR , RobertsJA , CuttsFT , HallAJ . A cohort study of the effectiveness of influenza vaccine in older people, performed using the United Kingdom general practice research database. Journal of Infectious Diseases2004;190(1):1-10. ">Mangtani 2004b</a>; <a href="./references#CD004876-bbs2-0061" title="MangtaniP , CumberlandP , HodgsonCR , RobertsJA , CuttsFT , HallAJ . A cohort study of the effectiveness of influenza vaccine in older people, performed using the United Kingdom general practice research database. Journal of Infectious Diseases2004;190(1):1-10. ">Mangtani 2004c</a>; <a href="./references#CD004876-bbs2-0062" title="MangtaniP , CumberlandP , HodgsonCR , RobertsJA , CuttsFT , HallAJ . A cohort study of the effectiveness of influenza vaccine in older people, performed using the United Kingdom general practice research database. Journal of Infectious Diseases2004;190(1):1-10. ">Mangtani 2004d</a>; <a href="./references#CD004876-bbs2-0063" title="MangtaniP , CumberlandP , HodgsonCR , RobertsJA , CuttsFT , HallAJ . A cohort study of the effectiveness of influenza vaccine in older people, performed using the United Kingdom general practice research database. Journal of Infectious Diseases2004;190(1):1-10. ">Mangtani 2004e</a>; <a href="./references#CD004876-bbs2-0064" title="MangtaniP , CumberlandP , HodgsonCR , RobertsJA , CuttsFT , HallAJ . A cohort study of the effectiveness of influenza vaccine in older people, performed using the United Kingdom general practice research database. Journal of Infectious Diseases2004;190(1):1-10. ">Mangtani 2004f</a>; <a href="./references#CD004876-bbs2-0065" title="MangtaniP , CumberlandP , HodgsonCR , RobertsJA , CuttsFT , HallAJ . A cohort study of the effectiveness of influenza vaccine in older people, performed using the United Kingdom general practice research database. Journal of Infectious Diseases2004;190(1):1-10. ">Mangtani 2004g</a>; <a href="./references#CD004876-bbs2-0066" title="MangtaniP , CumberlandP , HodgsonCR , RobertsJA , CuttsFT , HallAJ . A cohort study of the effectiveness of influenza vaccine in older people, performed using the United Kingdom general practice research database. Journal of Infectious Diseases2004;190(1):1-10. ">Mangtani 2004h</a>; <a href="./references#CD004876-bbs2-0067" title="MangtaniP , CumberlandP , HodgsonCR , RobertsJA , CuttsFT , HallAJ . A cohort study of the effectiveness of influenza vaccine in older people, performed using the United Kingdom general practice research database. Journal of Infectious Diseases2004;190(1):1-10. ">Mangtani 2004i</a>; <a href="./references#CD004876-bbs2-0068" title="MangtaniP , CumberlandP , HodgsonCR , RobertsJA , CuttsFT , HallAJ . A cohort study of the effectiveness of influenza vaccine in older people, performed using the United Kingdom general practice research database. Journal of Infectious Diseases2004;190(1):1-10. ">Mangtani 2004j</a>; <a href="./references#CD004876-bbs2-0070" title="MeiklejohnG , HallH . Unusual outbreak of influenza A in a Wyoming nursing home. Journal of the American Geriatric Society1987;35(8):742-6. ">Meiklejohn 1987</a>; <a href="./references#CD004876-bbs2-0071" title="MontoAS , HornbuckleK , OhmitSE . Influenza vaccine effectiveness among elderly nursing home residents: a cohort study. American Journal of Epidemiology2001;154(2):155-60. ">Monto 2001</a>; <a href="./references#CD004876-bbs2-0072" title="MorensDM , RashVM . Lessons from a nursing home outbreak of influenza A. Infection Control and Hospital Epidemiology1995;16(5):275-80. ">Morens 1995</a>; <a href="./references#CD004876-bbs2-0073" title="MukerjeeA . Spread of influenza: a study of risk factors in homes for the elderly in Wales. Journal of Epidemiology and Community Health1994;48(6):602-3. ">Mukerjee 1994</a>; <a href="./references#CD004876-bbs2-0075" title="MurayamaN , SuzukiH , ArakawaM , NeromeK , MizutaK , KameyamaK . Two outbreaks of influenza A (H3N2) in a Japanese nursing home in the winter of 1996-1997, with differing vaccine efficacy. Tohoku Journal of Experimental Medicine1999;188(4):289-98. ">Murayama 1999</a>; <a href="./references#CD004876-bbs2-0076" title="NicholKL , MargolisKL , WuorenmaJ , Von SternbergT . The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. New England Journal of Medicine1994;331(12):778-84. ">Nichol 1994a</a>; <a href="./references#CD004876-bbs2-0077" title="NicholKL , MargolisKL , WuorenmaJ , Von SternbergT . The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. New England Journal of Medicine1994;331(12):778-84. ">Nichol 1994b</a>; <a href="./references#CD004876-bbs2-0078" title="NicholKL , MargolisKL , WuorenmaJ , Von SternbergT . The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. New England Journal of Medicine1994;331(12):778-84. ">Nichol 1994c</a>; <a href="./references#CD004876-bbs2-0079" title="NicholKL , WuorenmaJ , vonSternbergT . Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens. Archives of Internal Medicine1998;158(16):1769-76. ">Nichol 1998a</a>; <a href="./references#CD004876-bbs2-0080" title="NicholKL , WuorenmaJ , vonSternbergT . Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens. Archives of Internal Medicine1998;158(16):1769-76. ">Nichol 1998b</a>; <a href="./references#CD004876-bbs2-0081" title="NicholKL , NordinJ , MulloolyJ , LaskR , FillbrandtK , IwaneM . Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. New England Journal of Medicine2003;348(14):1322-32. ">Nichol 2003a</a>; <a href="./references#CD004876-bbs2-0082" title="NicholKL , NordinJ , MulloolyJ , LaskR , FillbrandtK , IwaneM . Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. New England Journal of Medicine2003;348(14):1322-32. ">Nichol 2003b</a>; <a href="./references#CD004876-bbs2-0083" title="NicholsonKG , KentJ , HammersleyV . Influenza A among community-dwelling elderly persons in Leicestershire during winter 1993-4; cigarette smoking as a risk factor and the efficacy of influenza vaccination. Epidemiology and Infection1999;123(1):103-8. ">Nicholson 1999</a>; <a href="./references#CD004876-bbs2-0084" title="NordinJ , MulloolyJ , PobleteS , StrikasR , PetrucciR , WeiF , et al. Influenza vaccine effectiveness in preventing hospitalizations and deaths in persons 65 years or older in Minnesota, New York, and Oregon: data from 3 health plans. Journal of Infectious Diseases2001;184(6):665-70. ">Nordin 2001a</a>; <a href="./references#CD004876-bbs2-0085" title="NordinJ , MulloolyJ , PobleteS , StrikasR , PetrucciR , WeiF , et al. Influenza vaccine effectiveness in preventing hospitalizations and deaths in persons 65 years or older in Minnesota, New York, and Oregon: data from 3 health plans. Journal of Infectious Diseases2001;184(6):665-70. ">Nordin 2001b</a>; <a href="./references#CD004876-bbs2-0089" title="PatriarcaPA , WeberJA , ParkerRA , HallWN , KendalAP , BregmanDJ , et al. Efficacy of influenza vaccine in nursing homes. Reduction in illness and complications during an influenza A (H3N2) epidemic. JAMA1985;253(8):1136-9. ">Patriarca 1985a</a>; <a href="./references#CD004876-bbs2-0090" title="PatriarcaPA , WeberJA , ParkerRA , HallWN , KendalAP , BregmanDJ , et al. Efficacy of influenza vaccine in nursing homes. Reduction in illness and complications during an influenza A (H3N2) epidemic. JAMA1985;253(8):1136-9. ">Patriarca 1985b</a>; <a href="./references#CD004876-bbs2-0091" title="PregliascoF , GiardiniG , SandriniMC , PerucchiniE , VerganiC . Protective efficacy of Inflexal V in the elderly pazinte [Efficacia protettiva di Inflexal V nel pazinte anziano]. Vaccine at a Glance2002;1(1):2-5. ">Pregliasco 2002</a>; <a href="./references#CD004876-bbs2-0095" title="RubenFL , JohnstonF , StreiffEJ . Influenza in a partially immunized aged population. Effectiveness of killed Hong Kong vaccine against infection with the England strain. JAMA1974;230(6):863-6. ">Ruben 1974</a>; <a href="./references#CD004876-bbs2-0097" title="SaahAJ , NeufeldR , RodsteinM , La MontagneJR , BlackwelderWC , GrossP , et al. Influenza vaccine and pneumonia mortality in a nursing home population. Archives of Internal Medicine1986;146(12):2353-7. ">Saah 1986a</a>; <a href="./references#CD004876-bbs2-0098" title="SaahAJ , NeufeldR , RodsteinM , La MontagneJR , BlackwelderWC , GrossP , et al. Influenza vaccine and pneumonia mortality in a nursing home population. Archives of Internal Medicine1986;146(12):2353-7. ">Saah 1986b</a>; <a href="./references#CD004876-bbs2-0099" title="SaahAJ , NeufeldR , RodsteinM , La MontagneJR , BlackwelderWC , GrossP , et al. Influenza vaccine and pneumonia mortality in a nursing home population. Archives of Internal Medicine1986;146(12):2353-7. ">Saah 1986c</a>; <a href="./references#CD004876-bbs2-0100" title="SaitoR , SuzukiH , OshitaniH , SakaiT , SekiN , TanabeN . The effectiveness of influenza vaccine against influenza A (H3N2) virus infections in nursing homes in Niigata, Japan, during the 1998-1999 and 1999-2000 seasons. Infection Control and Hospital Epidemiology2002;23(2):82-6. ">Saito 2002a</a>; <a href="./references#CD004876-bbs2-0101" title="SaitoR , SuzukiH , OshitaniH , SakaiT , SekiN , TanabeN . The effectiveness of influenza vaccine against influenza A (H3N2) virus infections in nursing homes in Niigata, Japan, during the 1998-1999 and 1999-2000 seasons. Infection Control and Hospital Epidemiology2002;23(2):82-6. ">Saito 2002b</a>; <a href="./references#CD004876-bbs2-0103" title='ShapiroY , ShemerJ , HeymannA , ShalevV , MaharshakN , ChodikG , et al. Influenza vaccination: reduction in hospitalizations and death rates among members of "Maccabi Healthcare Services" during the 2000-2001 influenza season. Israel Medical Association Journal2003;5(10):706-8. '>Shapiro 2003</a>; <a href="./references#CD004876-bbs2-0104" title="StrassburgMA , GreenlandS , SorvilloFJ , LiebLE , HabelLA . Influenza in the elderly: report of an outbreak and a review of vaccine effectiveness reports. Vaccine1986;4(1):38-44. ">Strassburg 1986</a>; <a href="./references#CD004876-bbs2-0106" title="TaylorJL , DwyerDM , CoffmanT , GrovesC , PatelJ , IsraelE . Nursing home outbreak of influenza A (H3N2): evaluation of vaccine efficacy and influenza case definitions. Infection Control and Hospital Epidemiology1992;13(2):93-7. ">Taylor 1992</a>; <a href="./references#CD004876-bbs2-0108" title="VoordouwBC , van derLindenPD , SimonianS , van derLeiJ , SturkenboomMC , StrickerBH . Influenza vaccination in community-dwelling elderly: impact on mortality and influenza-associated morbidity. Archives of Internal Medicine2003;163(9):1089-94. ">Voordouw 2003</a>). </p> <p>Twelve case‐control studies resulted in 14 data sets (<a href="./references#CD004876-bbs2-0001" title="AhmedAE , NicholsonKG , Nguyen-Van-TamJS . Reduction in mortality associated with influenza vaccine during 1989-90 epidemic. Lancet1995;346(8975):591-5. ">Ahmed 1995</a>; <a href="./references#CD004876-bbs2-0002" title="AhmedAH , NicholsonKG , Nguyen-van TamJS , PearsonJC . Effectiveness of influenza vaccine in reducing hospital admissions during the 1989-90 epidemic. Epidemiology and Infection1997;118(1):27-33. ">Ahmed 1997</a>; <a href="./references#CD004876-bbs2-0020" title="CrocettiE , ArnianiS , BordoniF , MacioccoG , ZappaM , BuiattiE . Effectiveness of influenza vaccination in the elderly in a community in Italy. European Journal of Epidemiology2001;17(2):163-8. ">Crocetti 2001</a>; <a href="./references#CD004876-bbs2-0029" title="FedsonDS , WajdaA , NicolJP , HammondGW , KaiserDL , RoosLL . Clinical effectiveness of influenza vaccination in Manitoba. JAMA1993;270(16):1956-61. ">Fedson 1993a</a>; <a href="./references#CD004876-bbs2-0030" title="FedsonDS , WajdaA , NicolJP , HammondGW , KaiserDL , RoosLL . Clinical effectiveness of influenza vaccination in Manitoba. JAMA1993;270(16):1956-61. ">Fedson 1993b</a>; <a href="./references#CD004876-bbs2-0033" title="FosterDA , TalsmaA , Furumoto-DawsonA , OhmitSE , MarguliesJR , ArdenNH , et al. Influenza vaccine effectiveness in preventing hospitalization for pneumonia in the elderly. American Journal of Epidemiology1992;136(3):296-307. ">Foster 1992</a>; <a href="./references#CD004876-bbs2-0052" title="JordanRE , HawkerJI , AyresJG , TunnicliffeW , AdabP , OlowokureB , et al. A case-control study of elderly patients with acute respiratory illness: effect of influenza vaccination on admission to hospital in winter 2003-2004. Vaccine2007;25(46):7909-13. ">Jordan 2007</a>; <a href="./references#CD004876-bbs2-0074" title="MulloolyJP , BennettMD , HornbrookMC , BarkerWH , WilliamsWW , PatriarcaPA , et al. Influenza vaccination programs for elderly persons: cost-effectiveness in a health maintenance organization. Annals of Internal Medicine1994;121(12):947-52. ">Mullooly 1994</a>; <a href="./references#CD004876-bbs2-0086" title="OhmitSE , MontoAS . Influenza vaccine effectiveness in preventing hospitalization among the elderly during influenza type A and type B seasons. International Journal of Epidemiology1995;24(6):1240-8. ">Ohmit 1995a</a>; <a href="./references#CD004876-bbs2-0087" title="OhmitSE , MontoAS . Influenza vaccine effectiveness in preventing hospitalization among the elderly during influenza type A and type B seasons. International Journal of Epidemiology1995;24(6):1240-8. ">Ohmit 1995b</a>; <a href="./references#CD004876-bbs2-0088" title="OhmitSE , ArdenNH , MontoAS . Effectiveness of inactivated influenza vaccine among nursing home residents during an influenza type A (H3N2) epidemic. Journal of the American Geriatric Society1999;47(2):165-71. ">Ohmit 1999</a>; <a href="./references#CD004876-bbs2-0092" title="Puig-BarberaJ , Marquez-CalderonS , Masoliver-ForesA , Lloria-PaesF , Ortega-DichaA , Gil-MartinM , et al. Reduction in hospital admissions for pneumonia in non-institutionalised elderly people as a result of influenza vaccination: a case-control study in Spain. Journal of Epidemiology and Community Health1997;51(5):526-30. ">Puig‐Barberà 1997</a>; <a href="./references#CD004876-bbs2-0093" title="Puig-BarberaJ , Diez-DomingoJ , Perez HoyosS , Belenguer VareaA , Gonzalez VidalD . Effectiveness of the MF59-adjuvanted influenza vaccine in preventing emergency admissions for pneumonia in the elderly over 64 years of age. Vaccine2004;23(3):283-9. ">Puig‐Barberà 2004</a>; <a href="./references#CD004876-bbs2-0094" title="Puig-BarberàJ , Díez-DomingoJ , VareaAB , ChavarriGS , RodrigoJA , Hoyos SP et al. Effectiveness of MF59-adjuvanted subunit influenza vaccine in preventing hospitalisations for cardiovascular disease, cerebrovascular disease and pneumonia in the elderly. Vaccine2007;25(42):7313-21. ">Puig‐Barbera 2007</a>). </p> <p>Roughly half (n = 52) the data sets reported A/H3N2 virus circulating; 4% (n = 4) B viruses, 1% (n = 1) A/H1N1, 1% (n = 1) A/H2N2, and 7% (n = 7) reported A/H3N2 and A/H1N1 circulating at the same time. The remaining 37% (n = 35) of the data sets provided insufficient information on circulating subtypes. </p> <p>Twenty‐four studies resulting in 39 data sets collected information about the health conditions of vaccinated and unvaccinated people and reported stratified results or adjusted rates. Participants suffering from lung disease, heart disease, renal disease, diabetes and other endocrine disorders, immunodeficiency or immunosuppressive diseases, cancer, dementia or stroke, vasculitis, and rheumatic disease were considered as belonging to risk groups. </p> <p>The included studies used the recommended and licenced vaccine formulation, even if some authors did not declare vaccine composition. </p> <p>In the RCTs, the comparison was placebo. All cohort studies compared the effects of vaccination against no vaccination. </p> <p>In our safety assessment, we included four RCTs (<a href="./references#CD004876-bbs2-0039" title="GovaertTM , DinantGJ , AretzK , MasurelN , SprengerMJ , KnottnerusJA . Adverse reactions to influenza vaccine in elderly people: randomised double blind placebo controlled trial. BMJ1993;307(6910):988-90. ">Govaert 1993</a>; <a href="./references#CD004876-bbs2-0055" title="KeitelWA , CateTR , AtmarRL , TurnerCS , NinoD , DukesCM , et al. Increasing doses of purified influenza virus hemagglutinin and subvirion vaccines enhance antibody responses in the elderly. Clinical and Diagnostic Laboratory Immunology1996;3(5):507-10. ">Keitel 1996</a>; <a href="./references#CD004876-bbs2-0069" title="MargolisKL , NicholKL , PolandGA , PluharRE . Frequency of adverse reactions to influenza vaccine in the elderly. A randomized, placebo-controlled trial. JAMA1990;264(9):1139-41. ">Margolis 1990a</a>; <a href="./references#CD004876-bbs2-0107" title="TreanorJ , DumyatiG , O'BrienD , RileyMA , RileyG , ErbS , et al. Evaluation of cold-adapted, reassortant influenza B virus vaccines in elderly and chronically ill adults. Journal of Infectious Diseases1994;169(2):402-7. ">Treanor 1994</a>), and we commented on three surveillance studies with a non‐comparative design assessing rare events (Guillain‐Barré syndrome) in the text but did not include them in our meta‐analysis (<a href="./references#CD004876-bbs2-0053" title="KaplanJE , KatonaP , HurwitzES , SchonbergerLB . Guillain-Barre syndrome in the United States, 1979-1980 and 1980-1981. Lack of an association with influenza vaccination. JAMA1982;248(6):698-700. ">Kaplan 1982</a>; <a href="./references#CD004876-bbs2-0056" title="LaskyT , TerraccianoGJ , MagderL , KoskiCL , BallesterosM , NashD , et al. The Guillain-Barre syndrome and the 1992-1993 and 1993-1994 influenza vaccines. New England Journal of Medicine1998;339(25):1797-802. ">Lasky 1998</a>; <a href="./references#CD004876-bbs2-0102" title="SchonbergerLB , BregmanDJ , Sullivan-BolyaiJZ , KeenlysideRA , ZieglerDW , RetailliauHF , et al. Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976-1977. American Journal of Epidemiology1979;110(2):105-23. ">Schonberger 1979</a>). One RCT assessed a vaccine that has not been in production for decades (<a href="./references#CD004876-bbs2-0105" title="StuartWH , DullHB , NewtonLH , McQueenJL , SchiffER . Evaluation of monovalent influenza vaccine in a retirement community during the epidemic of 1965-66. JAMA1969;209(2):232-8. ">Stuart 1969</a>); its harms data were not extracted. </p> </section> <section id="CD004876-sec-0052"> <h4 class="title">Excluded studies</h4> <p>The most frequent reasons for study exclusion were lack of presentation of original data, lack of placebo or standard care comparator, and presence of antibody titres as outcomes. A complete list with reasons for exclusion is provided in the <a href="./references#CD004876-sec-0137" title="">Characteristics of excluded studies</a> table. </p> </section> </section> <section id="CD004876-sec-0053"> <h3 class="title">Risk of bias in included studies</h3> <p>The results of our 'Risk of bias' assessment were as follows.</p> <section id="CD004876-sec-0054"> <h4 class="title">Cohort/case‐control studies (from previous versions of the review)</h4> <p> <ul id="CD004876-list-0007"> <li> <p>Low risk of bias: 18</p> </li> <li> <p>Medium risk of bias: 31</p> </li> <li> <p>High risk of bias: 11</p> </li> <li> <p>Very high risk of bias: 3</p> </li> </ul> </p> </section> <section id="CD004876-sec-0055"> <h4 class="title">Surveillance studies (from previous versions of the review)</h4> <p>For three surveillance studies assessing rare harms, we did not perform quality evaluation. All studies were population based with good case findings and case definitions. </p> </section> <section id="CD004876-sec-0056"> <h4 class="title">Allocation</h4> <section id="CD004876-sec-0057"> <h5 class="title">Experimental studies</h5> <p> <ul id="CD004876-list-0008"> <li> <p>Allocation concealment: adequate 3</p> </li> <li> <p>Allocation concealment: unclear 1</p> </li> <li> <p>Allocation concealment: inadequate 0</p> </li> <li> <p>Allocation concealment: not described 5</p> </li> </ul> </p> </section> </section> <section id="CD004876-sec-0058"> <h4 class="title">Blinding</h4> <p>See 'Potential biases in the review process' in the <a href="#CD004876-sec-0079">Discussion</a>. </p> </section> <section id="CD004876-sec-0059"> <h4 class="title">Incomplete outcome data</h4> <p>The vast majority of evidence for our review stems from non‐RCTs. In most of the trials, the quality of the text was such that we could not assess the impact of any incomplete outcome data (<a href="./references#CD004876-bbs2-0397" title="JeffersonT , Di PietrantonjC , DebaliniMG , RivettiA , DemicheliV . Study  quality, concordance, take home message, funding and impact: their relationship in influenza vaccines studies. BMJ2009;338:b354. [DOI: 10.1136/bmj.b354 ]">Jefferson 2009b</a>). </p> </section> <section id="CD004876-sec-0060"> <h4 class="title">Selective reporting</h4> <p>Selective reporting including major inconsistencies between different parts of the text was a common feature. See 'Potential biases in the review process' in the <a href="#CD004876-sec-0079">Discussion</a>. </p> </section> <section id="CD004876-sec-0061"> <h4 class="title">Other potential sources of bias</h4> <p>See 'Potential biases in the review process' in the <a href="#CD004876-sec-0079">Discussion</a>. </p> </section> </section> <section id="CD004876-sec-0062"> <h3 class="title" id="CD004876-sec-0062">Effects of interventions</h3> <p>See: <a href="./full#CD004876-tbl-0001"><b>Summary of findings 1</b> Influenza vaccine compared to placebo for preventing influenza in the elderly</a> </p> <section id="CD004876-sec-0063"> <h4 class="title">Randomised controlled trials</h4> <p>Given the heterogeneous nature of the vaccines tested (monovalent, trivalent, live, or inactivated aerosol vaccines), setting, follow‐up, and outcome definition, we could draw no firm conclusions from this body of evidence. Only three trials specified follow‐up (<a href="./references#CD004876-bbs2-0040" title="GovaertTM , ThijsCT , MasurelN , SprengerMJ , DinantGJ , KnottnerusJA . The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial. JAMA1994;272(21):1661-5. ">Govaert 1994a</a>; <a href="./references#CD004876-bbs2-0096" title="RudenkoLG , ArdenNH , GrigorievaE , NaychinA , RekstinA , KlimovAI , et al. Immunogenicity and efficacy of Russian live attenuated and US inactivated influenza vaccines used alone and in combination in nursing home residents. Vaccine2000;19(2-3):308-18. ">Rudenko 2001</a>; <a href="./references#CD004876-bbs2-0105" title="StuartWH , DullHB , NewtonLH , McQueenJL , SchiffER . Evaluation of monovalent influenza vaccine in a retirement community during the epidemic of 1965-66. JAMA1969;209(2):232-8. ">Stuart 1969</a>), which ranged from 42 to 180 days. </p> <p>We have presented the findings of the most important outcomes in <a href="./full#CD004876-tbl-0001">summary of findings Table 1</a>. </p> <p>Influenza vaccines may reduce the risk of influenza from 6% in unvaccinated people to 2.4% following vaccination (vaccine efficacy (VE) 58%, risk ratio (RR) 0.42, 95% confidence interval (CI) 0.27 to 0.66; low‐certainty evidence) (<a href="./full#CD004876-tbl-0001">summary of findings Table 1</a>). These results gave a number needed to vaccinate (NNV) of 30 (<a href="./references#CD004876-fig-0003" title="">Analysis 1.1</a>). </p> <p>Based on a meta‐analysis of four trials of inactivated vaccines (<a href="./references#CD004876-bbs2-0003" title="AllsupS , HaycoxA , ReganM , GosneyM . Is influenza vaccination cost effective for healthy people between ages 65 and 74 years? A randomised controlled trial. Vaccine2004;23(5):639-45. ">Allsup 2004</a>; <a href="./references#CD004876-bbs2-0028" title="Edmondson WP Jr, RothenbergR , WhitePW , Gwaltney JM Jr. A comparison of subcutaneous, nasal, and combined influenza vaccination. II. Protection against natural challenge. American Journal of Epidemiology1971;93(6):480-6. ">Edmondson 1971</a>; <a href="./references#CD004876-bbs2-0040" title="GovaertTM , ThijsCT , MasurelN , SprengerMJ , DinantGJ , KnottnerusJA . The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial. JAMA1994;272(21):1661-5. ">Govaert 1994a</a>; <a href="./references#CD004876-bbs2-0105" title="StuartWH , DullHB , NewtonLH , McQueenJL , SchiffER . Evaluation of monovalent influenza vaccine in a retirement community during the epidemic of 1965-66. JAMA1969;209(2):232-8. ">Stuart 1969</a>), vaccines probably reduce the risk of ILI from 6% in unvaccinated people to 3.5% following vaccination (VE 41%, RR 0.59 95% CI 0.47 to 0.73; moderate‐certainty evidence). These results gave a NNV of 42 (<a href="./references#CD004876-fig-0004" title="">Analysis 1.2</a>). </p> <p>There was very limited information available regarding the effects of vaccines on risk of hospitalisation, pneumonia, and death. No study reported hospitalisations. One study of 699 participants reported no cases of pneumonia (very low‐certainty evidence), and that 4 deaths occurred at comparable rates between the groups (RR 1.02, 95% CI 0.11 to 9.72; very low‐certainty evidence). </p> <p>Although small increases in fever (from 1.6% to 2.5%; RR 1.57, 95% CI 0.92 to 2.71; moderate‐certainty evidence) and nausea (from 2.4% to 4.2%; RR 1.75, 95% CI 0.74 to 4.12; low‐certainty evidence) occurred following influenza vaccination, CIs for these results are wide, and we downgraded the certainty of evidence in both cases for imprecision (<a href="./full#CD004876-tbl-0001">summary of findings Table 1</a>). </p> <p>Increased risks of general malaise, upper respiratory tract symptoms, and headache following vaccination ranged between 1.1 and 1.57, although the CIs are wide for all of these outcomes (see <a href="./references#CD004876-fig-0007" title="">Analysis 2.1</a>; <a href="./references#CD004876-fig-0009" title="">Analysis 2.3</a>; <a href="./references#CD004876-fig-0010" title="">Analysis 2.4</a>). Following vaccination there were increased risks of sore arm (RR 3.56, 95% CI 2.61 to 4.87) (<a href="./references#CD004876-fig-0012" title="">Analysis 2.6</a>) and swelling (RR 8.23, 95% CI 3.98 to 17.05) (<a href="./references#CD004876-fig-0013" title="">Analysis 2.7</a>) compared with placebo. </p> <p>Three studies assessed the effects of inactivated aerosol vaccine (<a href="./references#CD004876-bbs2-0028" title="Edmondson WP Jr, RothenbergR , WhitePW , Gwaltney JM Jr. A comparison of subcutaneous, nasal, and combined influenza vaccination. II. Protection against natural challenge. American Journal of Epidemiology1971;93(6):480-6. ">Edmondson 1971</a>; <a href="./references#CD004876-bbs2-0096" title="RudenkoLG , ArdenNH , GrigorievaE , NaychinA , RekstinA , KlimovAI , et al. Immunogenicity and efficacy of Russian live attenuated and US inactivated influenza vaccines used alone and in combination in nursing home residents. Vaccine2000;19(2-3):308-18. ">Rudenko 2001</a>; <a href="./references#CD004876-bbs2-0107" title="TreanorJ , DumyatiG , O'BrienD , RileyMA , RileyG , ErbS , et al. Evaluation of cold-adapted, reassortant influenza B virus vaccines in elderly and chronically ill adults. Journal of Infectious Diseases1994;169(2):402-7. ">Treanor 1994</a>). There was no evidence of lower risk of influenza or ILI following vaccination compared with placebo with vaccine matching in the presence of an outbreak (<a href="./references#CD004876-fig-0014" title="">Analysis 3.1</a>; <a href="./references#CD004876-fig-0015" title="">Analysis 3.2</a>), or with vaccine matching outside of an outbreak (influenza: <a href="./references#CD004876-fig-0016" title="">Analysis 4.1</a>). Effect sizes for harms (namely malaise, fever, upper and lower respiratory tract symptoms) were all higher with vaccines, but the size of the study contributing data to these outcomes was small, and the confidence interval includes there being no increase in these events with the vaccines (see <a href="./references#CD004876-fig-0017" title="">Analysis 5.1</a>; <a href="./references#CD004876-fig-0018" title="">Analysis 5.2</a>; <a href="./references#CD004876-fig-0019" title="">Analysis 5.3</a>; <a href="./references#CD004876-fig-0020" title="">Analysis 5.4</a>). </p> </section> <section id="CD004876-sec-0064"> <h4 class="title">Cohort studies in long‐term care facilities (from previous versions of the review)</h4> <p>Thirty cohort studies in long‐term care facilities contributed data to 41 data sets and over 34,000 observations (<a href="./references#CD004876-bbs2-0004" title="ArdenNH , PatriarcaPA , FasanoMB , LuiKJ , HarmonMW , KendalAP , et al. The roles of vaccination and amantadine prophylaxis in controlling an outbreak of influenza A (H3N2) in a nursing home. Archives of Internal Medicine1988;148(4):865-8. ">Arden 1988</a>; <a href="./references#CD004876-bbs2-0005" title="ArroyoJC , PosticB , BrownA , HarrisonK , BirgenheierR , DowdaH . Influenza A/Philippines/2/82 outbreak in a nursing home: limitations of influenza vaccination in the aged. American Journal of Infection Control1984;12(6):329-34. ">Arroyo 1984</a>; <a href="./references#CD004876-bbs2-0006" title="AymardM , BentejacMC , LarbaigtG , MichautD , TriauR . Efficacy of the antiinfluenza A vaccination during epidemics due to A/VIC/3/75 and A/Texas/1/77 viruses. Developments in Biological Standardization1979;43:231-9. ">Aymard 1979a</a>; <a href="./references#CD004876-bbs2-0007" title="AymardM , BentejacMC , LarbaigtG , MichautD , TriauR . Efficacy of the antiinfluenza A vaccination during epidemics due to A/VIC/3/75 and A/Texas/1/77 viruses. Developments in Biological Standardization1979;43:231-9. ">Aymard 1979b</a>; <a href="./references#CD004876-bbs2-0009" title="CartterML , RenzulloPO , HelgersonSD , MartinSM , JekelJF . Influenza outbreaks in nursing homes: how effective is influenza vaccine in the institutionalized elderly?Infection Control and Hospital Epidemiology1990;11(9):473-8. ">Cartter 1990a</a>; <a href="./references#CD004876-bbs2-0010" title="CartterML , RenzulloPO , HelgersonSD , MartinSM , JekelJF . Influenza outbreaks in nursing homes: how effective is influenza vaccine in the institutionalized elderly?Infection Control and Hospital Epidemiology1990;11(9):473-8. ">Cartter 1990b</a>; <a href="./references#CD004876-bbs2-0011" title="CartterML , RenzulloPO , HelgersonSD , MartinSM , JekelJF . Influenza outbreaks in nursing homes: how effective is influenza vaccine in the institutionalized elderly?Infection Control and Hospital Epidemiology1990;11(9):473-8. ">Cartter 1990c</a>; <a href="./references#CD004876-bbs2-0016" title="ColesFB , BalzanoGJ , MorseDL . An outbreak of influenza A (H3N2) in a well immunized nursing home population. Journal of the American Geriatrics Society1992;40(6):589-92. ">Coles 1992</a>; <a href="./references#CD004876-bbs2-0021" title="Cuneo CrovariP , GaspariniR , CrovariP . Efficacy of influenza vaccination: results in a community controlled for 2 years. Bollettino dell’Istituto Sieroterapico Milanese1980;59(4):306-13. ">Cuneo Crovari 1980</a>; <a href="./references#CD004876-bbs2-0022" title="CurrierM , CoffmanT , BoydP , FremdB , IsraelE . Influenza vaccine efficacy in a Maryland nursing home. Maryland Medical Journal1988;37(10):781-3. ">Currier 1988</a>; <a href="./references#CD004876-bbs2-0027" title="DeguchiY , NishimuraK . Efficacy of influenza vaccine in elderly persons in welfare nursing homes: reduction in risks of mortality and morbidity during an influenza A (H3N2) epidemic. Journals of Gerontology. Series A, Biological Sciences and Medical Sciences2001;56(6):M391-4. ">Deguchi 2001</a>; <a href="./references#CD004876-bbs2-0031" title="FeeryBJ , EveredMG , MorrisonEI . Different protection rates in various groups of volunteers given subunit influenza virus vaccine in 1976. Journal of Infectious Diseases1979;139(2):237-41. ">Feery 1976</a>; <a href="./references#CD004876-bbs2-0034" title="FysonRE . Influenza outbreaks in two institutions for the elderly - Ontario. Canadian Diseases Weekly Report1983;9:37. ">Fyson 1983a</a>; <a href="./references#CD004876-bbs2-0035" title="FysonRE . Influenza outbreaks in two institutions for the elderly - Ontario. Canadian Diseases Weekly Report1983;9:37. ">Fyson 1983b</a>; <a href="./references#CD004876-bbs2-0038" title="GoodmanRA , OrensteinWA , MunroTF , SmithSC , SikesRK . Impact of influenza A in a nursing home. JAMA1982;247(10):1451-3. ">Goodman 1982</a>; <a href="./references#CD004876-bbs2-0041" title="GrossPA , QuinnanGV , RodsteinM , LaMontagneJR , KaslowRA , SaahAJ , et al. Association of influenza immunization with reduction in mortality in an elderly population. A prospective study. Archives of Internal Medicine1988;148(3):562-5. ">Gross 1988</a>; <a href="./references#CD004876-bbs2-0045" title="HormanJT , StetlerHC , IsraelE , SorleyD , SchipperMT , JosephJM . An outbreak of influenza A in a nursing home. American Journal of Public Health1986;76(5):501-4. ">Horman 1986</a>; <a href="./references#CD004876-bbs2-0046" title="HowarthDM , ChastonTM , LickissK , WeekesJR , O'DohertyC , FosterRE , et al. Age-related responses to influenza vaccination in the Newcastle region during 1983 and 1984. Medical Journal of Australia1987;146(10):514-7. ">Howarth 1987a</a>; <a href="./references#CD004876-bbs2-0047" title="HowarthDM , ChastonTM , LickissK , WeekesJR , O'DohertyC , FosterRE , et al. Age-related responses to influenza vaccination in the Newcastle region during 1983 and 1984. Medical Journal of Australia1987;146(10):514-7. ">Howarth 1987b</a>; <a href="./references#CD004876-bbs2-0048" title="HowellsCH , Vesselinova-JenkinsCK , EvansAD , JamesJ . Influenza vaccination and mortality from bronchopneumonia in the elderly. Lancet1975;1(7903):381-3. ">Howells 1975a</a>; <a href="./references#CD004876-bbs2-0049" title="HowellsCH , Vesselinova-JenkinsCK , EvansAD , JamesJ . Influenza vaccination and mortality from bronchopneumonia in the elderly. Lancet1975;1(7903):381-3. ">Howells 1975b</a>; <a href="./references#CD004876-bbs2-0050" title="HowellsCH , Vesselinova-JenkinsCK , EvansAD , JamesJ . Influenza vaccination and mortality from bronchopneumonia in the elderly. Lancet1975;1(7903):381-3. ">Howells 1975c</a>; <a href="./references#CD004876-bbs2-0051" title="IsaacsS , DickinsonC , BrimmerG . Outbreak of influenza A in an Ontario nursing home - January 1997. Canada Communicable Disease Report1997;23(14):105-8. ">Isaacs 1997</a>; <a href="./references#CD004876-bbs2-0057" title="LeungJCK . Effectiveness of influenza vaccination among elderly home residents in Hong Kong: a retrospective cohort study. Hong Kong Practitioner2007;29(4):123-33. ">Leung 2007</a>; <a href="./references#CD004876-bbs2-0070" title="MeiklejohnG , HallH . Unusual outbreak of influenza A in a Wyoming nursing home. Journal of the American Geriatric Society1987;35(8):742-6. ">Meiklejohn 1987</a>; <a href="./references#CD004876-bbs2-0071" title="MontoAS , HornbuckleK , OhmitSE . Influenza vaccine effectiveness among elderly nursing home residents: a cohort study. American Journal of Epidemiology2001;154(2):155-60. ">Monto 2001</a>; <a href="./references#CD004876-bbs2-0072" title="MorensDM , RashVM . Lessons from a nursing home outbreak of influenza A. Infection Control and Hospital Epidemiology1995;16(5):275-80. ">Morens 1995</a>; <a href="./references#CD004876-bbs2-0073" title="MukerjeeA . Spread of influenza: a study of risk factors in homes for the elderly in Wales. Journal of Epidemiology and Community Health1994;48(6):602-3. ">Mukerjee 1994</a>; <a href="./references#CD004876-bbs2-0075" title="MurayamaN , SuzukiH , ArakawaM , NeromeK , MizutaK , KameyamaK . Two outbreaks of influenza A (H3N2) in a Japanese nursing home in the winter of 1996-1997, with differing vaccine efficacy. Tohoku Journal of Experimental Medicine1999;188(4):289-98. ">Murayama 1999</a>; <a href="./references#CD004876-bbs2-0089" title="PatriarcaPA , WeberJA , ParkerRA , HallWN , KendalAP , BregmanDJ , et al. Efficacy of influenza vaccine in nursing homes. Reduction in illness and complications during an influenza A (H3N2) epidemic. JAMA1985;253(8):1136-9. ">Patriarca 1985a</a>; <a href="./references#CD004876-bbs2-0090" title="PatriarcaPA , WeberJA , ParkerRA , HallWN , KendalAP , BregmanDJ , et al. Efficacy of influenza vaccine in nursing homes. Reduction in illness and complications during an influenza A (H3N2) epidemic. JAMA1985;253(8):1136-9. ">Patriarca 1985b</a>; <a href="./references#CD004876-bbs2-0095" title="RubenFL , JohnstonF , StreiffEJ . Influenza in a partially immunized aged population. Effectiveness of killed Hong Kong vaccine against infection with the England strain. JAMA1974;230(6):863-6. ">Ruben 1974</a>; <a href="./references#CD004876-bbs2-0097" title="SaahAJ , NeufeldR , RodsteinM , La MontagneJR , BlackwelderWC , GrossP , et al. Influenza vaccine and pneumonia mortality in a nursing home population. Archives of Internal Medicine1986;146(12):2353-7. ">Saah 1986a</a>; <a href="./references#CD004876-bbs2-0098" title="SaahAJ , NeufeldR , RodsteinM , La MontagneJR , BlackwelderWC , GrossP , et al. Influenza vaccine and pneumonia mortality in a nursing home population. Archives of Internal Medicine1986;146(12):2353-7. ">Saah 1986b</a>; <a href="./references#CD004876-bbs2-0099" title="SaahAJ , NeufeldR , RodsteinM , La MontagneJR , BlackwelderWC , GrossP , et al. Influenza vaccine and pneumonia mortality in a nursing home population. Archives of Internal Medicine1986;146(12):2353-7. ">Saah 1986c</a>; <a href="./references#CD004876-bbs2-0100" title="SaitoR , SuzukiH , OshitaniH , SakaiT , SekiN , TanabeN . The effectiveness of influenza vaccine against influenza A (H3N2) virus infections in nursing homes in Niigata, Japan, during the 1998-1999 and 1999-2000 seasons. Infection Control and Hospital Epidemiology2002;23(2):82-6. ">Saito 2002a</a>; <a href="./references#CD004876-bbs2-0101" title="SaitoR , SuzukiH , OshitaniH , SakaiT , SekiN , TanabeN . The effectiveness of influenza vaccine against influenza A (H3N2) virus infections in nursing homes in Niigata, Japan, during the 1998-1999 and 1999-2000 seasons. Infection Control and Hospital Epidemiology2002;23(2):82-6. ">Saito 2002b</a>; <a href="./references#CD004876-bbs2-0104" title="StrassburgMA , GreenlandS , SorvilloFJ , LiebLE , HabelLA . Influenza in the elderly: report of an outbreak and a review of vaccine effectiveness reports. Vaccine1986;4(1):38-44. ">Strassburg 1986</a>; <a href="./references#CD004876-bbs2-0106" title="TaylorJL , DwyerDM , CoffmanT , GrovesC , PatelJ , IsraelE . Nursing home outbreak of influenza A (H3N2): evaluation of vaccine efficacy and influenza case definitions. Infection Control and Hospital Epidemiology1992;13(2):93-7. ">Taylor 1992</a>). These studies were very focused and were fairly well resourced: 35 data sets reported virologic surveillance that confirmed influenza virus circulation, and 22 data sets had short follow‐up (less than three months). The studies assessed the effects of vaccines in residential communities. The resident population is described in about half of the included data sets as predominantly aged older than 75 years, with multiple chronic pathologies and a high dependency level. However, breakdown of potential confounding factors (such as age, sex, smoking status, and underlying chronic disease) is rarely reported by vaccine exposure, making correction of confounders impossible. </p> <section id="CD004876-sec-0065"> <h5 class="title">Studies recorded during outbreaks or periods of high viral circulation (from previous versions of the review) </h5> <p>Of the 41 data sets, 30 data sets with a total of 9879 observations were recorded during outbreaks or periods of high viral circulation (<a href="./references#CD004876-bbs2-0004" title="ArdenNH , PatriarcaPA , FasanoMB , LuiKJ , HarmonMW , KendalAP , et al. The roles of vaccination and amantadine prophylaxis in controlling an outbreak of influenza A (H3N2) in a nursing home. Archives of Internal Medicine1988;148(4):865-8. ">Arden 1988</a>; <a href="./references#CD004876-bbs2-0005" title="ArroyoJC , PosticB , BrownA , HarrisonK , BirgenheierR , DowdaH . Influenza A/Philippines/2/82 outbreak in a nursing home: limitations of influenza vaccination in the aged. American Journal of Infection Control1984;12(6):329-34. ">Arroyo 1984</a>; <a href="./references#CD004876-bbs2-0006" title="AymardM , BentejacMC , LarbaigtG , MichautD , TriauR . Efficacy of the antiinfluenza A vaccination during epidemics due to A/VIC/3/75 and A/Texas/1/77 viruses. Developments in Biological Standardization1979;43:231-9. ">Aymard 1979a</a>; <a href="./references#CD004876-bbs2-0007" title="AymardM , BentejacMC , LarbaigtG , MichautD , TriauR . Efficacy of the antiinfluenza A vaccination during epidemics due to A/VIC/3/75 and A/Texas/1/77 viruses. Developments in Biological Standardization1979;43:231-9. ">Aymard 1979b</a>; <a href="./references#CD004876-bbs2-0009" title="CartterML , RenzulloPO , HelgersonSD , MartinSM , JekelJF . Influenza outbreaks in nursing homes: how effective is influenza vaccine in the institutionalized elderly?Infection Control and Hospital Epidemiology1990;11(9):473-8. ">Cartter 1990a</a>; <a href="./references#CD004876-bbs2-0010" title="CartterML , RenzulloPO , HelgersonSD , MartinSM , JekelJF . Influenza outbreaks in nursing homes: how effective is influenza vaccine in the institutionalized elderly?Infection Control and Hospital Epidemiology1990;11(9):473-8. ">Cartter 1990b</a>; <a href="./references#CD004876-bbs2-0011" title="CartterML , RenzulloPO , HelgersonSD , MartinSM , JekelJF . Influenza outbreaks in nursing homes: how effective is influenza vaccine in the institutionalized elderly?Infection Control and Hospital Epidemiology1990;11(9):473-8. ">Cartter 1990c</a>; <a href="./references#CD004876-bbs2-0016" title="ColesFB , BalzanoGJ , MorseDL . An outbreak of influenza A (H3N2) in a well immunized nursing home population. Journal of the American Geriatrics Society1992;40(6):589-92. ">Coles 1992</a>; <a href="./references#CD004876-bbs2-0021" title="Cuneo CrovariP , GaspariniR , CrovariP . Efficacy of influenza vaccination: results in a community controlled for 2 years. Bollettino dell’Istituto Sieroterapico Milanese1980;59(4):306-13. ">Cuneo Crovari 1980</a>; <a href="./references#CD004876-bbs2-0022" title="CurrierM , CoffmanT , BoydP , FremdB , IsraelE . Influenza vaccine efficacy in a Maryland nursing home. Maryland Medical Journal1988;37(10):781-3. ">Currier 1988</a>; <a href="./references#CD004876-bbs2-0031" title="FeeryBJ , EveredMG , MorrisonEI . Different protection rates in various groups of volunteers given subunit influenza virus vaccine in 1976. Journal of Infectious Diseases1979;139(2):237-41. ">Feery 1976</a>; <a href="./references#CD004876-bbs2-0034" title="FysonRE . Influenza outbreaks in two institutions for the elderly - Ontario. Canadian Diseases Weekly Report1983;9:37. ">Fyson 1983a</a>; <a href="./references#CD004876-bbs2-0035" title="FysonRE . Influenza outbreaks in two institutions for the elderly - Ontario. Canadian Diseases Weekly Report1983;9:37. ">Fyson 1983b</a>; <a href="./references#CD004876-bbs2-0038" title="GoodmanRA , OrensteinWA , MunroTF , SmithSC , SikesRK . Impact of influenza A in a nursing home. JAMA1982;247(10):1451-3. ">Goodman 1982</a>; <a href="./references#CD004876-bbs2-0041" title="GrossPA , QuinnanGV , RodsteinM , LaMontagneJR , KaslowRA , SaahAJ , et al. Association of influenza immunization with reduction in mortality in an elderly population. A prospective study. Archives of Internal Medicine1988;148(3):562-5. ">Gross 1988</a>; <a href="./references#CD004876-bbs2-0045" title="HormanJT , StetlerHC , IsraelE , SorleyD , SchipperMT , JosephJM . An outbreak of influenza A in a nursing home. American Journal of Public Health1986;76(5):501-4. ">Horman 1986</a>; <a href="./references#CD004876-bbs2-0051" title="IsaacsS , DickinsonC , BrimmerG . Outbreak of influenza A in an Ontario nursing home - January 1997. Canada Communicable Disease Report1997;23(14):105-8. ">Isaacs 1997</a>; <a href="./references#CD004876-bbs2-0057" title="LeungJCK . Effectiveness of influenza vaccination among elderly home residents in Hong Kong: a retrospective cohort study. Hong Kong Practitioner2007;29(4):123-33. ">Leung 2007</a>; <a href="./references#CD004876-bbs2-0070" title="MeiklejohnG , HallH . Unusual outbreak of influenza A in a Wyoming nursing home. Journal of the American Geriatric Society1987;35(8):742-6. ">Meiklejohn 1987</a>; <a href="./references#CD004876-bbs2-0071" title="MontoAS , HornbuckleK , OhmitSE . Influenza vaccine effectiveness among elderly nursing home residents: a cohort study. American Journal of Epidemiology2001;154(2):155-60. ">Monto 2001</a>; <a href="./references#CD004876-bbs2-0072" title="MorensDM , RashVM . Lessons from a nursing home outbreak of influenza A. Infection Control and Hospital Epidemiology1995;16(5):275-80. ">Morens 1995</a>; <a href="./references#CD004876-bbs2-0073" title="MukerjeeA . Spread of influenza: a study of risk factors in homes for the elderly in Wales. Journal of Epidemiology and Community Health1994;48(6):602-3. ">Mukerjee 1994</a>; <a href="./references#CD004876-bbs2-0075" title="MurayamaN , SuzukiH , ArakawaM , NeromeK , MizutaK , KameyamaK . Two outbreaks of influenza A (H3N2) in a Japanese nursing home in the winter of 1996-1997, with differing vaccine efficacy. Tohoku Journal of Experimental Medicine1999;188(4):289-98. ">Murayama 1999</a>; <a href="./references#CD004876-bbs2-0089" title="PatriarcaPA , WeberJA , ParkerRA , HallWN , KendalAP , BregmanDJ , et al. Efficacy of influenza vaccine in nursing homes. Reduction in illness and complications during an influenza A (H3N2) epidemic. JAMA1985;253(8):1136-9. ">Patriarca 1985a</a>; <a href="./references#CD004876-bbs2-0095" title="RubenFL , JohnstonF , StreiffEJ . Influenza in a partially immunized aged population. Effectiveness of killed Hong Kong vaccine against infection with the England strain. JAMA1974;230(6):863-6. ">Ruben 1974</a>; <a href="./references#CD004876-bbs2-0097" title="SaahAJ , NeufeldR , RodsteinM , La MontagneJR , BlackwelderWC , GrossP , et al. Influenza vaccine and pneumonia mortality in a nursing home population. Archives of Internal Medicine1986;146(12):2353-7. ">Saah 1986a</a>; <a href="./references#CD004876-bbs2-0098" title="SaahAJ , NeufeldR , RodsteinM , La MontagneJR , BlackwelderWC , GrossP , et al. Influenza vaccine and pneumonia mortality in a nursing home population. Archives of Internal Medicine1986;146(12):2353-7. ">Saah 1986b</a>; <a href="./references#CD004876-bbs2-0104" title="StrassburgMA , GreenlandS , SorvilloFJ , LiebLE , HabelLA . Influenza in the elderly: report of an outbreak and a review of vaccine effectiveness reports. Vaccine1986;4(1):38-44. ">Strassburg 1986</a>; <a href="./references#CD004876-bbs2-0106" title="TaylorJL , DwyerDM , CoffmanT , GrovesC , PatelJ , IsraelE . Nursing home outbreak of influenza A (H3N2): evaluation of vaccine efficacy and influenza case definitions. Infection Control and Hospital Epidemiology1992;13(2):93-7. ">Taylor 1992</a>). The influenza virus subtype is positively identified in 28 data sets (A/H3N2 in 25 data sets). The focus of 22 data sets from 19 studies was on assessment of the effect of vaccination on single epidemic sources (<a href="./references#CD004876-bbs2-0004" title="ArdenNH , PatriarcaPA , FasanoMB , LuiKJ , HarmonMW , KendalAP , et al. The roles of vaccination and amantadine prophylaxis in controlling an outbreak of influenza A (H3N2) in a nursing home. Archives of Internal Medicine1988;148(4):865-8. ">Arden 1988</a>; <a href="./references#CD004876-bbs2-0005" title="ArroyoJC , PosticB , BrownA , HarrisonK , BirgenheierR , DowdaH . Influenza A/Philippines/2/82 outbreak in a nursing home: limitations of influenza vaccination in the aged. American Journal of Infection Control1984;12(6):329-34. ">Arroyo 1984</a>; <a href="./references#CD004876-bbs2-0009" title="CartterML , RenzulloPO , HelgersonSD , MartinSM , JekelJF . Influenza outbreaks in nursing homes: how effective is influenza vaccine in the institutionalized elderly?Infection Control and Hospital Epidemiology1990;11(9):473-8. ">Cartter 1990a</a>; <a href="./references#CD004876-bbs2-0010" title="CartterML , RenzulloPO , HelgersonSD , MartinSM , JekelJF . Influenza outbreaks in nursing homes: how effective is influenza vaccine in the institutionalized elderly?Infection Control and Hospital Epidemiology1990;11(9):473-8. ">Cartter 1990b</a>; <a href="./references#CD004876-bbs2-0011" title="CartterML , RenzulloPO , HelgersonSD , MartinSM , JekelJF . Influenza outbreaks in nursing homes: how effective is influenza vaccine in the institutionalized elderly?Infection Control and Hospital Epidemiology1990;11(9):473-8. ">Cartter 1990c</a>; <a href="./references#CD004876-bbs2-0016" title="ColesFB , BalzanoGJ , MorseDL . An outbreak of influenza A (H3N2) in a well immunized nursing home population. Journal of the American Geriatrics Society1992;40(6):589-92. ">Coles 1992</a>; <a href="./references#CD004876-bbs2-0021" title="Cuneo CrovariP , GaspariniR , CrovariP . Efficacy of influenza vaccination: results in a community controlled for 2 years. Bollettino dell’Istituto Sieroterapico Milanese1980;59(4):306-13. ">Cuneo Crovari 1980</a>; <a href="./references#CD004876-bbs2-0022" title="CurrierM , CoffmanT , BoydP , FremdB , IsraelE . Influenza vaccine efficacy in a Maryland nursing home. Maryland Medical Journal1988;37(10):781-3. ">Currier 1988</a>; <a href="./references#CD004876-bbs2-0031" title="FeeryBJ , EveredMG , MorrisonEI . Different protection rates in various groups of volunteers given subunit influenza virus vaccine in 1976. Journal of Infectious Diseases1979;139(2):237-41. ">Feery 1976</a>; <a href="./references#CD004876-bbs2-0034" title="FysonRE . Influenza outbreaks in two institutions for the elderly - Ontario. Canadian Diseases Weekly Report1983;9:37. ">Fyson 1983a</a>; <a href="./references#CD004876-bbs2-0035" title="FysonRE . Influenza outbreaks in two institutions for the elderly - Ontario. Canadian Diseases Weekly Report1983;9:37. ">Fyson 1983b</a>; <a href="./references#CD004876-bbs2-0038" title="GoodmanRA , OrensteinWA , MunroTF , SmithSC , SikesRK . Impact of influenza A in a nursing home. JAMA1982;247(10):1451-3. ">Goodman 1982</a>; <a href="./references#CD004876-bbs2-0045" title="HormanJT , StetlerHC , IsraelE , SorleyD , SchipperMT , JosephJM . An outbreak of influenza A in a nursing home. American Journal of Public Health1986;76(5):501-4. ">Horman 1986</a>; <a href="./references#CD004876-bbs2-0051" title="IsaacsS , DickinsonC , BrimmerG . Outbreak of influenza A in an Ontario nursing home - January 1997. Canada Communicable Disease Report1997;23(14):105-8. ">Isaacs 1997</a>; <a href="./references#CD004876-bbs2-0070" title="MeiklejohnG , HallH . Unusual outbreak of influenza A in a Wyoming nursing home. Journal of the American Geriatric Society1987;35(8):742-6. ">Meiklejohn 1987</a>; <a href="./references#CD004876-bbs2-0072" title="MorensDM , RashVM . Lessons from a nursing home outbreak of influenza A. Infection Control and Hospital Epidemiology1995;16(5):275-80. ">Morens 1995</a>; <a href="./references#CD004876-bbs2-0075" title="MurayamaN , SuzukiH , ArakawaM , NeromeK , MizutaK , KameyamaK . Two outbreaks of influenza A (H3N2) in a Japanese nursing home in the winter of 1996-1997, with differing vaccine efficacy. Tohoku Journal of Experimental Medicine1999;188(4):289-98. ">Murayama 1999</a>; <a href="./references#CD004876-bbs2-0095" title="RubenFL , JohnstonF , StreiffEJ . Influenza in a partially immunized aged population. Effectiveness of killed Hong Kong vaccine against infection with the England strain. JAMA1974;230(6):863-6. ">Ruben 1974</a>; <a href="./references#CD004876-bbs2-0097" title="SaahAJ , NeufeldR , RodsteinM , La MontagneJR , BlackwelderWC , GrossP , et al. Influenza vaccine and pneumonia mortality in a nursing home population. Archives of Internal Medicine1986;146(12):2353-7. ">Saah 1986a</a>; <a href="./references#CD004876-bbs2-0098" title="SaahAJ , NeufeldR , RodsteinM , La MontagneJR , BlackwelderWC , GrossP , et al. Influenza vaccine and pneumonia mortality in a nursing home population. Archives of Internal Medicine1986;146(12):2353-7. ">Saah 1986b</a>; <a href="./references#CD004876-bbs2-0104" title="StrassburgMA , GreenlandS , SorvilloFJ , LiebLE , HabelLA . Influenza in the elderly: report of an outbreak and a review of vaccine effectiveness reports. Vaccine1986;4(1):38-44. ">Strassburg 1986</a>; <a href="./references#CD004876-bbs2-0106" title="TaylorJL , DwyerDM , CoffmanT , GrovesC , PatelJ , IsraelE . Nursing home outbreak of influenza A (H3N2): evaluation of vaccine efficacy and influenza case definitions. Infection Control and Hospital Epidemiology1992;13(2):93-7. ">Taylor 1992</a>). Viral circulation was confirmed by isolates, increases in antibody titres, or observation of an epidemic of ILI in an institution at the same time as influenza A or B circulation in the surrounding community. A high proportion of cases classified as ILI were probably influenza cases. Twenty‐two data sets from 18 studies provided information about vaccine content match with circulating influenza viruses (<a href="./references#CD004876-bbs2-0004" title="ArdenNH , PatriarcaPA , FasanoMB , LuiKJ , HarmonMW , KendalAP , et al. The roles of vaccination and amantadine prophylaxis in controlling an outbreak of influenza A (H3N2) in a nursing home. Archives of Internal Medicine1988;148(4):865-8. ">Arden 1988</a>; <a href="./references#CD004876-bbs2-0006" title="AymardM , BentejacMC , LarbaigtG , MichautD , TriauR . Efficacy of the antiinfluenza A vaccination during epidemics due to A/VIC/3/75 and A/Texas/1/77 viruses. Developments in Biological Standardization1979;43:231-9. ">Aymard 1979a</a>; <a href="./references#CD004876-bbs2-0009" title="CartterML , RenzulloPO , HelgersonSD , MartinSM , JekelJF . Influenza outbreaks in nursing homes: how effective is influenza vaccine in the institutionalized elderly?Infection Control and Hospital Epidemiology1990;11(9):473-8. ">Cartter 1990a</a>; <a href="./references#CD004876-bbs2-0010" title="CartterML , RenzulloPO , HelgersonSD , MartinSM , JekelJF . Influenza outbreaks in nursing homes: how effective is influenza vaccine in the institutionalized elderly?Infection Control and Hospital Epidemiology1990;11(9):473-8. ">Cartter 1990b</a>; <a href="./references#CD004876-bbs2-0011" title="CartterML , RenzulloPO , HelgersonSD , MartinSM , JekelJF . Influenza outbreaks in nursing homes: how effective is influenza vaccine in the institutionalized elderly?Infection Control and Hospital Epidemiology1990;11(9):473-8. ">Cartter 1990c</a>; <a href="./references#CD004876-bbs2-0031" title="FeeryBJ , EveredMG , MorrisonEI . Different protection rates in various groups of volunteers given subunit influenza virus vaccine in 1976. Journal of Infectious Diseases1979;139(2):237-41. ">Feery 1976</a>; <a href="./references#CD004876-bbs2-0034" title="FysonRE . Influenza outbreaks in two institutions for the elderly - Ontario. Canadian Diseases Weekly Report1983;9:37. ">Fyson 1983a</a>; <a href="./references#CD004876-bbs2-0035" title="FysonRE . Influenza outbreaks in two institutions for the elderly - Ontario. Canadian Diseases Weekly Report1983;9:37. ">Fyson 1983b</a>; <a href="./references#CD004876-bbs2-0038" title="GoodmanRA , OrensteinWA , MunroTF , SmithSC , SikesRK . Impact of influenza A in a nursing home. JAMA1982;247(10):1451-3. ">Goodman 1982</a>; <a href="./references#CD004876-bbs2-0041" title="GrossPA , QuinnanGV , RodsteinM , LaMontagneJR , KaslowRA , SaahAJ , et al. Association of influenza immunization with reduction in mortality in an elderly population. A prospective study. Archives of Internal Medicine1988;148(3):562-5. ">Gross 1988</a>; <a href="./references#CD004876-bbs2-0044" title="HaraM , SakamotoT , TanakaK . Effectiveness of influenza vaccination in preventing influenza-like illness among community-dwelling elderly: population-based cohort study in Japan. Vaccine2006;24(27-8):5546-51. ">Hara 2006</a>; <a href="./references#CD004876-bbs2-0045" title="HormanJT , StetlerHC , IsraelE , SorleyD , SchipperMT , JosephJM . An outbreak of influenza A in a nursing home. American Journal of Public Health1986;76(5):501-4. ">Horman 1986</a>; <a href="./references#CD004876-bbs2-0051" title="IsaacsS , DickinsonC , BrimmerG . Outbreak of influenza A in an Ontario nursing home - January 1997. Canada Communicable Disease Report1997;23(14):105-8. ">Isaacs 1997</a>; <a href="./references#CD004876-bbs2-0070" title="MeiklejohnG , HallH . Unusual outbreak of influenza A in a Wyoming nursing home. Journal of the American Geriatric Society1987;35(8):742-6. ">Meiklejohn 1987</a>; <a href="./references#CD004876-bbs2-0071" title="MontoAS , HornbuckleK , OhmitSE . Influenza vaccine effectiveness among elderly nursing home residents: a cohort study. American Journal of Epidemiology2001;154(2):155-60. ">Monto 2001</a>; <a href="./references#CD004876-bbs2-0072" title="MorensDM , RashVM . Lessons from a nursing home outbreak of influenza A. Infection Control and Hospital Epidemiology1995;16(5):275-80. ">Morens 1995</a>; <a href="./references#CD004876-bbs2-0073" title="MukerjeeA . Spread of influenza: a study of risk factors in homes for the elderly in Wales. Journal of Epidemiology and Community Health1994;48(6):602-3. ">Mukerjee 1994</a>; <a href="./references#CD004876-bbs2-0075" title="MurayamaN , SuzukiH , ArakawaM , NeromeK , MizutaK , KameyamaK . Two outbreaks of influenza A (H3N2) in a Japanese nursing home in the winter of 1996-1997, with differing vaccine efficacy. Tohoku Journal of Experimental Medicine1999;188(4):289-98. ">Murayama 1999</a>; <a href="./references#CD004876-bbs2-0089" title="PatriarcaPA , WeberJA , ParkerRA , HallWN , KendalAP , BregmanDJ , et al. Efficacy of influenza vaccine in nursing homes. Reduction in illness and complications during an influenza A (H3N2) epidemic. JAMA1985;253(8):1136-9. ">Patriarca 1985a</a>; <a href="./references#CD004876-bbs2-0098" title="SaahAJ , NeufeldR , RodsteinM , La MontagneJR , BlackwelderWC , GrossP , et al. Influenza vaccine and pneumonia mortality in a nursing home population. Archives of Internal Medicine1986;146(12):2353-7. ">Saah 1986b</a>; <a href="./references#CD004876-bbs2-0104" title="StrassburgMA , GreenlandS , SorvilloFJ , LiebLE , HabelLA . Influenza in the elderly: report of an outbreak and a review of vaccine effectiveness reports. Vaccine1986;4(1):38-44. ">Strassburg 1986</a>; <a href="./references#CD004876-bbs2-0106" title="TaylorJL , DwyerDM , CoffmanT , GrovesC , PatelJ , IsraelE . Nursing home outbreak of influenza A (H3N2): evaluation of vaccine efficacy and influenza case definitions. Infection Control and Hospital Epidemiology1992;13(2):93-7. ">Taylor 1992</a>). We thus grouped our analyses by viral circulation and vaccine match. </p> <p>Efficacy of the vaccines against influenza was tested in only six data sets (1250 observations) (<a href="./references#CD004876-bbs2-0021" title="Cuneo CrovariP , GaspariniR , CrovariP . Efficacy of influenza vaccination: results in a community controlled for 2 years. Bollettino dell’Istituto Sieroterapico Milanese1980;59(4):306-13. ">Cuneo Crovari 1980</a>; <a href="./references#CD004876-bbs2-0031" title="FeeryBJ , EveredMG , MorrisonEI . Different protection rates in various groups of volunteers given subunit influenza virus vaccine in 1976. Journal of Infectious Diseases1979;139(2):237-41. ">Feery 1976</a>; <a href="./references#CD004876-bbs2-0041" title="GrossPA , QuinnanGV , RodsteinM , LaMontagneJR , KaslowRA , SaahAJ , et al. Association of influenza immunization with reduction in mortality in an elderly population. A prospective study. Archives of Internal Medicine1988;148(3):562-5. ">Gross 1988</a>; <a href="./references#CD004876-bbs2-0072" title="MorensDM , RashVM . Lessons from a nursing home outbreak of influenza A. Infection Control and Hospital Epidemiology1995;16(5):275-80. ">Morens 1995</a>; <a href="./references#CD004876-bbs2-0095" title="RubenFL , JohnstonF , StreiffEJ . Influenza in a partially immunized aged population. Effectiveness of killed Hong Kong vaccine against infection with the England strain. JAMA1974;230(6):863-6. ">Ruben 1974</a>; <a href="./references#CD004876-bbs2-0106" title="TaylorJL , DwyerDM , CoffmanT , GrovesC , PatelJ , IsraelE . Nursing home outbreak of influenza A (H3N2): evaluation of vaccine efficacy and influenza case definitions. Infection Control and Hospital Epidemiology1992;13(2):93-7. ">Taylor 1992</a>), and was not significant both for vaccine matching (RR 1.04, 95% CI 0.43 to 2.51; Analysis 6.1.1) and when matching was absent or unknown (RR 0.47, 95% CI 0.22 to 1.04; Analysis 6.1.2). </p> <p>Twenty‐two data sets assessed the effectiveness of influenza vaccines in preventing ILI (<a href="./references#CD004876-fig-0021" title="">Analysis 6.1</a>; <a href="./references#CD004876-fig-0022" title="">Analysis 6.2</a>). In these data sets, follow‐up was restricted to an outbreak period, and the authors reported a virologic surveillance that confirmed influenza virus circulation. </p> <p>The overall effectiveness of vaccines (VE) against ILI was 23% (6% to 36%; RR 0.77, 95% CI 0.64 to 0.94; Analysis 6.2.1) when vaccine matching was good and not significantly different from no vaccination (RR 0.80, 95% CI 0.60 to 1.05; Analysis 6.2.2) when matching was poor or unknown. Heterogeneity was high, even within the same influenza season and within the same institution when data from different accommodation blocks were analysed. We noted no association (correlation coefficient 0.09) between vaccine coverage and attack rate of ILI (<a href="#CD004876-fig-0002">Figure 2</a>). </p> <div class="figure" id="CD004876-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Relationship between vaccination rate and attack rate" data-id="CD004876-fig-0002" src="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-FIG-02.jpg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Relationship between vaccination rate and attack rate</p> </div> </div> </div> <p>The effectiveness of the vaccines in preventing pneumonia was assessed in 13 data sets (Analysis 6.3.1 and Analysis 6.3.2; 8446 observations). All of them reported virologic surveillance, and eight had follow‐ups shorter than three months (<a href="./references#CD004876-bbs2-0005" title="ArroyoJC , PosticB , BrownA , HarrisonK , BirgenheierR , DowdaH . Influenza A/Philippines/2/82 outbreak in a nursing home: limitations of influenza vaccination in the aged. American Journal of Infection Control1984;12(6):329-34. ">Arroyo 1984</a>; <a href="./references#CD004876-bbs2-0016" title="ColesFB , BalzanoGJ , MorseDL . An outbreak of influenza A (H3N2) in a well immunized nursing home population. Journal of the American Geriatrics Society1992;40(6):589-92. ">Coles 1992</a>; <a href="./references#CD004876-bbs2-0022" title="CurrierM , CoffmanT , BoydP , FremdB , IsraelE . Influenza vaccine efficacy in a Maryland nursing home. Maryland Medical Journal1988;37(10):781-3. ">Currier 1988</a>; <a href="./references#CD004876-bbs2-0045" title="HormanJT , StetlerHC , IsraelE , SorleyD , SchipperMT , JosephJM . An outbreak of influenza A in a nursing home. American Journal of Public Health1986;76(5):501-4. ">Horman 1986</a>; <a href="./references#CD004876-bbs2-0070" title="MeiklejohnG , HallH . Unusual outbreak of influenza A in a Wyoming nursing home. Journal of the American Geriatric Society1987;35(8):742-6. ">Meiklejohn 1987</a>; <a href="./references#CD004876-bbs2-0072" title="MorensDM , RashVM . Lessons from a nursing home outbreak of influenza A. Infection Control and Hospital Epidemiology1995;16(5):275-80. ">Morens 1995</a>; <a href="./references#CD004876-bbs2-0089" title="PatriarcaPA , WeberJA , ParkerRA , HallWN , KendalAP , BregmanDJ , et al. Efficacy of influenza vaccine in nursing homes. Reduction in illness and complications during an influenza A (H3N2) epidemic. JAMA1985;253(8):1136-9. ">Patriarca 1985a</a>; <a href="./references#CD004876-bbs2-0106" title="TaylorJL , DwyerDM , CoffmanT , GrovesC , PatelJ , IsraelE . Nursing home outbreak of influenza A (H3N2): evaluation of vaccine efficacy and influenza case definitions. Infection Control and Hospital Epidemiology1992;13(2):93-7. ">Taylor 1992</a>). Well‐matched vaccines were 46% (30% to 58%; Analysis 6.3.1) effective in preventing pneumonia (<a href="./references#CD004876-bbs2-0041" title="GrossPA , QuinnanGV , RodsteinM , LaMontagneJR , KaslowRA , SaahAJ , et al. Association of influenza immunization with reduction in mortality in an elderly population. A prospective study. Archives of Internal Medicine1988;148(3):562-5. ">Gross 1988</a>; <a href="./references#CD004876-bbs2-0045" title="HormanJT , StetlerHC , IsraelE , SorleyD , SchipperMT , JosephJM . An outbreak of influenza A in a nursing home. American Journal of Public Health1986;76(5):501-4. ">Horman 1986</a>; <a href="./references#CD004876-bbs2-0070" title="MeiklejohnG , HallH . Unusual outbreak of influenza A in a Wyoming nursing home. Journal of the American Geriatric Society1987;35(8):742-6. ">Meiklejohn 1987</a>; <a href="./references#CD004876-bbs2-0071" title="MontoAS , HornbuckleK , OhmitSE . Influenza vaccine effectiveness among elderly nursing home residents: a cohort study. American Journal of Epidemiology2001;154(2):155-60. ">Monto 2001</a>; <a href="./references#CD004876-bbs2-0072" title="MorensDM , RashVM . Lessons from a nursing home outbreak of influenza A. Infection Control and Hospital Epidemiology1995;16(5):275-80. ">Morens 1995</a>; <a href="./references#CD004876-bbs2-0089" title="PatriarcaPA , WeberJA , ParkerRA , HallWN , KendalAP , BregmanDJ , et al. Efficacy of influenza vaccine in nursing homes. Reduction in illness and complications during an influenza A (H3N2) epidemic. JAMA1985;253(8):1136-9. ">Patriarca 1985a</a>; <a href="./references#CD004876-bbs2-0098" title="SaahAJ , NeufeldR , RodsteinM , La MontagneJR , BlackwelderWC , GrossP , et al. Influenza vaccine and pneumonia mortality in a nursing home population. Archives of Internal Medicine1986;146(12):2353-7. ">Saah 1986b</a>; <a href="./references#CD004876-bbs2-0106" title="TaylorJL , DwyerDM , CoffmanT , GrovesC , PatelJ , IsraelE . Nursing home outbreak of influenza A (H3N2): evaluation of vaccine efficacy and influenza case definitions. Infection Control and Hospital Epidemiology1992;13(2):93-7. ">Taylor 1992</a>). When matching was poor or unknown (<a href="./references#CD004876-bbs2-0005" title="ArroyoJC , PosticB , BrownA , HarrisonK , BirgenheierR , DowdaH . Influenza A/Philippines/2/82 outbreak in a nursing home: limitations of influenza vaccination in the aged. American Journal of Infection Control1984;12(6):329-34. ">Arroyo 1984</a>; <a href="./references#CD004876-bbs2-0016" title="ColesFB , BalzanoGJ , MorseDL . An outbreak of influenza A (H3N2) in a well immunized nursing home population. Journal of the American Geriatrics Society1992;40(6):589-92. ">Coles 1992</a>; <a href="./references#CD004876-bbs2-0022" title="CurrierM , CoffmanT , BoydP , FremdB , IsraelE . Influenza vaccine efficacy in a Maryland nursing home. Maryland Medical Journal1988;37(10):781-3. ">Currier 1988</a>; <a href="./references#CD004876-bbs2-0057" title="LeungJCK . Effectiveness of influenza vaccination among elderly home residents in Hong Kong: a retrospective cohort study. Hong Kong Practitioner2007;29(4):123-33. ">Leung 2007</a>; <a href="./references#CD004876-bbs2-0097" title="SaahAJ , NeufeldR , RodsteinM , La MontagneJR , BlackwelderWC , GrossP , et al. Influenza vaccine and pneumonia mortality in a nursing home population. Archives of Internal Medicine1986;146(12):2353-7. ">Saah 1986a</a>), vaccines had no effect (RR 0.68, 95% CI 0.39 to 1.21; Analysis 6.3.2). Excluding studies with the longest follow‐up, that is six months, did not affect our conclusions (<a href="./references#CD004876-bbs2-0041" title="GrossPA , QuinnanGV , RodsteinM , LaMontagneJR , KaslowRA , SaahAJ , et al. Association of influenza immunization with reduction in mortality in an elderly population. A prospective study. Archives of Internal Medicine1988;148(3):562-5. ">Gross 1988</a>; <a href="./references#CD004876-bbs2-0097" title="SaahAJ , NeufeldR , RodsteinM , La MontagneJR , BlackwelderWC , GrossP , et al. Influenza vaccine and pneumonia mortality in a nursing home population. Archives of Internal Medicine1986;146(12):2353-7. ">Saah 1986a</a>; <a href="./references#CD004876-bbs2-0098" title="SaahAJ , NeufeldR , RodsteinM , La MontagneJR , BlackwelderWC , GrossP , et al. Influenza vaccine and pneumonia mortality in a nursing home population. Archives of Internal Medicine1986;146(12):2353-7. ">Saah 1986b</a>). </p> <p>Eight data sets assessed the effectiveness of well‐matched vaccines in preventing hospitalisation for influenza or pneumonia (<a href="./references#CD004876-bbs2-0004" title="ArdenNH , PatriarcaPA , FasanoMB , LuiKJ , HarmonMW , KendalAP , et al. The roles of vaccination and amantadine prophylaxis in controlling an outbreak of influenza A (H3N2) in a nursing home. Archives of Internal Medicine1988;148(4):865-8. ">Arden 1988</a>; <a href="./references#CD004876-bbs2-0009" title="CartterML , RenzulloPO , HelgersonSD , MartinSM , JekelJF . Influenza outbreaks in nursing homes: how effective is influenza vaccine in the institutionalized elderly?Infection Control and Hospital Epidemiology1990;11(9):473-8. ">Cartter 1990a</a>; <a href="./references#CD004876-bbs2-0010" title="CartterML , RenzulloPO , HelgersonSD , MartinSM , JekelJF . Influenza outbreaks in nursing homes: how effective is influenza vaccine in the institutionalized elderly?Infection Control and Hospital Epidemiology1990;11(9):473-8. ">Cartter 1990b</a>; <a href="./references#CD004876-bbs2-0011" title="CartterML , RenzulloPO , HelgersonSD , MartinSM , JekelJF . Influenza outbreaks in nursing homes: how effective is influenza vaccine in the institutionalized elderly?Infection Control and Hospital Epidemiology1990;11(9):473-8. ">Cartter 1990c</a>; <a href="./references#CD004876-bbs2-0070" title="MeiklejohnG , HallH . Unusual outbreak of influenza A in a Wyoming nursing home. Journal of the American Geriatric Society1987;35(8):742-6. ">Meiklejohn 1987</a>; <a href="./references#CD004876-bbs2-0075" title="MurayamaN , SuzukiH , ArakawaM , NeromeK , MizutaK , KameyamaK . Two outbreaks of influenza A (H3N2) in a Japanese nursing home in the winter of 1996-1997, with differing vaccine efficacy. Tohoku Journal of Experimental Medicine1999;188(4):289-98. ">Murayama 1999</a>; <a href="./references#CD004876-bbs2-0089" title="PatriarcaPA , WeberJA , ParkerRA , HallWN , KendalAP , BregmanDJ , et al. Efficacy of influenza vaccine in nursing homes. Reduction in illness and complications during an influenza A (H3N2) epidemic. JAMA1985;253(8):1136-9. ">Patriarca 1985a</a>; <a href="./references#CD004876-bbs2-0106" title="TaylorJL , DwyerDM , CoffmanT , GrovesC , PatelJ , IsraelE . Nursing home outbreak of influenza A (H3N2): evaluation of vaccine efficacy and influenza case definitions. Infection Control and Hospital Epidemiology1992;13(2):93-7. ">Taylor 1992</a>). All of them had a brief and well‐defined follow‐up; effectiveness was 45% (16% to 64%; Analysis 6.4.1). Two studies reported a non‐significant effect when the vaccine did not match the circulating strain or was not reported (Analysis 6.4.2) (<a href="./references#CD004876-bbs2-0016" title="ColesFB , BalzanoGJ , MorseDL . An outbreak of influenza A (H3N2) in a well immunized nursing home population. Journal of the American Geriatrics Society1992;40(6):589-92. ">Coles 1992</a>; <a href="./references#CD004876-bbs2-0057" title="LeungJCK . Effectiveness of influenza vaccination among elderly home residents in Hong Kong: a retrospective cohort study. Hong Kong Practitioner2007;29(4):123-33. ">Leung 2007</a>). </p> <p>Vaccination had a significant effect on the prevention of deaths due to influenza or pneumonia, though this was in the presence of considerable heterogeneity between the 20 data sets (Analysis 6.5.1 and Analysis 6.5.2) (<a href="./references#CD004876-bbs2-0005" title="ArroyoJC , PosticB , BrownA , HarrisonK , BirgenheierR , DowdaH . Influenza A/Philippines/2/82 outbreak in a nursing home: limitations of influenza vaccination in the aged. American Journal of Infection Control1984;12(6):329-34. ">Arroyo 1984</a>; <a href="./references#CD004876-bbs2-0009" title="CartterML , RenzulloPO , HelgersonSD , MartinSM , JekelJF . Influenza outbreaks in nursing homes: how effective is influenza vaccine in the institutionalized elderly?Infection Control and Hospital Epidemiology1990;11(9):473-8. ">Cartter 1990a</a>; <a href="./references#CD004876-bbs2-0010" title="CartterML , RenzulloPO , HelgersonSD , MartinSM , JekelJF . Influenza outbreaks in nursing homes: how effective is influenza vaccine in the institutionalized elderly?Infection Control and Hospital Epidemiology1990;11(9):473-8. ">Cartter 1990b</a>; <a href="./references#CD004876-bbs2-0011" title="CartterML , RenzulloPO , HelgersonSD , MartinSM , JekelJF . Influenza outbreaks in nursing homes: how effective is influenza vaccine in the institutionalized elderly?Infection Control and Hospital Epidemiology1990;11(9):473-8. ">Cartter 1990c</a>; <a href="./references#CD004876-bbs2-0016" title="ColesFB , BalzanoGJ , MorseDL . An outbreak of influenza A (H3N2) in a well immunized nursing home population. Journal of the American Geriatrics Society1992;40(6):589-92. ">Coles 1992</a>; <a href="./references#CD004876-bbs2-0031" title="FeeryBJ , EveredMG , MorrisonEI . Different protection rates in various groups of volunteers given subunit influenza virus vaccine in 1976. Journal of Infectious Diseases1979;139(2):237-41. ">Feery 1976</a>; <a href="./references#CD004876-bbs2-0034" title="FysonRE . Influenza outbreaks in two institutions for the elderly - Ontario. Canadian Diseases Weekly Report1983;9:37. ">Fyson 1983a</a>; <a href="./references#CD004876-bbs2-0035" title="FysonRE . Influenza outbreaks in two institutions for the elderly - Ontario. Canadian Diseases Weekly Report1983;9:37. ">Fyson 1983b</a>; <a href="./references#CD004876-bbs2-0038" title="GoodmanRA , OrensteinWA , MunroTF , SmithSC , SikesRK . Impact of influenza A in a nursing home. JAMA1982;247(10):1451-3. ">Goodman 1982</a>; <a href="./references#CD004876-bbs2-0045" title="HormanJT , StetlerHC , IsraelE , SorleyD , SchipperMT , JosephJM . An outbreak of influenza A in a nursing home. American Journal of Public Health1986;76(5):501-4. ">Horman 1986</a>; <a href="./references#CD004876-bbs2-0070" title="MeiklejohnG , HallH . Unusual outbreak of influenza A in a Wyoming nursing home. Journal of the American Geriatric Society1987;35(8):742-6. ">Meiklejohn 1987</a>; <a href="./references#CD004876-bbs2-0071" title="MontoAS , HornbuckleK , OhmitSE . Influenza vaccine effectiveness among elderly nursing home residents: a cohort study. American Journal of Epidemiology2001;154(2):155-60. ">Monto 2001</a>; <a href="./references#CD004876-bbs2-0072" title="MorensDM , RashVM . Lessons from a nursing home outbreak of influenza A. Infection Control and Hospital Epidemiology1995;16(5):275-80. ">Morens 1995</a>; <a href="./references#CD004876-bbs2-0075" title="MurayamaN , SuzukiH , ArakawaM , NeromeK , MizutaK , KameyamaK . Two outbreaks of influenza A (H3N2) in a Japanese nursing home in the winter of 1996-1997, with differing vaccine efficacy. Tohoku Journal of Experimental Medicine1999;188(4):289-98. ">Murayama 1999</a>; <a href="./references#CD004876-bbs2-0089" title="PatriarcaPA , WeberJA , ParkerRA , HallWN , KendalAP , BregmanDJ , et al. Efficacy of influenza vaccine in nursing homes. Reduction in illness and complications during an influenza A (H3N2) epidemic. JAMA1985;253(8):1136-9. ">Patriarca 1985a</a>; <a href="./references#CD004876-bbs2-0095" title="RubenFL , JohnstonF , StreiffEJ . Influenza in a partially immunized aged population. Effectiveness of killed Hong Kong vaccine against infection with the England strain. JAMA1974;230(6):863-6. ">Ruben 1974</a>; <a href="./references#CD004876-bbs2-0097" title="SaahAJ , NeufeldR , RodsteinM , La MontagneJR , BlackwelderWC , GrossP , et al. Influenza vaccine and pneumonia mortality in a nursing home population. Archives of Internal Medicine1986;146(12):2353-7. ">Saah 1986a</a>; <a href="./references#CD004876-bbs2-0098" title="SaahAJ , NeufeldR , RodsteinM , La MontagneJR , BlackwelderWC , GrossP , et al. Influenza vaccine and pneumonia mortality in a nursing home population. Archives of Internal Medicine1986;146(12):2353-7. ">Saah 1986b</a>; <a href="./references#CD004876-bbs2-0104" title="StrassburgMA , GreenlandS , SorvilloFJ , LiebLE , HabelLA . Influenza in the elderly: report of an outbreak and a review of vaccine effectiveness reports. Vaccine1986;4(1):38-44. ">Strassburg 1986</a>; <a href="./references#CD004876-bbs2-0106" title="TaylorJL , DwyerDM , CoffmanT , GrovesC , PatelJ , IsraelE . Nursing home outbreak of influenza A (H3N2): evaluation of vaccine efficacy and influenza case definitions. Infection Control and Hospital Epidemiology1992;13(2):93-7. ">Taylor 1992</a>). Eighteen studies reported virologic surveillance to confirm influenza virus circulation; of these, 16 had a follow‐up shorter than three months, and two had a four‐month follow‐up (<a href="./references#CD004876-bbs2-0031" title="FeeryBJ , EveredMG , MorrisonEI . Different protection rates in various groups of volunteers given subunit influenza virus vaccine in 1976. Journal of Infectious Diseases1979;139(2):237-41. ">Feery 1976</a>; <a href="./references#CD004876-bbs2-0071" title="MontoAS , HornbuckleK , OhmitSE . Influenza vaccine effectiveness among elderly nursing home residents: a cohort study. American Journal of Epidemiology2001;154(2):155-60. ">Monto 2001</a>). Two studies lacked virologic surveillance and had a follow‐up of six months (<a href="./references#CD004876-bbs2-0097" title="SaahAJ , NeufeldR , RodsteinM , La MontagneJR , BlackwelderWC , GrossP , et al. Influenza vaccine and pneumonia mortality in a nursing home population. Archives of Internal Medicine1986;146(12):2353-7. ">Saah 1986a</a>; <a href="./references#CD004876-bbs2-0098" title="SaahAJ , NeufeldR , RodsteinM , La MontagneJR , BlackwelderWC , GrossP , et al. Influenza vaccine and pneumonia mortality in a nursing home population. Archives of Internal Medicine1986;146(12):2353-7. ">Saah 1986b</a>). </p> <p>The vaccine was effective if it was a good match (VE 42%; 17% to 59%; Analysis 6.5.1), otherwise it was not effective (RR 0.34, 95% CI 0.11 to 1.02; Analysis 6.5.2). </p> <p>Excluding two studies with a six‐month follow‐up and absence of viral surveillance affects the summary estimate more than the efficacy in the 'epidemic‐matching' group, which drops from 42% to 39% (95% CI 12 to 58) (<a href="./references#CD004876-bbs2-0097" title="SaahAJ , NeufeldR , RodsteinM , La MontagneJR , BlackwelderWC , GrossP , et al. Influenza vaccine and pneumonia mortality in a nursing home population. Archives of Internal Medicine1986;146(12):2353-7. ">Saah 1986a</a>; <a href="./references#CD004876-bbs2-0098" title="SaahAJ , NeufeldR , RodsteinM , La MontagneJR , BlackwelderWC , GrossP , et al. Influenza vaccine and pneumonia mortality in a nursing home population. Archives of Internal Medicine1986;146(12):2353-7. ">Saah 1986b</a>). </p> <p>Only one small study with a six‐month follow‐up assessed the effectiveness in reducing all‐cause mortality (<a href="./references#CD004876-bbs2-0041" title="GrossPA , QuinnanGV , RodsteinM , LaMontagneJR , KaslowRA , SaahAJ , et al. Association of influenza immunization with reduction in mortality in an elderly population. A prospective study. Archives of Internal Medicine1988;148(3):562-5. ">Gross 1988</a>), which was found to be significant (60%; 23% to 79%; Analysis 6.6.1). </p> </section> <section id="CD004876-sec-0066"> <h5 class="title">Studies carried out during low viral circulation (from previous versions of the review)</h5> <p>Eleven data sets (27,283 observations) assessed the effects of influenza vaccines in 350 institutional facilities during low viral circulation (<a href="./references#CD004876-bbs2-0008" title="CaminitiC , RiccoD , TanziML , BorriniB , CorselloA , BiasioLR , et al. Field evaluation of influenza vaccine efficacy in a population of institutionalized elderly. L’igiene Moderna1994;101(2):163-75. ">Caminiti 1994</a>; <a href="./references#CD004876-bbs2-0027" title="DeguchiY , NishimuraK . Efficacy of influenza vaccine in elderly persons in welfare nursing homes: reduction in risks of mortality and morbidity during an influenza A (H3N2) epidemic. Journals of Gerontology. Series A, Biological Sciences and Medical Sciences2001;56(6):M391-4. ">Deguchi 2001</a>; <a href="./references#CD004876-bbs2-0046" title="HowarthDM , ChastonTM , LickissK , WeekesJR , O'DohertyC , FosterRE , et al. Age-related responses to influenza vaccination in the Newcastle region during 1983 and 1984. Medical Journal of Australia1987;146(10):514-7. ">Howarth 1987a</a>; <a href="./references#CD004876-bbs2-0047" title="HowarthDM , ChastonTM , LickissK , WeekesJR , O'DohertyC , FosterRE , et al. Age-related responses to influenza vaccination in the Newcastle region during 1983 and 1984. Medical Journal of Australia1987;146(10):514-7. ">Howarth 1987b</a>; <a href="./references#CD004876-bbs2-0048" title="HowellsCH , Vesselinova-JenkinsCK , EvansAD , JamesJ . Influenza vaccination and mortality from bronchopneumonia in the elderly. Lancet1975;1(7903):381-3. ">Howells 1975a</a>; <a href="./references#CD004876-bbs2-0049" title="HowellsCH , Vesselinova-JenkinsCK , EvansAD , JamesJ . Influenza vaccination and mortality from bronchopneumonia in the elderly. Lancet1975;1(7903):381-3. ">Howells 1975b</a>; <a href="./references#CD004876-bbs2-0050" title="HowellsCH , Vesselinova-JenkinsCK , EvansAD , JamesJ . Influenza vaccination and mortality from bronchopneumonia in the elderly. Lancet1975;1(7903):381-3. ">Howells 1975c</a>; <a href="./references#CD004876-bbs2-0090" title="PatriarcaPA , WeberJA , ParkerRA , HallWN , KendalAP , BregmanDJ , et al. Efficacy of influenza vaccine in nursing homes. Reduction in illness and complications during an influenza A (H3N2) epidemic. JAMA1985;253(8):1136-9. ">Patriarca 1985b</a>; <a href="./references#CD004876-bbs2-0099" title="SaahAJ , NeufeldR , RodsteinM , La MontagneJR , BlackwelderWC , GrossP , et al. Influenza vaccine and pneumonia mortality in a nursing home population. Archives of Internal Medicine1986;146(12):2353-7. ">Saah 1986c</a>; <a href="./references#CD004876-bbs2-0100" title="SaitoR , SuzukiH , OshitaniH , SakaiT , SekiN , TanabeN . The effectiveness of influenza vaccine against influenza A (H3N2) virus infections in nursing homes in Niigata, Japan, during the 1998-1999 and 1999-2000 seasons. Infection Control and Hospital Epidemiology2002;23(2):82-6. ">Saito 2002a</a>; <a href="./references#CD004876-bbs2-0101" title="SaitoR , SuzukiH , OshitaniH , SakaiT , SekiN , TanabeN . The effectiveness of influenza vaccine against influenza A (H3N2) virus infections in nursing homes in Niigata, Japan, during the 1998-1999 and 1999-2000 seasons. Infection Control and Hospital Epidemiology2002;23(2):82-6. ">Saito 2002b</a>). Apart from <a href="./references#CD004876-bbs2-0259" title="PatriarcaPA , WeberJA , MeissnerMK , StricofRL , DatenoB , BraunJE . Use of influenza vaccine in nursing homes. Journal of the American Geriatrics Society1985;33(7):463-6. ">Patriarca 1985</a>, in this subgroup we found studies with the longest (five to six months) and most poorly defined follow‐up. Two of these studies did not report virologic surveillance (<a href="./references#CD004876-bbs2-0027" title="DeguchiY , NishimuraK . Efficacy of influenza vaccine in elderly persons in welfare nursing homes: reduction in risks of mortality and morbidity during an influenza A (H3N2) epidemic. Journals of Gerontology. Series A, Biological Sciences and Medical Sciences2001;56(6):M391-4. ">Deguchi 2001</a>; <a href="./references#CD004876-bbs2-0099" title="SaahAJ , NeufeldR , RodsteinM , La MontagneJR , BlackwelderWC , GrossP , et al. Influenza vaccine and pneumonia mortality in a nursing home population. Archives of Internal Medicine1986;146(12):2353-7. ">Saah 1986c</a>). </p> <p>The vaccines were 33% effective (2% to 54%; Analysis 6.2.3) in preventing ILI (<a href="./references#CD004876-bbs2-0008" title="CaminitiC , RiccoD , TanziML , BorriniB , CorselloA , BiasioLR , et al. Field evaluation of influenza vaccine efficacy in a population of institutionalized elderly. L’igiene Moderna1994;101(2):163-75. ">Caminiti 1994</a>; <a href="./references#CD004876-bbs2-0090" title="PatriarcaPA , WeberJA , ParkerRA , HallWN , KendalAP , BregmanDJ , et al. Efficacy of influenza vaccine in nursing homes. Reduction in illness and complications during an influenza A (H3N2) epidemic. JAMA1985;253(8):1136-9. ">Patriarca 1985b</a>; <a href="./references#CD004876-bbs2-0100" title="SaitoR , SuzukiH , OshitaniH , SakaiT , SekiN , TanabeN . The effectiveness of influenza vaccine against influenza A (H3N2) virus infections in nursing homes in Niigata, Japan, during the 1998-1999 and 1999-2000 seasons. Infection Control and Hospital Epidemiology2002;23(2):82-6. ">Saito 2002a</a>; <a href="./references#CD004876-bbs2-0101" title="SaitoR , SuzukiH , OshitaniH , SakaiT , SekiN , TanabeN . The effectiveness of influenza vaccine against influenza A (H3N2) virus infections in nursing homes in Niigata, Japan, during the 1998-1999 and 1999-2000 seasons. Infection Control and Hospital Epidemiology2002;23(2):82-6. ">Saito 2002b</a>), but had no significant effects in preventing influenza (RR 0.23, 95% CI 0.05 to 1.03; Analysis 6.1.3). This observations is based on two data sets from a single, relatively small study (691 observations) (<a href="./references#CD004876-bbs2-0046" title="HowarthDM , ChastonTM , LickissK , WeekesJR , O'DohertyC , FosterRE , et al. Age-related responses to influenza vaccination in the Newcastle region during 1983 and 1984. Medical Journal of Australia1987;146(10):514-7. ">Howarth 1987a</a>; <a href="./references#CD004876-bbs2-0047" title="HowarthDM , ChastonTM , LickissK , WeekesJR , O'DohertyC , FosterRE , et al. Age-related responses to influenza vaccination in the Newcastle region during 1983 and 1984. Medical Journal of Australia1987;146(10):514-7. ">Howarth 1987b</a>). Both comparisons are from well‐matched vaccines. </p> <p>We identified a few data sets that assessed the effectiveness of vaccines in preventing complications. Four briefly reported data sets from two studies carried out in situations of low viral circulation and poor vaccine matching reported a combined effectiveness of 65% (32% to 82%; Analysis 6.3.4) in preventing pneumonia (<a href="./references#CD004876-bbs2-0048" title="HowellsCH , Vesselinova-JenkinsCK , EvansAD , JamesJ . Influenza vaccination and mortality from bronchopneumonia in the elderly. Lancet1975;1(7903):381-3. ">Howells 1975a</a>; <a href="./references#CD004876-bbs2-0049" title="HowellsCH , Vesselinova-JenkinsCK , EvansAD , JamesJ . Influenza vaccination and mortality from bronchopneumonia in the elderly. Lancet1975;1(7903):381-3. ">Howells 1975b</a>; <a href="./references#CD004876-bbs2-0050" title="HowellsCH , Vesselinova-JenkinsCK , EvansAD , JamesJ . Influenza vaccination and mortality from bronchopneumonia in the elderly. Lancet1975;1(7903):381-3. ">Howells 1975c</a>; <a href="./references#CD004876-bbs2-0099" title="SaahAJ , NeufeldR , RodsteinM , La MontagneJR , BlackwelderWC , GrossP , et al. Influenza vaccine and pneumonia mortality in a nursing home population. Archives of Internal Medicine1986;146(12):2353-7. ">Saah 1986c</a>). </p> <p>During periods of low viral circulation, vaccines did prevent hospital admission for pneumonia or influenza (VE 68%; 24% to 86%; Analysis 6.4.3). However, one of the included studies was at high risk of bias, meaning that this outcome may not be accurate (<a href="./references#CD004876-bbs2-0027" title="DeguchiY , NishimuraK . Efficacy of influenza vaccine in elderly persons in welfare nursing homes: reduction in risks of mortality and morbidity during an influenza A (H3N2) epidemic. Journals of Gerontology. Series A, Biological Sciences and Medical Sciences2001;56(6):M391-4. ">Deguchi 2001</a>). The study was set in 301 nursing homes comprising 22,462 elderly participants during the non‐epidemic 1998 to 1999 season in Japan. The same study has a large weight in the analysis of effectiveness against deaths by influenza and pneumonia (VE 71%; 43% to 85%; Analysis 6.5.3 and Analysis 6.5.4) (<a href="./references#CD004876-bbs2-0008" title="CaminitiC , RiccoD , TanziML , BorriniB , CorselloA , BiasioLR , et al. Field evaluation of influenza vaccine efficacy in a population of institutionalized elderly. L’igiene Moderna1994;101(2):163-75. ">Caminiti 1994</a>; <a href="./references#CD004876-bbs2-0027" title="DeguchiY , NishimuraK . Efficacy of influenza vaccine in elderly persons in welfare nursing homes: reduction in risks of mortality and morbidity during an influenza A (H3N2) epidemic. Journals of Gerontology. Series A, Biological Sciences and Medical Sciences2001;56(6):M391-4. ">Deguchi 2001</a>; <a href="./references#CD004876-bbs2-0048" title="HowellsCH , Vesselinova-JenkinsCK , EvansAD , JamesJ . Influenza vaccination and mortality from bronchopneumonia in the elderly. Lancet1975;1(7903):381-3. ">Howells 1975a</a>; <a href="./references#CD004876-bbs2-0049" title="HowellsCH , Vesselinova-JenkinsCK , EvansAD , JamesJ . Influenza vaccination and mortality from bronchopneumonia in the elderly. Lancet1975;1(7903):381-3. ">Howells 1975b</a>; <a href="./references#CD004876-bbs2-0050" title="HowellsCH , Vesselinova-JenkinsCK , EvansAD , JamesJ . Influenza vaccination and mortality from bronchopneumonia in the elderly. Lancet1975;1(7903):381-3. ">Howells 1975c</a>; <a href="./references#CD004876-bbs2-0090" title="PatriarcaPA , WeberJA , ParkerRA , HallWN , KendalAP , BregmanDJ , et al. Efficacy of influenza vaccine in nursing homes. Reduction in illness and complications during an influenza A (H3N2) epidemic. JAMA1985;253(8):1136-9. ">Patriarca 1985b</a>; <a href="./references#CD004876-bbs2-0099" title="SaahAJ , NeufeldR , RodsteinM , La MontagneJR , BlackwelderWC , GrossP , et al. Influenza vaccine and pneumonia mortality in a nursing home population. Archives of Internal Medicine1986;146(12):2353-7. ">Saah 1986c</a>). </p> </section> </section> <section id="CD004876-sec-0067"> <h4 class="title">Cohort studies in community‐dwelling elderly (from previous versions of the review)</h4> <p>We included 21 studies with 40 data sets in elderly participants living in open communities (<a href="./references#CD004876-bbs2-0012" title="ChristensonB , LundberghP , HedlundJ , OrtqvistA . Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in adults aged 65 years or older: a prospective study. Lancet2001;357(9261):1008-11. ">Christenson 2001a</a>; <a href="./references#CD004876-bbs2-0013" title="ChristensonB , LundberghP , HedlundJ , OrtqvistA . Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in adults aged 65 years or older: a prospective study. Lancet2001;357(9261):1008-11. ">Christenson 2001b</a>; <a href="./references#CD004876-bbs2-0014" title="ChristensonB , HedlundJ , LundberghP , OrtqvistA . Additive preventive effect of influenza and pneumococcal vaccines in elderly persons. European Respiratory Journal2004;23(3):363-8. ">Christenson 2004a</a>; <a href="./references#CD004876-bbs2-0015" title="ChristensonB , HedlundJ , LundberghP , OrtqvistA . Additive preventive effect of influenza and pneumococcal vaccines in elderly persons. European Respiratory Journal2004;23(3):363-8. ">Christenson 2004b</a>; <a href="./references#CD004876-bbs2-0017" title="ComeriL , TinellaM , CroceE , ArzeseM . Protective efficacy of antiinfluenza vaccination in the elderly. L’igiene Moderna1995;103(6):651-6. ">Comeri 1995</a>; <a href="./references#CD004876-bbs2-0018" title="ConsonniS , SandriniC , SegatoE , PerruchiniE , BergamaschiniL , VerganiC . Tolerability and efficacy of anti-influenza vaccination alone and associated with antipneumococcal vaccination in an elderly ambulatory population and adherence to the vaccination campaign. Journal of Preventive Medicine and Hygiene2004;45:45-50. ">Consonni 2004a</a>; <a href="./references#CD004876-bbs2-0019" title="ConsonniS , SandriniC , SegatoE , PerruchiniE , BergamaschiniL , VerganiC . Tolerability and efficacy of anti-influenza vaccination alone and associated with antipneumococcal vaccination in an elderly ambulatory population and adherence to the vaccination campaign. Journal of Preventive Medicine and Hygiene2004;45:45-50. ">Consonni 2004b</a>; <a href="./references#CD004876-bbs2-0024" title="DavisJW , LeeE , TairaDA , ChungRS . Influenza vaccination, hospitalizations, and costs among members of a Medicare managed care plan. Medical Care2001;39(12):1273-80. ">Davis 2001a</a>; <a href="./references#CD004876-bbs2-0025" title="DavisJW , LeeE , TairaDA , ChungRS . Influenza vaccination, hospitalizations, and costs among members of a Medicare managed care plan. Medical Care2001;39(12):1273-80. ">Davis 2001b</a>; <a href="./references#CD004876-bbs2-0026" title="DavisJW , LeeE , TairaDA , ChungRS . Influenza vaccination, hospitalizations, and costs among members of a Medicare managed care plan. Medical Care2001;39(12):1273-80. ">Davis 2001c</a>; <a href="./references#CD004876-bbs2-0032" title="FlemingDM , WatsonJM , NicholasS , SmithGE , SwanAV . Study of the effectiveness of influenza vaccination in the elderly in the epidemic of 1989-90 using a general practice database. Epidemiology and Infection1995;115(3):581-9. ">Fleming 1995</a>; <a href="./references#CD004876-bbs2-0036" title="Gavira IglesiasFJ , Rodriguez LopezFC , Berni MaestreRM . Analysis of an influenza vaccination campaign in rural environment. Revista de Sanidad e Higiene Publica1987;61(7-8):759-81. ">Gavira Iglesias 1987</a>; <a href="./references#CD004876-bbs2-0037" title="Gene BadiaJ , Calero MunozS , Castanera RibeC , Gran RoviretaA . Effectiveness of an anti-influenza vaccination program in 4 primary care centers. Gaceta Sanitaria1991;5(26):203-8. ">Gené Badia 1991</a>; <a href="./references#CD004876-bbs2-0042" title="HakE , NordinJ , WeiF , MulloolyJ , PobleteS , StrikasR , et al. Influence of high-risk medical conditions on the effectiveness of influenza vaccination among elderly members of 3 large managed-care organizations. Clinical Infectious Diseases2002;35(4):370-7. ">Hak 2002a</a>; <a href="./references#CD004876-bbs2-0043" title="HakE , NordinJ , WeiF , MulloolyJ , PobleteS , StrikasR , et al. Influence of high-risk medical conditions on the effectiveness of influenza vaccination among elderly members of 3 large managed-care organizations. Clinical Infectious Diseases2002;35(4):370-7. ">Hak 2002b</a>; <a href="./references#CD004876-bbs2-0044" title="HaraM , SakamotoT , TanakaK . Effectiveness of influenza vaccination in preventing influenza-like illness among community-dwelling elderly: population-based cohort study in Japan. Vaccine2006;24(27-8):5546-51. ">Hara 2006</a>; <a href="./references#CD004876-bbs2-0054" title="KawaiN , IkematsuH , IwakiN , SatohI , KawashimaT , TsuchimotoT , et al. A prospective, internet-based study of the effectiveness and safety of influenza vaccination in the 2001-2002 influenza season. Vaccine2003;21(31):4507-13. ">Kawai 2003</a>; <a href="./references#CD004876-bbs2-0058" title="Lopez HernandezB , VazquezJ , FernandezE , MartinezB , RomeroJ , ArribasL . Effectiveness of anti-flu vaccine in the elderly. Atencion Primaria1994;14(1):532-6. ">Lopez Hernandez 1994</a>; <a href="./references#CD004876-bbs2-0060" title="MangtaniP , CumberlandP , HodgsonCR , RobertsJA , CuttsFT , HallAJ . A cohort study of the effectiveness of influenza vaccine in older people, performed using the United Kingdom general practice research database. Journal of Infectious Diseases2004;190(1):1-10. ">Mangtani 2004b</a>; <a href="./references#CD004876-bbs2-0061" title="MangtaniP , CumberlandP , HodgsonCR , RobertsJA , CuttsFT , HallAJ . A cohort study of the effectiveness of influenza vaccine in older people, performed using the United Kingdom general practice research database. Journal of Infectious Diseases2004;190(1):1-10. ">Mangtani 2004c</a>; <a href="./references#CD004876-bbs2-0062" title="MangtaniP , CumberlandP , HodgsonCR , RobertsJA , CuttsFT , HallAJ . A cohort study of the effectiveness of influenza vaccine in older people, performed using the United Kingdom general practice research database. Journal of Infectious Diseases2004;190(1):1-10. ">Mangtani 2004d</a>; <a href="./references#CD004876-bbs2-0063" title="MangtaniP , CumberlandP , HodgsonCR , RobertsJA , CuttsFT , HallAJ . A cohort study of the effectiveness of influenza vaccine in older people, performed using the United Kingdom general practice research database. Journal of Infectious Diseases2004;190(1):1-10. ">Mangtani 2004e</a>; <a href="./references#CD004876-bbs2-0064" title="MangtaniP , CumberlandP , HodgsonCR , RobertsJA , CuttsFT , HallAJ . A cohort study of the effectiveness of influenza vaccine in older people, performed using the United Kingdom general practice research database. Journal of Infectious Diseases2004;190(1):1-10. ">Mangtani 2004f</a>; <a href="./references#CD004876-bbs2-0065" title="MangtaniP , CumberlandP , HodgsonCR , RobertsJA , CuttsFT , HallAJ . A cohort study of the effectiveness of influenza vaccine in older people, performed using the United Kingdom general practice research database. Journal of Infectious Diseases2004;190(1):1-10. ">Mangtani 2004g</a>; <a href="./references#CD004876-bbs2-0066" title="MangtaniP , CumberlandP , HodgsonCR , RobertsJA , CuttsFT , HallAJ . A cohort study of the effectiveness of influenza vaccine in older people, performed using the United Kingdom general practice research database. Journal of Infectious Diseases2004;190(1):1-10. ">Mangtani 2004h</a>; <a href="./references#CD004876-bbs2-0067" title="MangtaniP , CumberlandP , HodgsonCR , RobertsJA , CuttsFT , HallAJ . A cohort study of the effectiveness of influenza vaccine in older people, performed using the United Kingdom general practice research database. Journal of Infectious Diseases2004;190(1):1-10. ">Mangtani 2004i</a>; <a href="./references#CD004876-bbs2-0068" title="MangtaniP , CumberlandP , HodgsonCR , RobertsJA , CuttsFT , HallAJ . A cohort study of the effectiveness of influenza vaccine in older people, performed using the United Kingdom general practice research database. Journal of Infectious Diseases2004;190(1):1-10. ">Mangtani 2004j</a>; <a href="./references#CD004876-bbs2-0076" title="NicholKL , MargolisKL , WuorenmaJ , Von SternbergT . The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. New England Journal of Medicine1994;331(12):778-84. ">Nichol 1994a</a>; <a href="./references#CD004876-bbs2-0077" title="NicholKL , MargolisKL , WuorenmaJ , Von SternbergT . The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. New England Journal of Medicine1994;331(12):778-84. ">Nichol 1994b</a>; <a href="./references#CD004876-bbs2-0078" title="NicholKL , MargolisKL , WuorenmaJ , Von SternbergT . The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. New England Journal of Medicine1994;331(12):778-84. ">Nichol 1994c</a>; <a href="./references#CD004876-bbs2-0079" title="NicholKL , WuorenmaJ , vonSternbergT . Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens. Archives of Internal Medicine1998;158(16):1769-76. ">Nichol 1998a</a>; <a href="./references#CD004876-bbs2-0080" title="NicholKL , WuorenmaJ , vonSternbergT . Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens. Archives of Internal Medicine1998;158(16):1769-76. ">Nichol 1998b</a>; <a href="./references#CD004876-bbs2-0081" title="NicholKL , NordinJ , MulloolyJ , LaskR , FillbrandtK , IwaneM . Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. New England Journal of Medicine2003;348(14):1322-32. ">Nichol 2003a</a>; <a href="./references#CD004876-bbs2-0082" title="NicholKL , NordinJ , MulloolyJ , LaskR , FillbrandtK , IwaneM . Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. New England Journal of Medicine2003;348(14):1322-32. ">Nichol 2003b</a>; <a href="./references#CD004876-bbs2-0083" title="NicholsonKG , KentJ , HammersleyV . Influenza A among community-dwelling elderly persons in Leicestershire during winter 1993-4; cigarette smoking as a risk factor and the efficacy of influenza vaccination. Epidemiology and Infection1999;123(1):103-8. ">Nicholson 1999</a>; <a href="./references#CD004876-bbs2-0084" title="NordinJ , MulloolyJ , PobleteS , StrikasR , PetrucciR , WeiF , et al. Influenza vaccine effectiveness in preventing hospitalizations and deaths in persons 65 years or older in Minnesota, New York, and Oregon: data from 3 health plans. Journal of Infectious Diseases2001;184(6):665-70. ">Nordin 2001a</a>; <a href="./references#CD004876-bbs2-0085" title="NordinJ , MulloolyJ , PobleteS , StrikasR , PetrucciR , WeiF , et al. Influenza vaccine effectiveness in preventing hospitalizations and deaths in persons 65 years or older in Minnesota, New York, and Oregon: data from 3 health plans. Journal of Infectious Diseases2001;184(6):665-70. ">Nordin 2001b</a>; <a href="./references#CD004876-bbs2-0091" title="PregliascoF , GiardiniG , SandriniMC , PerucchiniE , VerganiC . Protective efficacy of Inflexal V in the elderly pazinte [Efficacia protettiva di Inflexal V nel pazinte anziano]. Vaccine at a Glance2002;1(1):2-5. ">Pregliasco 2002</a>; <a href="./references#CD004876-bbs2-0103" title='ShapiroY , ShemerJ , HeymannA , ShalevV , MaharshakN , ChodikG , et al. Influenza vaccination: reduction in hospitalizations and death rates among members of "Maccabi Healthcare Services" during the 2000-2001 influenza season. Israel Medical Association Journal2003;5(10):706-8. '>Shapiro 2003</a>; <a href="./references#CD004876-bbs2-0108" title="VoordouwBC , van derLindenPD , SimonianS , van derLeiJ , SturkenboomMC , StrickerBH . Influenza vaccination in community-dwelling elderly: impact on mortality and influenza-associated morbidity. Archives of Internal Medicine2003;163(9):1089-94. ">Voordouw 2003</a>). The studies contained over 3 million observations, mainly collected using data‐linkage from insurance reimbursement, hospital, or primary care databases; 13 of these studies reported data stratified or adjusted by risk factors and other potential confounders. These studies had long follow‐ups: 12 data sets had a follow‐up =&lt; 3 months; 13 data sets had a follow‐up ranging from 4 to 5 months; 8 data sets had a follow‐up ranging from 6 to 7 months; 4 data sets had a follow‐up ranging from 8 to 12 months; and 2 data sets were without a well‐defined follow‐up. In nine data sets, follow‐up was defined by relying on virologic surveillance, and three data sets had laboratory confirmation of cases. On the basis of this large body of evidence, we divided our analysis into six separate comparisons. </p> <section id="CD004876-sec-0068"> <h5 class="title">Inactivated influenza vaccines in all community‐dwelling elderly (from previous versions of the review) </h5> <p>Our second comparison relied on 1 million observations in 20 data sets from 16 studies (<a href="./references#CD004876-bbs2-0012" title="ChristensonB , LundberghP , HedlundJ , OrtqvistA . Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in adults aged 65 years or older: a prospective study. Lancet2001;357(9261):1008-11. ">Christenson 2001a</a>; <a href="./references#CD004876-bbs2-0014" title="ChristensonB , HedlundJ , LundberghP , OrtqvistA . Additive preventive effect of influenza and pneumococcal vaccines in elderly persons. European Respiratory Journal2004;23(3):363-8. ">Christenson 2004a</a>; <a href="./references#CD004876-bbs2-0017" title="ComeriL , TinellaM , CroceE , ArzeseM . Protective efficacy of antiinfluenza vaccination in the elderly. L’igiene Moderna1995;103(6):651-6. ">Comeri 1995</a>; <a href="./references#CD004876-bbs2-0026" title="DavisJW , LeeE , TairaDA , ChungRS . Influenza vaccination, hospitalizations, and costs among members of a Medicare managed care plan. Medical Care2001;39(12):1273-80. ">Davis 2001c</a>; <a href="./references#CD004876-bbs2-0032" title="FlemingDM , WatsonJM , NicholasS , SmithGE , SwanAV . Study of the effectiveness of influenza vaccination in the elderly in the epidemic of 1989-90 using a general practice database. Epidemiology and Infection1995;115(3):581-9. ">Fleming 1995</a>; <a href="./references#CD004876-bbs2-0036" title="Gavira IglesiasFJ , Rodriguez LopezFC , Berni MaestreRM . Analysis of an influenza vaccination campaign in rural environment. Revista de Sanidad e Higiene Publica1987;61(7-8):759-81. ">Gavira Iglesias 1987</a>; <a href="./references#CD004876-bbs2-0037" title="Gene BadiaJ , Calero MunozS , Castanera RibeC , Gran RoviretaA . Effectiveness of an anti-influenza vaccination program in 4 primary care centers. Gaceta Sanitaria1991;5(26):203-8. ">Gené Badia 1991</a>; <a href="./references#CD004876-bbs2-0044" title="HaraM , SakamotoT , TanakaK . Effectiveness of influenza vaccination in preventing influenza-like illness among community-dwelling elderly: population-based cohort study in Japan. Vaccine2006;24(27-8):5546-51. ">Hara 2006</a>; <a href="./references#CD004876-bbs2-0054" title="KawaiN , IkematsuH , IwakiN , SatohI , KawashimaT , TsuchimotoT , et al. A prospective, internet-based study of the effectiveness and safety of influenza vaccination in the 2001-2002 influenza season. Vaccine2003;21(31):4507-13. ">Kawai 2003</a>; <a href="./references#CD004876-bbs2-0058" title="Lopez HernandezB , VazquezJ , FernandezE , MartinezB , RomeroJ , ArribasL . Effectiveness of anti-flu vaccine in the elderly. Atencion Primaria1994;14(1):532-6. ">Lopez Hernandez 1994</a>; <a href="./references#CD004876-bbs2-0059" title="MangtaniP , CumberlandP , HodgsonCR , RobertsJA , CuttsFT , HallAJ . A cohort study of the effectiveness of influenza vaccine in older people, performed using the United Kingdom general practice research database. Journal of Infectious Diseases2004;190(1):1-10. ">Mangtani 2004a</a>; <a href="./references#CD004876-bbs2-0076" title="NicholKL , MargolisKL , WuorenmaJ , Von SternbergT . The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. New England Journal of Medicine1994;331(12):778-84. ">Nichol 1994a</a>; <a href="./references#CD004876-bbs2-0077" title="NicholKL , MargolisKL , WuorenmaJ , Von SternbergT . The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. New England Journal of Medicine1994;331(12):778-84. ">Nichol 1994b</a>; <a href="./references#CD004876-bbs2-0078" title="NicholKL , MargolisKL , WuorenmaJ , Von SternbergT . The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. New England Journal of Medicine1994;331(12):778-84. ">Nichol 1994c</a>; <a href="./references#CD004876-bbs2-0080" title="NicholKL , WuorenmaJ , vonSternbergT . Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens. Archives of Internal Medicine1998;158(16):1769-76. ">Nichol 1998b</a>; <a href="./references#CD004876-bbs2-0081" title="NicholKL , NordinJ , MulloolyJ , LaskR , FillbrandtK , IwaneM . Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. New England Journal of Medicine2003;348(14):1322-32. ">Nichol 2003a</a>; <a href="./references#CD004876-bbs2-0082" title="NicholKL , NordinJ , MulloolyJ , LaskR , FillbrandtK , IwaneM . Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. New England Journal of Medicine2003;348(14):1322-32. ">Nichol 2003b</a>; <a href="./references#CD004876-bbs2-0083" title="NicholsonKG , KentJ , HammersleyV . Influenza A among community-dwelling elderly persons in Leicestershire during winter 1993-4; cigarette smoking as a risk factor and the efficacy of influenza vaccination. Epidemiology and Infection1999;123(1):103-8. ">Nicholson 1999</a>; <a href="./references#CD004876-bbs2-0103" title='ShapiroY , ShemerJ , HeymannA , ShalevV , MaharshakN , ChodikG , et al. Influenza vaccination: reduction in hospitalizations and death rates among members of "Maccabi Healthcare Services" during the 2000-2001 influenza season. Israel Medical Association Journal2003;5(10):706-8. '>Shapiro 2003</a>; <a href="./references#CD004876-bbs2-0108" title="VoordouwBC , van derLindenPD , SimonianS , van derLeiJ , SturkenboomMC , StrickerBH . Influenza vaccination in community-dwelling elderly: impact on mortality and influenza-associated morbidity. Archives of Internal Medicine2003;163(9):1089-94. ">Voordouw 2003</a>). </p> <p>In elderly individuals living in the community, inactivated influenza vaccines were not effective against ILI, influenza, or pneumonia. No comparison provided enough data for stratification by viral circulation and vaccine matching. </p> <p>Eight data sets (784,643 observations) with medium to long follow‐up (135 to 365 days) addressed vaccine effectiveness against hospitalisations for influenza or pneumonia (<a href="./references#CD004876-bbs2-0012" title="ChristensonB , LundberghP , HedlundJ , OrtqvistA . Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in adults aged 65 years or older: a prospective study. Lancet2001;357(9261):1008-11. ">Christenson 2001a</a>; <a href="./references#CD004876-bbs2-0014" title="ChristensonB , HedlundJ , LundberghP , OrtqvistA . Additive preventive effect of influenza and pneumococcal vaccines in elderly persons. European Respiratory Journal2004;23(3):363-8. ">Christenson 2004a</a>; <a href="./references#CD004876-bbs2-0076" title="NicholKL , MargolisKL , WuorenmaJ , Von SternbergT . The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. New England Journal of Medicine1994;331(12):778-84. ">Nichol 1994a</a>; <a href="./references#CD004876-bbs2-0077" title="NicholKL , MargolisKL , WuorenmaJ , Von SternbergT . The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. New England Journal of Medicine1994;331(12):778-84. ">Nichol 1994b</a>; <a href="./references#CD004876-bbs2-0078" title="NicholKL , MargolisKL , WuorenmaJ , Von SternbergT . The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. New England Journal of Medicine1994;331(12):778-84. ">Nichol 1994c</a>; <a href="./references#CD004876-bbs2-0080" title="NicholKL , WuorenmaJ , vonSternbergT . Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens. Archives of Internal Medicine1998;158(16):1769-76. ">Nichol 1998b</a>; <a href="./references#CD004876-bbs2-0081" title="NicholKL , NordinJ , MulloolyJ , LaskR , FillbrandtK , IwaneM . Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. New England Journal of Medicine2003;348(14):1322-32. ">Nichol 2003a</a>; <a href="./references#CD004876-bbs2-0082" title="NicholKL , NordinJ , MulloolyJ , LaskR , FillbrandtK , IwaneM . Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. New England Journal of Medicine2003;348(14):1322-32. ">Nichol 2003b</a>). Well‐matched vaccines prevented hospital admissions for these illnesses (VE 26%; 12% to 38%; Analysis 8.4.1) but not for cardiac disease (RR 0.87, 95% CI 0.67 to 1.12; <a href="./references#CD004876-fig-0037" title="">Analysis 8.9</a>). Excluding the only study with a one‐year follow‐up (<a href="./references#CD004876-bbs2-0014" title="ChristensonB , HedlundJ , LundberghP , OrtqvistA . Additive preventive effect of influenza and pneumococcal vaccines in elderly persons. European Respiratory Journal2004;23(3):363-8. ">Christenson 2004a</a>), effectiveness in preventing hospital admissions was increased to 29% (95% CI 14 to 42). </p> </section> <section id="CD004876-sec-0069"> <h5 class="title">Inactivated influenza vaccines in all community‐dwelling elderly (adjusted for confounders) (from previous versions of the review) </h5> <p>This is another data set with seven studies contributing 19 data sets with over a million observations from several consecutive influenza seasons (<a href="./references#CD004876-bbs2-0024" title="DavisJW , LeeE , TairaDA , ChungRS . Influenza vaccination, hospitalizations, and costs among members of a Medicare managed care plan. Medical Care2001;39(12):1273-80. ">Davis 2001a</a>; <a href="./references#CD004876-bbs2-0025" title="DavisJW , LeeE , TairaDA , ChungRS . Influenza vaccination, hospitalizations, and costs among members of a Medicare managed care plan. Medical Care2001;39(12):1273-80. ">Davis 2001b</a>; <a href="./references#CD004876-bbs2-0026" title="DavisJW , LeeE , TairaDA , ChungRS . Influenza vaccination, hospitalizations, and costs among members of a Medicare managed care plan. Medical Care2001;39(12):1273-80. ">Davis 2001c</a>; <a href="./references#CD004876-bbs2-0032" title="FlemingDM , WatsonJM , NicholasS , SmithGE , SwanAV . Study of the effectiveness of influenza vaccination in the elderly in the epidemic of 1989-90 using a general practice database. Epidemiology and Infection1995;115(3):581-9. ">Fleming 1995</a>; <a href="./references#CD004876-bbs2-0060" title="MangtaniP , CumberlandP , HodgsonCR , RobertsJA , CuttsFT , HallAJ . A cohort study of the effectiveness of influenza vaccine in older people, performed using the United Kingdom general practice research database. Journal of Infectious Diseases2004;190(1):1-10. ">Mangtani 2004b</a>; <a href="./references#CD004876-bbs2-0061" title="MangtaniP , CumberlandP , HodgsonCR , RobertsJA , CuttsFT , HallAJ . A cohort study of the effectiveness of influenza vaccine in older people, performed using the United Kingdom general practice research database. Journal of Infectious Diseases2004;190(1):1-10. ">Mangtani 2004c</a>; <a href="./references#CD004876-bbs2-0062" title="MangtaniP , CumberlandP , HodgsonCR , RobertsJA , CuttsFT , HallAJ . A cohort study of the effectiveness of influenza vaccine in older people, performed using the United Kingdom general practice research database. Journal of Infectious Diseases2004;190(1):1-10. ">Mangtani 2004d</a>; <a href="./references#CD004876-bbs2-0063" title="MangtaniP , CumberlandP , HodgsonCR , RobertsJA , CuttsFT , HallAJ . A cohort study of the effectiveness of influenza vaccine in older people, performed using the United Kingdom general practice research database. Journal of Infectious Diseases2004;190(1):1-10. ">Mangtani 2004e</a>; <a href="./references#CD004876-bbs2-0064" title="MangtaniP , CumberlandP , HodgsonCR , RobertsJA , CuttsFT , HallAJ . A cohort study of the effectiveness of influenza vaccine in older people, performed using the United Kingdom general practice research database. Journal of Infectious Diseases2004;190(1):1-10. ">Mangtani 2004f</a>; <a href="./references#CD004876-bbs2-0065" title="MangtaniP , CumberlandP , HodgsonCR , RobertsJA , CuttsFT , HallAJ . A cohort study of the effectiveness of influenza vaccine in older people, performed using the United Kingdom general practice research database. Journal of Infectious Diseases2004;190(1):1-10. ">Mangtani 2004g</a>; <a href="./references#CD004876-bbs2-0066" title="MangtaniP , CumberlandP , HodgsonCR , RobertsJA , CuttsFT , HallAJ . A cohort study of the effectiveness of influenza vaccine in older people, performed using the United Kingdom general practice research database. Journal of Infectious Diseases2004;190(1):1-10. ">Mangtani 2004h</a>; <a href="./references#CD004876-bbs2-0067" title="MangtaniP , CumberlandP , HodgsonCR , RobertsJA , CuttsFT , HallAJ . A cohort study of the effectiveness of influenza vaccine in older people, performed using the United Kingdom general practice research database. Journal of Infectious Diseases2004;190(1):1-10. ">Mangtani 2004i</a>; <a href="./references#CD004876-bbs2-0068" title="MangtaniP , CumberlandP , HodgsonCR , RobertsJA , CuttsFT , HallAJ . A cohort study of the effectiveness of influenza vaccine in older people, performed using the United Kingdom general practice research database. Journal of Infectious Diseases2004;190(1):1-10. ">Mangtani 2004j</a>; <a href="./references#CD004876-bbs2-0079" title="NicholKL , WuorenmaJ , vonSternbergT . Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens. Archives of Internal Medicine1998;158(16):1769-76. ">Nichol 1998a</a>; <a href="./references#CD004876-bbs2-0081" title="NicholKL , NordinJ , MulloolyJ , LaskR , FillbrandtK , IwaneM . Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. New England Journal of Medicine2003;348(14):1322-32. ">Nichol 2003a</a>; <a href="./references#CD004876-bbs2-0082" title="NicholKL , NordinJ , MulloolyJ , LaskR , FillbrandtK , IwaneM . Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. New England Journal of Medicine2003;348(14):1322-32. ">Nichol 2003b</a>; <a href="./references#CD004876-bbs2-0084" title="NordinJ , MulloolyJ , PobleteS , StrikasR , PetrucciR , WeiF , et al. Influenza vaccine effectiveness in preventing hospitalizations and deaths in persons 65 years or older in Minnesota, New York, and Oregon: data from 3 health plans. Journal of Infectious Diseases2001;184(6):665-70. ">Nordin 2001a</a>; <a href="./references#CD004876-bbs2-0085" title="NordinJ , MulloolyJ , PobleteS , StrikasR , PetrucciR , WeiF , et al. Influenza vaccine effectiveness in preventing hospitalizations and deaths in persons 65 years or older in Minnesota, New York, and Oregon: data from 3 health plans. Journal of Infectious Diseases2001;184(6):665-70. ">Nordin 2001b</a>; <a href="./references#CD004876-bbs2-0108" title="VoordouwBC , van derLindenPD , SimonianS , van derLeiJ , SturkenboomMC , StrickerBH . Influenza vaccination in community-dwelling elderly: impact on mortality and influenza-associated morbidity. Archives of Internal Medicine2003;163(9):1089-94. ">Voordouw 2003</a>). Most of the studies included in this analysis used data linkage and adjusted their odds ratio (OR) calculations to allow for the effect of confounding of several variables (sex, age, smoking, comorbidities). The effects of the vaccines were all significant. </p> <p>Hospitalisations for influenza or pneumonia: eight data sets (based on 949,215 observations), all but one with a follow‐up lasting 135 days (OR 0.73, 95% CI 0.67 to 0.79; <a href="./references#CD004876-fig-0039" title="">Analysis 9.1</a>) (<a href="./references#CD004876-bbs2-0024" title="DavisJW , LeeE , TairaDA , ChungRS . Influenza vaccination, hospitalizations, and costs among members of a Medicare managed care plan. Medical Care2001;39(12):1273-80. ">Davis 2001a</a>; <a href="./references#CD004876-bbs2-0025" title="DavisJW , LeeE , TairaDA , ChungRS . Influenza vaccination, hospitalizations, and costs among members of a Medicare managed care plan. Medical Care2001;39(12):1273-80. ">Davis 2001b</a>; <a href="./references#CD004876-bbs2-0026" title="DavisJW , LeeE , TairaDA , ChungRS . Influenza vaccination, hospitalizations, and costs among members of a Medicare managed care plan. Medical Care2001;39(12):1273-80. ">Davis 2001c</a>; <a href="./references#CD004876-bbs2-0079" title="NicholKL , WuorenmaJ , vonSternbergT . Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens. Archives of Internal Medicine1998;158(16):1769-76. ">Nichol 1998a</a>; <a href="./references#CD004876-bbs2-0081" title="NicholKL , NordinJ , MulloolyJ , LaskR , FillbrandtK , IwaneM . Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. New England Journal of Medicine2003;348(14):1322-32. ">Nichol 2003a</a>; <a href="./references#CD004876-bbs2-0082" title="NicholKL , NordinJ , MulloolyJ , LaskR , FillbrandtK , IwaneM . Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. New England Journal of Medicine2003;348(14):1322-32. ">Nichol 2003b</a>; <a href="./references#CD004876-bbs2-0085" title="NordinJ , MulloolyJ , PobleteS , StrikasR , PetrucciR , WeiF , et al. Influenza vaccine effectiveness in preventing hospitalizations and deaths in persons 65 years or older in Minnesota, New York, and Oregon: data from 3 health plans. Journal of Infectious Diseases2001;184(6):665-70. ">Nordin 2001b</a>). Excluding the data set with the longest follow‐up (eight months), <a href="./references#CD004876-bbs2-0084" title="NordinJ , MulloolyJ , PobleteS , StrikasR , PetrucciR , WeiF , et al. Influenza vaccine effectiveness in preventing hospitalizations and deaths in persons 65 years or older in Minnesota, New York, and Oregon: data from 3 health plans. Journal of Infectious Diseases2001;184(6):665-70. ">Nordin 2001a</a>, did not change the result. </p> <p>Hospitalisations for respiratory diseases: OR 0.78, 95% CI 0.72 to 0.85 (<a href="./references#CD004876-fig-0040" title="">Analysis 9.2</a>). Data sets have a follow‐up of 135 days or less, so a sensitivity analysis appears to be superfluous. </p> <p>Hospitalisation for cardiac disease: OR 0.76, 95% CI 0.70 to 0.82 (<a href="./references#CD004876-fig-0041" title="">Analysis 9.3</a>). Data sets have a follow‐up of 135 days or less, so a sensitivity analysis appears to be superfluous. </p> <p>Mortality due to all causes: seven data sets with follow‐up ranging from 75 to 240 days: OR 0.53, 95% CI 0.46 to 0.61 (<a href="./references#CD004876-fig-0042" title="">Analysis 9.4</a>) (<a href="./references#CD004876-bbs2-0032" title="FlemingDM , WatsonJM , NicholasS , SmithGE , SwanAV . Study of the effectiveness of influenza vaccination in the elderly in the epidemic of 1989-90 using a general practice database. Epidemiology and Infection1995;115(3):581-9. ">Fleming 1995</a>; <a href="./references#CD004876-bbs2-0079" title="NicholKL , WuorenmaJ , vonSternbergT . Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens. Archives of Internal Medicine1998;158(16):1769-76. ">Nichol 1998a</a>; <a href="./references#CD004876-bbs2-0081" title="NicholKL , NordinJ , MulloolyJ , LaskR , FillbrandtK , IwaneM . Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. New England Journal of Medicine2003;348(14):1322-32. ">Nichol 2003a</a>; <a href="./references#CD004876-bbs2-0082" title="NicholKL , NordinJ , MulloolyJ , LaskR , FillbrandtK , IwaneM . Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. New England Journal of Medicine2003;348(14):1322-32. ">Nichol 2003b</a>; <a href="./references#CD004876-bbs2-0084" title="NordinJ , MulloolyJ , PobleteS , StrikasR , PetrucciR , WeiF , et al. Influenza vaccine effectiveness in preventing hospitalizations and deaths in persons 65 years or older in Minnesota, New York, and Oregon: data from 3 health plans. Journal of Infectious Diseases2001;184(6):665-70. ">Nordin 2001a</a>; <a href="./references#CD004876-bbs2-0085" title="NordinJ , MulloolyJ , PobleteS , StrikasR , PetrucciR , WeiF , et al. Influenza vaccine effectiveness in preventing hospitalizations and deaths in persons 65 years or older in Minnesota, New York, and Oregon: data from 3 health plans. Journal of Infectious Diseases2001;184(6):665-70. ">Nordin 2001b</a>; <a href="./references#CD004876-bbs2-0108" title="VoordouwBC , van derLindenPD , SimonianS , van derLeiJ , SturkenboomMC , StrickerBH . Influenza vaccination in community-dwelling elderly: impact on mortality and influenza-associated morbidity. Archives of Internal Medicine2003;163(9):1089-94. ">Voordouw 2003</a>). Excluding data sets with a follow‐up period equal to or longer than six months, <a href="./references#CD004876-bbs2-0084" title="NordinJ , MulloolyJ , PobleteS , StrikasR , PetrucciR , WeiF , et al. Influenza vaccine effectiveness in preventing hospitalizations and deaths in persons 65 years or older in Minnesota, New York, and Oregon: data from 3 health plans. Journal of Infectious Diseases2001;184(6):665-70. ">Nordin 2001a</a> and <a href="./references#CD004876-bbs2-0108" title="VoordouwBC , van derLindenPD , SimonianS , van derLeiJ , SturkenboomMC , StrickerBH . Influenza vaccination in community-dwelling elderly: impact on mortality and influenza-associated morbidity. Archives of Internal Medicine2003;163(9):1089-94. ">Voordouw 2003</a>, did not change the final result. </p> <p>Death from respiratory disease was not significantly affected. Seven data sets with a follow‐up ranging from 75 to 210 days assessed the effect on mortality due to all causes (VE 42%; 24% to 55%; <a href="./references#CD004876-fig-0036" title="">Analysis 8.8</a>) (<a href="./references#CD004876-bbs2-0032" title="FlemingDM , WatsonJM , NicholasS , SmithGE , SwanAV . Study of the effectiveness of influenza vaccination in the elderly in the epidemic of 1989-90 using a general practice database. Epidemiology and Infection1995;115(3):581-9. ">Fleming 1995</a>; <a href="./references#CD004876-bbs2-0037" title="Gene BadiaJ , Calero MunozS , Castanera RibeC , Gran RoviretaA . Effectiveness of an anti-influenza vaccination program in 4 primary care centers. Gaceta Sanitaria1991;5(26):203-8. ">Gené Badia 1991</a>; <a href="./references#CD004876-bbs2-0058" title="Lopez HernandezB , VazquezJ , FernandezE , MartinezB , RomeroJ , ArribasL . Effectiveness of anti-flu vaccine in the elderly. Atencion Primaria1994;14(1):532-6. ">Lopez Hernandez 1994</a>; <a href="./references#CD004876-bbs2-0081" title="NicholKL , NordinJ , MulloolyJ , LaskR , FillbrandtK , IwaneM . Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. New England Journal of Medicine2003;348(14):1322-32. ">Nichol 2003a</a>; <a href="./references#CD004876-bbs2-0082" title="NicholKL , NordinJ , MulloolyJ , LaskR , FillbrandtK , IwaneM . Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. New England Journal of Medicine2003;348(14):1322-32. ">Nichol 2003b</a>; <a href="./references#CD004876-bbs2-0103" title='ShapiroY , ShemerJ , HeymannA , ShalevV , MaharshakN , ChodikG , et al. Influenza vaccination: reduction in hospitalizations and death rates among members of "Maccabi Healthcare Services" during the 2000-2001 influenza season. Israel Medical Association Journal2003;5(10):706-8. '>Shapiro 2003</a>; <a href="./references#CD004876-bbs2-0108" title="VoordouwBC , van derLindenPD , SimonianS , van derLeiJ , SturkenboomMC , StrickerBH . Influenza vaccination in community-dwelling elderly: impact on mortality and influenza-associated morbidity. Archives of Internal Medicine2003;163(9):1089-94. ">Voordouw 2003</a>). Excluding four data sets with a follow‐up equal to or longer than six months, <a href="./references#CD004876-bbs2-0037" title="Gene BadiaJ , Calero MunozS , Castanera RibeC , Gran RoviretaA . Effectiveness of an anti-influenza vaccination program in 4 primary care centers. Gaceta Sanitaria1991;5(26):203-8. ">Gené Badia 1991</a>, <a href="./references#CD004876-bbs2-0058" title="Lopez HernandezB , VazquezJ , FernandezE , MartinezB , RomeroJ , ArribasL . Effectiveness of anti-flu vaccine in the elderly. Atencion Primaria1994;14(1):532-6. ">Lopez Hernandez 1994</a>, <a href="./references#CD004876-bbs2-0108" title="VoordouwBC , van derLindenPD , SimonianS , van derLeiJ , SturkenboomMC , StrickerBH . Influenza vaccination in community-dwelling elderly: impact on mortality and influenza-associated morbidity. Archives of Internal Medicine2003;163(9):1089-94. ">Voordouw 2003</a>, or a non‐defined follow‐up (<a href="./references#CD004876-bbs2-0103" title='ShapiroY , ShemerJ , HeymannA , ShalevV , MaharshakN , ChodikG , et al. Influenza vaccination: reduction in hospitalizations and death rates among members of "Maccabi Healthcare Services" during the 2000-2001 influenza season. Israel Medical Association Journal2003;5(10):706-8. '>Shapiro 2003</a>), the efficacy falls from 42% to 39% (95% CI 28 to 49). </p> </section> <section id="CD004876-sec-0070"> <h5 class="title">Inactivated influenza vaccines in community‐dwelling elderly at risk of influenza complications (from previous versions of the review) </h5> <p>In the third comparison, we assessed the effectiveness of inactivated influenza vaccines in elderly individuals living in the community and at risk of complications associated with influenza. People with any of the following underlying conditions were considered at risk of complications: lung disease, heart disease, renal disease, diabetes and other endocrine disorders, immunodeficiency or immunosuppressive diseases, cancer, dementia or stroke, vasculitis, or rheumatic disease. Seven data sets from six studies were relevant. The only significant effect was that for deaths from all causes (VE 61%; 3% to 84%; <a href="./references#CD004876-fig-0049" title="">Analysis 10.6</a>) from 68,032 observations with high heterogeneity (I<sup>2</sup> = 94.1%) (<a href="./references#CD004876-bbs2-0032" title="FlemingDM , WatsonJM , NicholasS , SmithGE , SwanAV . Study of the effectiveness of influenza vaccination in the elderly in the epidemic of 1989-90 using a general practice database. Epidemiology and Infection1995;115(3):581-9. ">Fleming 1995</a>; <a href="./references#CD004876-bbs2-0103" title='ShapiroY , ShemerJ , HeymannA , ShalevV , MaharshakN , ChodikG , et al. Influenza vaccination: reduction in hospitalizations and death rates among members of "Maccabi Healthcare Services" during the 2000-2001 influenza season. Israel Medical Association Journal2003;5(10):706-8. '>Shapiro 2003</a>; <a href="./references#CD004876-bbs2-0108" title="VoordouwBC , van derLindenPD , SimonianS , van derLeiJ , SturkenboomMC , StrickerBH . Influenza vaccination in community-dwelling elderly: impact on mortality and influenza-associated morbidity. Archives of Internal Medicine2003;163(9):1089-94. ">Voordouw 2003</a>). </p> </section> <section id="CD004876-sec-0071"> <h5 class="title">Inactivated influenza vaccines in community‐dwelling elderly without risk of influenza complications (from previous versions of the review) </h5> <p>In this stratum, six studies with seven data sets contributed several hundred thousand observations (<a href="./references#CD004876-bbs2-0032" title="FlemingDM , WatsonJM , NicholasS , SmithGE , SwanAV . Study of the effectiveness of influenza vaccination in the elderly in the epidemic of 1989-90 using a general practice database. Epidemiology and Infection1995;115(3):581-9. ">Fleming 1995</a>; <a href="./references#CD004876-bbs2-0042" title="HakE , NordinJ , WeiF , MulloolyJ , PobleteS , StrikasR , et al. Influence of high-risk medical conditions on the effectiveness of influenza vaccination among elderly members of 3 large managed-care organizations. Clinical Infectious Diseases2002;35(4):370-7. ">Hak 2002a</a>; <a href="./references#CD004876-bbs2-0043" title="HakE , NordinJ , WeiF , MulloolyJ , PobleteS , StrikasR , et al. Influence of high-risk medical conditions on the effectiveness of influenza vaccination among elderly members of 3 large managed-care organizations. Clinical Infectious Diseases2002;35(4):370-7. ">Hak 2002b</a>; <a href="./references#CD004876-bbs2-0059" title="MangtaniP , CumberlandP , HodgsonCR , RobertsJA , CuttsFT , HallAJ . A cohort study of the effectiveness of influenza vaccine in older people, performed using the United Kingdom general practice research database. Journal of Infectious Diseases2004;190(1):1-10. ">Mangtani 2004a</a>; <a href="./references#CD004876-bbs2-0079" title="NicholKL , WuorenmaJ , vonSternbergT . Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens. Archives of Internal Medicine1998;158(16):1769-76. ">Nichol 1998a</a>; <a href="./references#CD004876-bbs2-0103" title='ShapiroY , ShemerJ , HeymannA , ShalevV , MaharshakN , ChodikG , et al. Influenza vaccination: reduction in hospitalizations and death rates among members of "Maccabi Healthcare Services" during the 2000-2001 influenza season. Israel Medical Association Journal2003;5(10):706-8. '>Shapiro 2003</a>; <a href="./references#CD004876-bbs2-0108" title="VoordouwBC , van derLindenPD , SimonianS , van derLeiJ , SturkenboomMC , StrickerBH . Influenza vaccination in community-dwelling elderly: impact on mortality and influenza-associated morbidity. Archives of Internal Medicine2003;163(9):1089-94. ">Voordouw 2003</a>). However, most outcomes were only assessed by one study. The only notable results were the vaccines' effectiveness in preventing hospital admission for influenza or pneumonia (VE 50%; 37% to 60%; <a href="./references#CD004876-fig-0054" title="">Analysis 11.3</a>), although this observation was based on only one data set with 101,619 observations (<a href="./references#CD004876-bbs2-0079" title="NicholKL , WuorenmaJ , vonSternbergT . Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens. Archives of Internal Medicine1998;158(16):1769-76. ">Nichol 1998a</a>), and there was a lack of effect on all‐cause mortality (RR 0.65, 95% CI 0.33 to 1.29; 43,821 observations; <a href="./references#CD004876-fig-0057" title="">Analysis 11.6</a>) (<a href="./references#CD004876-bbs2-0032" title="FlemingDM , WatsonJM , NicholasS , SmithGE , SwanAV . Study of the effectiveness of influenza vaccination in the elderly in the epidemic of 1989-90 using a general practice database. Epidemiology and Infection1995;115(3):581-9. ">Fleming 1995</a>; <a href="./references#CD004876-bbs2-0103" title='ShapiroY , ShemerJ , HeymannA , ShalevV , MaharshakN , ChodikG , et al. Influenza vaccination: reduction in hospitalizations and death rates among members of "Maccabi Healthcare Services" during the 2000-2001 influenza season. Israel Medical Association Journal2003;5(10):706-8. '>Shapiro 2003</a>; <a href="./references#CD004876-bbs2-0108" title="VoordouwBC , van derLindenPD , SimonianS , van derLeiJ , SturkenboomMC , StrickerBH . Influenza vaccination in community-dwelling elderly: impact on mortality and influenza-associated morbidity. Archives of Internal Medicine2003;163(9):1089-94. ">Voordouw 2003</a>). </p> </section> <section id="CD004876-sec-0072"> <h5 class="title">Inactivated influenza and polysaccharide vaccine (PPV) on community‐dwelling elderly (from previous versions of the review) </h5> <p>Three studies assessed the impact of inactivated influenza and concomitant PPV on hospitalisations for influenza or pneumonia or respiratory diseases (VE 33%; 30% to 36%, based on 518,748 observations; <a href="./references#CD004876-fig-0061" title="">Analysis 12.2</a>) (<a href="./references#CD004876-bbs2-0013" title="ChristensonB , LundberghP , HedlundJ , OrtqvistA . Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in adults aged 65 years or older: a prospective study. Lancet2001;357(9261):1008-11. ">Christenson 2001b</a>; <a href="./references#CD004876-bbs2-0015" title="ChristensonB , HedlundJ , LundberghP , OrtqvistA . Additive preventive effect of influenza and pneumococcal vaccines in elderly persons. European Respiratory Journal2004;23(3):363-8. ">Christenson 2004b</a>; <a href="./references#CD004876-bbs2-0019" title="ConsonniS , SandriniC , SegatoE , PerruchiniE , BergamaschiniL , VerganiC . Tolerability and efficacy of anti-influenza vaccination alone and associated with antipneumococcal vaccination in an elderly ambulatory population and adherence to the vaccination campaign. Journal of Preventive Medicine and Hygiene2004;45:45-50. ">Consonni 2004b</a>), and two data sets assessed the effect on all‐cause mortality (VE 56%; 54% to 59%; <a href="./references#CD004876-fig-0063" title="">Analysis 12.4</a>) (<a href="./references#CD004876-bbs2-0013" title="ChristensonB , LundberghP , HedlundJ , OrtqvistA . Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in adults aged 65 years or older: a prospective study. Lancet2001;357(9261):1008-11. ">Christenson 2001b</a>; <a href="./references#CD004876-bbs2-0019" title="ConsonniS , SandriniC , SegatoE , PerruchiniE , BergamaschiniL , VerganiC . Tolerability and efficacy of anti-influenza vaccination alone and associated with antipneumococcal vaccination in an elderly ambulatory population and adherence to the vaccination campaign. Journal of Preventive Medicine and Hygiene2004;45:45-50. ">Consonni 2004b</a>). </p> <p>The addition of PPV did not appear to improve the performance of influenza vaccines significantly. </p> </section> <section id="CD004876-sec-0073"> <h5 class="title">Adjuvant influenza vaccines in all community‐dwelling elderly (from previous versions of the review) </h5> <p>Two small studies with a combined denominator of 498 assessed the impact of vaccines containing a virosomal adjuvant in preventing ILI (VE 70%; 44% to 84%; <a href="./references#CD004876-fig-0064" title="">Analysis 13.1</a>) and hospitalisations (RR 0.17, 95% CI 0.02 to 1.28; Analysis 13.2.3) during a year of low viral circulation but with a vaccine with a good match (<a href="./references#CD004876-bbs2-0018" title="ConsonniS , SandriniC , SegatoE , PerruchiniE , BergamaschiniL , VerganiC . Tolerability and efficacy of anti-influenza vaccination alone and associated with antipneumococcal vaccination in an elderly ambulatory population and adherence to the vaccination campaign. Journal of Preventive Medicine and Hygiene2004;45:45-50. ">Consonni 2004a</a>; <a href="./references#CD004876-bbs2-0091" title="PregliascoF , GiardiniG , SandriniMC , PerucchiniE , VerganiC . Protective efficacy of Inflexal V in the elderly pazinte [Efficacia protettiva di Inflexal V nel pazinte anziano]. Vaccine at a Glance2002;1(1):2-5. ">Pregliasco 2002</a>). The study by <a href="./references#CD004876-bbs2-0018" title="ConsonniS , SandriniC , SegatoE , PerruchiniE , BergamaschiniL , VerganiC . Tolerability and efficacy of anti-influenza vaccination alone and associated with antipneumococcal vaccination in an elderly ambulatory population and adherence to the vaccination campaign. Journal of Preventive Medicine and Hygiene2004;45:45-50. ">Consonni 2004a</a> also assessed the impact on all‐cause mortality and found no effect (RR 2.10, 95% CI 0.10 to 43.10; Analysis 13.3.3). This is not surprising given its population size of 129 people (too small for any significant effect to be evident). </p> </section> </section> <section id="CD004876-sec-0074"> <h4 class="title">Case‐control studies (from previous versions of the review)</h4> <p>We included 12 studies contributing 14 data sets (<a href="./references#CD004876-bbs2-0001" title="AhmedAE , NicholsonKG , Nguyen-Van-TamJS . Reduction in mortality associated with influenza vaccine during 1989-90 epidemic. Lancet1995;346(8975):591-5. ">Ahmed 1995</a>; <a href="./references#CD004876-bbs2-0002" title="AhmedAH , NicholsonKG , Nguyen-van TamJS , PearsonJC . Effectiveness of influenza vaccine in reducing hospital admissions during the 1989-90 epidemic. Epidemiology and Infection1997;118(1):27-33. ">Ahmed 1997</a>; <a href="./references#CD004876-bbs2-0020" title="CrocettiE , ArnianiS , BordoniF , MacioccoG , ZappaM , BuiattiE . Effectiveness of influenza vaccination in the elderly in a community in Italy. European Journal of Epidemiology2001;17(2):163-8. ">Crocetti 2001</a>; <a href="./references#CD004876-bbs2-0029" title="FedsonDS , WajdaA , NicolJP , HammondGW , KaiserDL , RoosLL . Clinical effectiveness of influenza vaccination in Manitoba. JAMA1993;270(16):1956-61. ">Fedson 1993a</a>; <a href="./references#CD004876-bbs2-0030" title="FedsonDS , WajdaA , NicolJP , HammondGW , KaiserDL , RoosLL . Clinical effectiveness of influenza vaccination in Manitoba. JAMA1993;270(16):1956-61. ">Fedson 1993b</a>; <a href="./references#CD004876-bbs2-0033" title="FosterDA , TalsmaA , Furumoto-DawsonA , OhmitSE , MarguliesJR , ArdenNH , et al. Influenza vaccine effectiveness in preventing hospitalization for pneumonia in the elderly. American Journal of Epidemiology1992;136(3):296-307. ">Foster 1992</a>; <a href="./references#CD004876-bbs2-0052" title="JordanRE , HawkerJI , AyresJG , TunnicliffeW , AdabP , OlowokureB , et al. A case-control study of elderly patients with acute respiratory illness: effect of influenza vaccination on admission to hospital in winter 2003-2004. Vaccine2007;25(46):7909-13. ">Jordan 2007</a>; <a href="./references#CD004876-bbs2-0074" title="MulloolyJP , BennettMD , HornbrookMC , BarkerWH , WilliamsWW , PatriarcaPA , et al. Influenza vaccination programs for elderly persons: cost-effectiveness in a health maintenance organization. Annals of Internal Medicine1994;121(12):947-52. ">Mullooly 1994</a>; <a href="./references#CD004876-bbs2-0086" title="OhmitSE , MontoAS . Influenza vaccine effectiveness in preventing hospitalization among the elderly during influenza type A and type B seasons. International Journal of Epidemiology1995;24(6):1240-8. ">Ohmit 1995a</a>; <a href="./references#CD004876-bbs2-0087" title="OhmitSE , MontoAS . Influenza vaccine effectiveness in preventing hospitalization among the elderly during influenza type A and type B seasons. International Journal of Epidemiology1995;24(6):1240-8. ">Ohmit 1995b</a>; <a href="./references#CD004876-bbs2-0088" title="OhmitSE , ArdenNH , MontoAS . Effectiveness of inactivated influenza vaccine among nursing home residents during an influenza type A (H3N2) epidemic. Journal of the American Geriatric Society1999;47(2):165-71. ">Ohmit 1999</a>; <a href="./references#CD004876-bbs2-0092" title="Puig-BarberaJ , Marquez-CalderonS , Masoliver-ForesA , Lloria-PaesF , Ortega-DichaA , Gil-MartinM , et al. Reduction in hospital admissions for pneumonia in non-institutionalised elderly people as a result of influenza vaccination: a case-control study in Spain. Journal of Epidemiology and Community Health1997;51(5):526-30. ">Puig‐Barberà 1997</a>; <a href="./references#CD004876-bbs2-0093" title="Puig-BarberaJ , Diez-DomingoJ , Perez HoyosS , Belenguer VareaA , Gonzalez VidalD . Effectiveness of the MF59-adjuvanted influenza vaccine in preventing emergency admissions for pneumonia in the elderly over 64 years of age. Vaccine2004;23(3):283-9. ">Puig‐Barberà 2004</a>; <a href="./references#CD004876-bbs2-0094" title="Puig-BarberàJ , Díez-DomingoJ , VareaAB , ChavarriGS , RodrigoJA , Hoyos SP et al. Effectiveness of MF59-adjuvanted subunit influenza vaccine in preventing hospitalisations for cardiovascular disease, cerebrovascular disease and pneumonia in the elderly. Vaccine2007;25(42):7313-21. ">Puig‐Barbera 2007</a>). Eight data sets from seven studies assessed the effects of inactivated influenza vaccines on community‐dwelling elderly (<a href="./references#CD004876-bbs2-0001" title="AhmedAE , NicholsonKG , Nguyen-Van-TamJS . Reduction in mortality associated with influenza vaccine during 1989-90 epidemic. Lancet1995;346(8975):591-5. ">Ahmed 1995</a>; <a href="./references#CD004876-bbs2-0002" title="AhmedAH , NicholsonKG , Nguyen-van TamJS , PearsonJC . Effectiveness of influenza vaccine in reducing hospital admissions during the 1989-90 epidemic. Epidemiology and Infection1997;118(1):27-33. ">Ahmed 1997</a>; <a href="./references#CD004876-bbs2-0020" title="CrocettiE , ArnianiS , BordoniF , MacioccoG , ZappaM , BuiattiE . Effectiveness of influenza vaccination in the elderly in a community in Italy. European Journal of Epidemiology2001;17(2):163-8. ">Crocetti 2001</a>; <a href="./references#CD004876-bbs2-0029" title="FedsonDS , WajdaA , NicolJP , HammondGW , KaiserDL , RoosLL . Clinical effectiveness of influenza vaccination in Manitoba. JAMA1993;270(16):1956-61. ">Fedson 1993a</a>; <a href="./references#CD004876-bbs2-0030" title="FedsonDS , WajdaA , NicolJP , HammondGW , KaiserDL , RoosLL . Clinical effectiveness of influenza vaccination in Manitoba. JAMA1993;270(16):1956-61. ">Fedson 1993b</a>; <a href="./references#CD004876-bbs2-0052" title="JordanRE , HawkerJI , AyresJG , TunnicliffeW , AdabP , OlowokureB , et al. A case-control study of elderly patients with acute respiratory illness: effect of influenza vaccination on admission to hospital in winter 2003-2004. Vaccine2007;25(46):7909-13. ">Jordan 2007</a>; <a href="./references#CD004876-bbs2-0092" title="Puig-BarberaJ , Marquez-CalderonS , Masoliver-ForesA , Lloria-PaesF , Ortega-DichaA , Gil-MartinM , et al. Reduction in hospital admissions for pneumonia in non-institutionalised elderly people as a result of influenza vaccination: a case-control study in Spain. Journal of Epidemiology and Community Health1997;51(5):526-30. ">Puig‐Barberà 1997</a>; <a href="./references#CD004876-bbs2-0094" title="Puig-BarberàJ , Díez-DomingoJ , VareaAB , ChavarriGS , RodrigoJA , Hoyos SP et al. Effectiveness of MF59-adjuvanted subunit influenza vaccine in preventing hospitalisations for cardiovascular disease, cerebrovascular disease and pneumonia in the elderly. Vaccine2007;25(42):7313-21. ">Puig‐Barbera 2007</a>); five looked at the co‐administration of inactivated influenza with PPV on institutionalised elderly (<a href="./references#CD004876-bbs2-0033" title="FosterDA , TalsmaA , Furumoto-DawsonA , OhmitSE , MarguliesJR , ArdenNH , et al. Influenza vaccine effectiveness in preventing hospitalization for pneumonia in the elderly. American Journal of Epidemiology1992;136(3):296-307. ">Foster 1992</a>; <a href="./references#CD004876-bbs2-0074" title="MulloolyJP , BennettMD , HornbrookMC , BarkerWH , WilliamsWW , PatriarcaPA , et al. Influenza vaccination programs for elderly persons: cost-effectiveness in a health maintenance organization. Annals of Internal Medicine1994;121(12):947-52. ">Mullooly 1994</a>; <a href="./references#CD004876-bbs2-0086" title="OhmitSE , MontoAS . Influenza vaccine effectiveness in preventing hospitalization among the elderly during influenza type A and type B seasons. International Journal of Epidemiology1995;24(6):1240-8. ">Ohmit 1995a</a>; <a href="./references#CD004876-bbs2-0087" title="OhmitSE , MontoAS . Influenza vaccine effectiveness in preventing hospitalization among the elderly during influenza type A and type B seasons. International Journal of Epidemiology1995;24(6):1240-8. ">Ohmit 1995b</a>; <a href="./references#CD004876-bbs2-0088" title="OhmitSE , ArdenNH , MontoAS . Effectiveness of inactivated influenza vaccine among nursing home residents during an influenza type A (H3N2) epidemic. Journal of the American Geriatric Society1999;47(2):165-71. ">Ohmit 1999</a>); one study was of adjuvant influenza with PPV on community‐dwelling elderly (<a href="./references#CD004876-bbs2-0093" title="Puig-BarberaJ , Diez-DomingoJ , Perez HoyosS , Belenguer VareaA , Gonzalez VidalD . Effectiveness of the MF59-adjuvanted influenza vaccine in preventing emergency admissions for pneumonia in the elderly over 64 years of age. Vaccine2004;23(3):283-9. ">Puig‐Barberà 2004</a>); and one was of adjuvanted influenza vaccines (MF59) alone (<a href="./references#CD004876-bbs2-0094" title="Puig-BarberàJ , Díez-DomingoJ , VareaAB , ChavarriGS , RodrigoJA , Hoyos SP et al. Effectiveness of MF59-adjuvanted subunit influenza vaccine in preventing hospitalisations for cardiovascular disease, cerebrovascular disease and pneumonia in the elderly. Vaccine2007;25(42):7313-21. ">Puig‐Barbera 2007</a>). Only three of these studies, all of which assessed influenza and pneumococcal vaccines, had a long follow‐up (six months). Since all data sets adjusted their ORs for likely confounding factors, we structured our analysis on five strata, further subdividing each analysis by viral circulation and vaccine matching whenever possible. </p> <section id="CD004876-sec-0075"> <h5 class="title">Inactivated influenza vaccines on community‐dwelling elderly (from previous versions of the review) </h5> <p>Before adjustment, inactivated influenza vaccines were associated with an increased risk of admission for any respiratory disease (OR 1.08, 95% CI 0.92 to 1.26; 20,582 observations; Analysis 14.2.1) (<a href="./references#CD004876-bbs2-0002" title="AhmedAH , NicholsonKG , Nguyen-van TamJS , PearsonJC . Effectiveness of influenza vaccine in reducing hospital admissions during the 1989-90 epidemic. Epidemiology and Infection1997;118(1):27-33. ">Ahmed 1997</a>; <a href="./references#CD004876-bbs2-0029" title="FedsonDS , WajdaA , NicolJP , HammondGW , KaiserDL , RoosLL . Clinical effectiveness of influenza vaccination in Manitoba. JAMA1993;270(16):1956-61. ">Fedson 1993a</a>; <a href="./references#CD004876-bbs2-0030" title="FedsonDS , WajdaA , NicolJP , HammondGW , KaiserDL , RoosLL . Clinical effectiveness of influenza vaccination in Manitoba. JAMA1993;270(16):1956-61. ">Fedson 1993b</a>), and did not prevent hospital admission for influenza and pneumonia in elderly individuals living in the community (OR 0.89, 95% CI 0.69 to 1.15; 1074 observations; <a href="./references#CD004876-fig-0067" title="">Analysis 14.1</a>) (<a href="./references#CD004876-bbs2-0020" title="CrocettiE , ArnianiS , BordoniF , MacioccoG , ZappaM , BuiattiE . Effectiveness of influenza vaccination in the elderly in a community in Italy. European Journal of Epidemiology2001;17(2):163-8. ">Crocetti 2001</a>; <a href="./references#CD004876-bbs2-0092" title="Puig-BarberaJ , Marquez-CalderonS , Masoliver-ForesA , Lloria-PaesF , Ortega-DichaA , Gil-MartinM , et al. Reduction in hospital admissions for pneumonia in non-institutionalised elderly people as a result of influenza vaccination: a case-control study in Spain. Journal of Epidemiology and Community Health1997;51(5):526-30. ">Puig‐Barberà 1997</a>), or affect hospitalisation for ILI (Analysis 14.2.2), <a href="./references#CD004876-bbs2-0052" title="JordanRE , HawkerJI , AyresJG , TunnicliffeW , AdabP , OlowokureB , et al. A case-control study of elderly patients with acute respiratory illness: effect of influenza vaccination on admission to hospital in winter 2003-2004. Vaccine2007;25(46):7909-13. ">Jordan 2007</a>, or affect mortality from influenza and pneumonia, though this conclusion was based on a relatively small data set of 1092 observations (Analysis 14.3.1) (<a href="./references#CD004876-bbs2-0001" title="AhmedAE , NicholsonKG , Nguyen-Van-TamJS . Reduction in mortality associated with influenza vaccine during 1989-90 epidemic. Lancet1995;346(8975):591-5. ">Ahmed 1995</a>). The single study on adjuvanted vaccines showed no effect on pneumonia no better defined (Analysis 14.4.1) (<a href="./references#CD004876-bbs2-0094" title="Puig-BarberàJ , Díez-DomingoJ , VareaAB , ChavarriGS , RodrigoJA , Hoyos SP et al. Effectiveness of MF59-adjuvanted subunit influenza vaccine in preventing hospitalisations for cardiovascular disease, cerebrovascular disease and pneumonia in the elderly. Vaccine2007;25(42):7313-21. ">Puig‐Barbera 2007</a>). </p> </section> <section id="CD004876-sec-0076"> <h5 class="title">Inactivated influenza vaccines on community‐dwelling elderly ‐ adjusted analysis (from previous versions of the review) </h5> <p>After adjustment, however, the vaccines did reduce the risk of death from influenza and pneumonia (OR 0.74, 95% CI 0.60 to 0.92; <a href="./references#CD004876-fig-0073" title="">Analysis 15.3</a>) (<a href="./references#CD004876-bbs2-0001" title="AhmedAE , NicholsonKG , Nguyen-Van-TamJS . Reduction in mortality associated with influenza vaccine during 1989-90 epidemic. Lancet1995;346(8975):591-5. ">Ahmed 1995</a>; <a href="./references#CD004876-bbs2-0074" title="MulloolyJP , BennettMD , HornbrookMC , BarkerWH , WilliamsWW , PatriarcaPA , et al. Influenza vaccination programs for elderly persons: cost-effectiveness in a health maintenance organization. Annals of Internal Medicine1994;121(12):947-52. ">Mullooly 1994</a>), and prevent admission for influenza and pneumonia (OR 0.59, 95% CI 0.47 to 0.74; <a href="./references#CD004876-fig-0071" title="">Analysis 15.1</a>), <a href="./references#CD004876-bbs2-0020" title="CrocettiE , ArnianiS , BordoniF , MacioccoG , ZappaM , BuiattiE . Effectiveness of influenza vaccination in the elderly in a community in Italy. European Journal of Epidemiology2001;17(2):163-8. ">Crocetti 2001</a>, <a href="./references#CD004876-bbs2-0033" title="FosterDA , TalsmaA , Furumoto-DawsonA , OhmitSE , MarguliesJR , ArdenNH , et al. Influenza vaccine effectiveness in preventing hospitalization for pneumonia in the elderly. American Journal of Epidemiology1992;136(3):296-307. ">Foster 1992</a>, <a href="./references#CD004876-bbs2-0074" title="MulloolyJP , BennettMD , HornbrookMC , BarkerWH , WilliamsWW , PatriarcaPA , et al. Influenza vaccination programs for elderly persons: cost-effectiveness in a health maintenance organization. Annals of Internal Medicine1994;121(12):947-52. ">Mullooly 1994</a>, <a href="./references#CD004876-bbs2-0092" title="Puig-BarberaJ , Marquez-CalderonS , Masoliver-ForesA , Lloria-PaesF , Ortega-DichaA , Gil-MartinM , et al. Reduction in hospital admissions for pneumonia in non-institutionalised elderly people as a result of influenza vaccination: a case-control study in Spain. Journal of Epidemiology and Community Health1997;51(5):526-30. ">Puig‐Barberà 1997</a>, <a href="./references#CD004876-bbs2-0093" title="Puig-BarberaJ , Diez-DomingoJ , Perez HoyosS , Belenguer VareaA , Gonzalez VidalD . Effectiveness of the MF59-adjuvanted influenza vaccine in preventing emergency admissions for pneumonia in the elderly over 64 years of age. Vaccine2004;23(3):283-9. ">Puig‐Barberà 2004</a>, and for all respiratory diseases (OR 0.71, 95% CI 0.56 to 0.90; <a href="./references#CD004876-fig-0072" title="">Analysis 15.2</a>) (<a href="./references#CD004876-bbs2-0002" title="AhmedAH , NicholsonKG , Nguyen-van TamJS , PearsonJC . Effectiveness of influenza vaccine in reducing hospital admissions during the 1989-90 epidemic. Epidemiology and Infection1997;118(1):27-33. ">Ahmed 1997</a>; <a href="./references#CD004876-bbs2-0029" title="FedsonDS , WajdaA , NicolJP , HammondGW , KaiserDL , RoosLL . Clinical effectiveness of influenza vaccination in Manitoba. JAMA1993;270(16):1956-61. ">Fedson 1993a</a>; <a href="./references#CD004876-bbs2-0030" title="FedsonDS , WajdaA , NicolJP , HammondGW , KaiserDL , RoosLL . Clinical effectiveness of influenza vaccination in Manitoba. JAMA1993;270(16):1956-61. ">Fedson 1993b</a>). </p> </section> </section> <section id="CD004876-sec-0077"> <h4 class="title">Possible causes of observed heterogeneity ‐ post hoc analysis</h4> <p>Of the 15 main comparisons with 61 outcome combinations, we noted in a subsequent analysis that seven comparisons with 20 outcome combinations had an I<sup>2</sup> statistic greater than 30% and that the heterogeneity of these studies could be explained by grouping by viral circulation and vaccine matching. </p> </section> <section id="CD004876-sec-0078"> <h4 class="title">Safety</h4> <p>We included data on local and systemic harms. For local harms, we included tenderness, sore arm, swelling, erythema, and induration. Similar local symptoms were pooled in the analysis due to small data sets. Systemic symptoms were general malaise, fever, headache, nausea, and respiratory tract symptoms. </p> <p>The only studies evaluating rare adverse events were three surveillance studies assessing Guillain‐Barré syndrome with neither cohort nor case‐control design (<a href="#CD004876-tbl-0003">Table 2</a>) (<a href="./references#CD004876-bbs2-0053" title="KaplanJE , KatonaP , HurwitzES , SchonbergerLB . Guillain-Barre syndrome in the United States, 1979-1980 and 1980-1981. Lack of an association with influenza vaccination. JAMA1982;248(6):698-700. ">Kaplan 1982</a>; <a href="./references#CD004876-bbs2-0056" title="LaskyT , TerraccianoGJ , MagderL , KoskiCL , BallesterosM , NashD , et al. The Guillain-Barre syndrome and the 1992-1993 and 1993-1994 influenza vaccines. New England Journal of Medicine1998;339(25):1797-802. ">Lasky 1998</a>; <a href="./references#CD004876-bbs2-0102" title="SchonbergerLB , BregmanDJ , Sullivan-BolyaiJZ , KeenlysideRA , ZieglerDW , RetailliauHF , et al. Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976-1977. American Journal of Epidemiology1979;110(2):105-23. ">Schonberger 1979</a>). Case finding was carried out by interviewing neurologists or by searching discharge diagnoses databases. Vaccination rates in the relevant populations were estimated from specific survey or from national immunisation survey. All studies were conducted in the USA and assessed the entire population irrespective of age. <a href="./references#CD004876-bbs2-0056" title="LaskyT , TerraccianoGJ , MagderL , KoskiCL , BallesterosM , NashD , et al. The Guillain-Barre syndrome and the 1992-1993 and 1993-1994 influenza vaccines. New England Journal of Medicine1998;339(25):1797-802. ">Lasky 1998</a> and <a href="./references#CD004876-bbs2-0102" title="SchonbergerLB , BregmanDJ , Sullivan-BolyaiJZ , KeenlysideRA , ZieglerDW , RetailliauHF , et al. Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976-1977. American Journal of Epidemiology1979;110(2):105-23. ">Schonberger 1979</a> reported outcome stratified by age, allowing data extraction for elderly people. We reported the results of these studies in <a href="#CD004876-tbl-0003">Table 2</a>. The strong and significant association between A/New Jersey/76 swine vaccine and Guillain‐Barré syndrome during the 1976 to 1977 influenza season was not confirmed in subsequent seasons, when other vaccines not containing A/New Jersey/76 were used. </p> <div class="table" id="CD004876-tbl-0003"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Guillain‐Barré syndrome</span></div> <tbody> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Influenza season</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Vaccine</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Population</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Age</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>RR (95% CI)</b> </p> </th> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD004876-bbs2-0102" title="SchonbergerLB , BregmanDJ , Sullivan-BolyaiJZ , KeenlysideRA , ZieglerDW , RetailliauHF , et al. Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976-1977. American Journal of Epidemiology1979;110(2):105-23. ">Schonberger 1979</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1976 to 1977</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A/New Jersey/76 or A/New Jersey/76 and A/Victoria/75 swine vaccine</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All the USA population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&gt; 64 years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.2 (3.9 to 7.0)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD004876-bbs2-0053" title="KaplanJE , KatonaP , HurwitzES , SchonbergerLB . Guillain-Barre syndrome in the United States, 1979-1980 and 1980-1981. Lack of an association with influenza vaccination. JAMA1982;248(6):698-700. ">Kaplan 1982</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1979 to 1980</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Inactivated trivalent</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All the USA population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&gt; 18 years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.6 (0.45 to 1.32)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD004876-bbs2-0053" title="KaplanJE , KatonaP , HurwitzES , SchonbergerLB . Guillain-Barre syndrome in the United States, 1979-1980 and 1980-1981. Lack of an association with influenza vaccination. JAMA1982;248(6):698-700. ">Kaplan 1982</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1980 to 1981</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Inactivated trivalent</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All the USA population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&gt; 18 years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.4 (0.80 to 1.76)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD004876-bbs2-0056" title="LaskyT , TerraccianoGJ , MagderL , KoskiCL , BallesterosM , NashD , et al. The Guillain-Barre syndrome and the 1992-1993 and 1993-1994 influenza vaccines. New England Journal of Medicine1998;339(25):1797-802. ">Lasky 1998</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1992 to 1994</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Inactivated trivalent</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21 million</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&gt; 64 years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.5 (0.7 to 3.3)</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>Key: CI = confidence interval; RR = risk ratio</p> </div> </div> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD004876-sec-0079" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD004876-sec-0079"></div> <section id="CD004876-sec-0080"> <h3 class="title" id="CD004876-sec-0080">Summary of main results</h3> <p>Our findings show that according to randomised evidence, the effectiveness of trivalent inactivated influenza vaccines in elderly individuals, when considered in absolute terms, is modest irrespective of setting, outcome, population, and study design. The certainty of the evidence was low for influenza and moderate for ILI. Our estimates were consistently below those usually quoted for economic modelling or decision making. In view of the known variability of incidence and effect of influenza, we constructed a large number of comparisons and strata to minimise possible heterogeneity between studies and to aid comparability. We also performed subanalysis of studies describing better defined epidemic periods. Despite our attempts, we noted significant residual heterogeneity among studies that could be explained only in part by different study designs, methodological quality, settings, viral circulation, vaccine types and matching, age, population types, and risk factors. We think the residual heterogeneity could be the result of the unpredictable nature of the spread of influenza and ILI and the bias caused by the non‐randomised nature of our evidence base. Our sensitivity analysis did not affect the final result. </p> </section> <section id="CD004876-sec-0081"> <h3 class="title" id="CD004876-sec-0081">Overall completeness and applicability of evidence</h3> <p>Whatever the causes of observed variability, we believe that the decision to vaccinate against influenza cannot be made based on the results of single studies, or reporting observations from a few seasons; rather, it should be taken on the basis of all available evidence. The conclusions drawn from studies done in individuals living in long‐term care facilities differ from those drawn from studies in individuals living in the community. Studies done in residents of care homes often indicate the inevitably improvised nature of efforts to study the effect of vaccination during an epidemic. The resident population is usually more homogeneous than that in the community: older, with similar viral exposure and risk levels. Despite remaining heterogeneity and an overestimation of the effects as a result of study design, it is possible to detect a gradient of effectiveness, in which vaccines have little effect on cases of ILI. This finding suggests that control of influenza through vaccination is a possibility. However, the effectiveness of vaccines in the community is modest, irrespective of adjustment for systematic differences between vaccine recipients and non‐recipients. The difficulties of achieving good coverage in those who need it most or the diluting effect on vaccines for influenza of other agents circulating in the community (causing ILI, clinically indistinguishable from influenza) might be to blame. We noted empirical proof of both these possibilities, with differential vaccine uptake among the same population (linked to age, sex, and health status) and a low effect on ILI throughout our data sets, even in periods of supposedly high influenza viral circulation, when the proportion of cases of ILI caused by influenza are highest and the possible benefits of vaccination should be greatest. </p> <p>The impact of vaccines on pneumonia, mortality, and hospitalisations from the randomised evidence available is insufficient to draw conclusions. Very few studies have captured data on these outcomes, and where we have obtained data, the rate of events was too low to be able to determine the size of effect (<a href="./full#CD004876-tbl-0001">summary of findings Table 1</a>). </p> <p>Safety does not appear to be a particular problem: the public health safety profile of the vaccines is acceptable. However, relatively few studies assessed safety outcomes. </p> </section> <section id="CD004876-sec-0082"> <h3 class="title" id="CD004876-sec-0082">Quality of the evidence</h3> <p>We rated the quality of evidence to be moderate for ILI and fever, low for influenza and nausea, and very low for hospitalisations and death (<a href="./full#CD004876-tbl-0001">summary of findings Table 1</a>). Most of the available evidence for these outcomes is from studies with unclear risk of bias across multiple domains. Fever was the only outcome where we did not consider bias to be influential due to consistency in direction and size of effect with the low risk of bias study (<a href="./references#CD004876-bbs2-0040" title="GovaertTM , ThijsCT , MasurelN , SprengerMJ , DinantGJ , KnottnerusJA . The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial. JAMA1994;272(21):1661-5. ">Govaert 1994a</a>). The lack of detail regarding the diagnosis of influenza limits the applicability of our findings to laboratory‐confirmed influenza and is a source of indirectness. </p> <p>For other outcomes (e.g. nausea and fever), the method of ascertainment is less uncertain due to the expected mechanism of action of vaccines. </p> <p>Imprecision arising from wide CIs or low event rates, or both, affects the evidence for adverse events, death, and pneumonia to varying degrees. The CIs for fever and nausea were wide (serious imprecision), but death and pneumonia were rare events in the studies, prompting us to downgrade two levels for very serious imprecision. The rating of very low quality for the latter two outcomes reflects the sparse nature of the data available for analysis. </p> <p>The main problem with interpreting our substantial data set is caused by the relative scarcity of randomised controlled trials (RCTs). Only one trial assessed currently available vaccines and reached satisfactory completion (<a href="./references#CD004876-bbs2-0040" title="GovaertTM , ThijsCT , MasurelN , SprengerMJ , DinantGJ , KnottnerusJA . The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial. JAMA1994;272(21):1661-5. ">Govaert 1994a</a>). The remainder of the data set consists of evidence from non‐RCTs. </p> <p>Our main concern was the quality of the non‐RCTs, which likely affected the estimates of effect reported in our review. The findings of the included cohort studies are likely to have been affected to varying degrees by selection bias. Differential uptake of influenza vaccines is linked to several factors (anxiety over unwanted effects, disease threat perception, societal and economic conditions, education, health status) and hence to outcome. Confounding by indication (people with chronic illness or people who are perceived to be frailer than others are more likely to be vaccinated) might reduce the estimated vaccine efficacy. People with terminal illness or with socio‐economic disadvantages are less likely to be vaccinated, and this fact might enhance vaccine efficacy. Both these interpretations are based on empirical evidence. For example, one cohort study had difficulty achieving high coverage in those most at need (<a href="./references#CD004876-bbs2-0037" title="Gene BadiaJ , Calero MunozS , Castanera RibeC , Gran RoviretaA . Effectiveness of an anti-influenza vaccination program in 4 primary care centers. Gaceta Sanitaria1991;5(26):203-8. ">Gené Badia 1991</a>). Differential vaccine uptake and the resulting selection bias is the most likely explanation for the high effectiveness of influenza vaccines in preventing deaths from all causes. A good example of the potential effect of such confounders is the apparently counterintuitive effectiveness of the vaccines in elderly individuals living in the community. In this population, vaccine effectiveness shows an implausible sequence: the vaccines are apparently ineffective in the prevention of influenza, ILI, pneumonia, hospital admissions, or deaths from any respiratory disease, but are effective in the prevention of hospital admission for influenza and pneumonia and in the prevention of deaths from all causes. </p> <p>Non‐RCT evidence in this review is open to any alternative interpretation and consistently fails to give satisfactory answers. Since the publication of our 2006 review (<a href="./references#CD004876-bbs2-0415" title="RivettiD , JeffersonT , ThomasR , RudinM , RivettiA , Di PietrantonjC , et al. Vaccines for preventing influenza in the elderly. Cochrane Database of Systematic Reviews2006, Issue 3. Art. No: CD004876. [DOI: 10.1002/14651858.CD004876.pub2]">Rivetti 2006</a>), several empirical studies looking at the effect of selection bias in retrospective cohorts (variously called selection bias, confounding by indication, or healthy user effect) have been published. Some confirmed the presence and effect of confounders (<a href="./references#CD004876-bbs2-0377" title='EurichDT , MarrieTJ , JohnstoneJ , MajumdarSR . Mortality reduction with influenza vaccine in patients with pneumonia outside "flu" season: pleiotropic benefits or residual confounding? [see comment]. American Journal of Respiratory &amp; Critical Care Medicine2008;178(5):527-33.'>Eurich 2008</a>; <a href="./references#CD004876-bbs2-0379" title="FukushimaW , HayashiY , MizunoY , SuzukiK , KaseT , OhfujiS , et al. Selection bias in evaluating of influenza vaccine effectiveness: a lesson from an observational study of elderly nursing home residents. Vaccine2008;26(50):6466-9.">Fukushima 2008</a>; <a href="./references#CD004876-bbs2-0380" title="GlezenWP , SimonsenL . Commentary: benefits of influenza vaccine in US elderly - new studies raise questions. International Journal of Epidemiology2006;35(2):352-3. [DOI: 10.1093/ije/dyi293]">Glezen 2006</a>; <a href="./references#CD004876-bbs2-0390" title="HirotaY . Ecological fallacy and scepticism about influenza vaccine efficacy in Japan: the Maebashi study. Vaccine2008;26(50):6473-6.">Hirota 2008</a>; <a href="./references#CD004876-bbs2-0391" title="JacksonLA , JacksonML , NelsonJC , NeuzilKM , WeissNS . Evidence of bias in estimates of influenza vaccine effectiveness in seniors. International Journal of Epidemiology2006;35(2):337-44. [DOI: 10.1093/ije/dyi274]">Jackson 2006a</a>; <a href="./references#CD004876-bbs2-0392" title="JacksonLA , NelsonJC , BensonP , NeuzilKM , ReidRJ , PsatyBM , et al. Functional status is a confounder of the association of influenza vaccine and risk of all cause mortality in seniors. International Journal of Epidemiology2005;35(2):345-52. [DOI: 10.1093/ije/dyi275]">Jackson 2006b</a>; <a href="./references#CD004876-bbs2-0393" title="JacksonLA , JacksonML , WeissNS . Bias in studies of influenza vaccine effectiveness: the authors reply to Hak et al. International Journal of Epidemiology2006;35(3):799-800.">Jackson 2006c</a>; <a href="./references#CD004876-bbs2-0394" title="JacksonLA , NelsonJC , BensonP , NeuzilKM , ReidRJ , PsatyBM , et al. Functional status is a confounder of the association of influenza vaccine and risk of all cause mortality in seniors [see comment]. International Journal of Epidemiology2006;35(2):345-52.">Jackson 2006d</a>; <a href="./references#CD004876-bbs2-0395" title="JacksonLA , JacksonML , NelsonJC , NeuzilKM , WeissNS . Evidence of bias in estimates of influenza vaccine effectiveness in seniors [see comment]. International Journal of Epidemiology2006;35(2):337-44.">Jackson 2006e</a>). Other studies, mainly carried out by the authors of cohort studies in question, failed to find any effect of confounding on mortality once adjustment had been carried out (<a href="./references#CD004876-bbs2-0383" title="GroenwoldRHH , HoesAW , NicholKL , HakE . Quantifying the potential role of unmeasured confounders: the example of influenza vaccination. International Journal of Epidemiology2008;37(6):1422-9.">Groenwold 2008</a>; <a href="./references#CD004876-bbs2-0384" title="GroenwoldRHH , HakE , HoesAW . Pooling of confounders did not induce residual confounding in influenza vaccination studies. Annals of Epidemiology2009;19(6):432-6.">Groenwold 2009</a>; <a href="./references#CD004876-bbs2-0386" title="HakE , HoesAW , NordinJ , NicholKL . Benefits of influenza vaccine in US elderly - appreciating issues of confounding bias and precision. International Journal of Epidemiology2006;35(3):800-2.">Hak 2006</a>; <a href="./references#CD004876-bbs2-0243" title="NicholKL , NordinJD , NelsonDB , MulloolyJP , HakE . Effectiveness of influenza vaccine in the community-dwelling elderly [see comment]. New England Journal of Medicine2007;357(14):1373-81. ">Nichol 2007</a>). For example, proof of bias was provided by a study evaluating the risk of hospitalisation and death in vaccinated compared with unvaccinated seniors during influenza and non‐influenza periods (<a href="./references#CD004876-bbs2-0391" title="JacksonLA , JacksonML , NelsonJC , NeuzilKM , WeissNS . Evidence of bias in estimates of influenza vaccine effectiveness in seniors. International Journal of Epidemiology2006;35(2):337-44. [DOI: 10.1093/ije/dyi274]">Jackson 2006a</a>). Consistent with other published studies, during influenza season, vaccination was associated with a 44% reduction in risk of all‐cause mortality. However, in the period before the influenza season, vaccination was associated with a 61% reduction in risk of this outcome. The reduction in risk before the influenza season indicates the presence of bias due to preferential selection of vaccination by relatively healthy seniors, and the strength of that bias is sufficient to account entirely for the association found during the influenza season. In a second, nested case‐control study, seniors with functional markers of frailty (such as dependence on washing) were found to be at a greatly increased risk of death and were less likely to have received influenza vaccine, indicating that these factors are important sources of bias in assessment of influenza vaccine effectiveness (<a href="./references#CD004876-bbs2-0392" title="JacksonLA , NelsonJC , BensonP , NeuzilKM , ReidRJ , PsatyBM , et al. Functional status is a confounder of the association of influenza vaccine and risk of all cause mortality in seniors. International Journal of Epidemiology2005;35(2):345-52. [DOI: 10.1093/ije/dyi275]">Jackson 2006b</a>). </p> <p>Regardless of the results of empirical studies, the sheer implausibility of the effectiveness sequence which ends with high estimates of effect against mortality from all causes points to considerable confounding and calls into question the reliability of using such non‐specific outcomes. Systematic differences between the intervention and control arms of cohort studies are likely to be the result of a baseline imbalance in health status and other known and unknown systematic differences in the two groups of participants. The rationale of the work starts from the observation that the 47% reduction in risk of all‐cause mortality in elderly community dwellers observed in our review exceeds by far the estimated possible impact of influenza on winter‐seasonal mortality of 5% in an average season (<a href="./references#CD004876-bbs2-0380" title="GlezenWP , SimonsenL . Commentary: benefits of influenza vaccine in US elderly - new studies raise questions. International Journal of Epidemiology2006;35(2):352-3. [DOI: 10.1093/ije/dyi293]">Glezen 2006</a>). Until improvement of cohort study design is available, the use in non‐RCTs of highly non‐specific outcome indicators, such as all‐cause mortality, is likely to lead to unrealistic estimates of the effects of the vaccines. </p> <p>Evidence from RCTs, in which bias is reduced to a minimum, is scant and badly reported. Unfortunately, because of the global recommendations on influenza vaccination, placebo‐controlled trials, which could clarify the effects of influenza vaccines in individuals, are no longer considered possible on ethical grounds. </p> <p>Since publication of the first version of this review, we have noted increased reliance of the case test‐negative study design to assess influenza vaccine effectiveness post hoc, that is after the influenza 'season'. The case test‐negative design is described in detail elsewhere (<a href="./references#CD004876-bbs2-0378" title="FoppaI , HabercM , FerdinandsaJ , ShayaD . The case test-negative design for studies of the effectiveness of influenza vaccine. Vaccine2013;31(30):3104-9.">Foppa 2013</a>; <a href="./references#CD004876-bbs2-0410" title="ValencianoM , CiancioBC , the I-MOVE study team. I-MOVE: a European network to measure the effectiveness of influenza vaccines. Euro Surveillance2012;17(39):20281.">Valenciano 2012</a>). </p> <p>The data included in a case test‐negative design are sometimes harvested from an ongoing networked surveillance cohort. In this case, the case test‐negative design is described as 'nested' within the cohort. The source cohort can include community and hospitalised cases and controls, allowing flexibility. In Europe, the surveillance programme has a formal structure and is known as Influenza ‐ Monitoring Vaccine Effectiveness (I‐MOVE). I‐MOVE is partly funded and co‐ordinated by the European Centre for Disease Prevention and Control (sites.google.com/site/epiflu/Home) (<a href="./references#CD004876-bbs2-0399" title="KisslingE , RondyM , I-MOVE/I-MOVE+ study team. Early 2016/17 vaccine effectiveness estimates against influenza A(H3N2): I-MOVE multicentre case control studies at primary care and hospital levels in Europe. Euro Surveillance2017;22(7):30464. [DOI: 10.2807/1560-7917.ES.2017.22.7.30464]">Kissling 2017</a>). </p> <p>Briefly, the study design, which is similar to a case‐control design, consists of selecting influenza cases (e.g. cases of ILI who have tested positive for influenza) and controls (cases of ILI who have tested negative) and calculating the relevant odds ratio (OR). Cases and controls are subsequently stratified by vaccination status. An estimate of vaccines effectiveness (VE) is derived from the OR of influenza in vaccinated/unvaccinated participants using the standard formula VE = 1 ‐ OR%. The practice of using the OR estimate as an approximation of the risk ratio was first used in a 1980 study on pneumococcal vaccine (<a href="./references#CD004876-bbs2-0367" title="BroomeC , FacklamR , FraserD . Pneumococcal disease after pneumococcal vaccination - an alternative method to estimate the efficacy of pneumococcal vaccine. New England Journal of Medicine1980;303(10):549-52.">Broome 1980</a>). </p> <p>Despite their popularity, test‐negative designs have limited public health significance.</p> <p>The design does not test field effectiveness, but the capacity of the vaccines to generate a negative polymerase chain reaction result (what we would call laboratory efficacy). Both cases and controls are symptomatic, so any prevention is solely focused on the negativity of laboratory tests. In addition, no useful public health absolute measures of effect can be derived (such as absolute risk reduction and its reciprocal number needed to vaccinate) by such designs, as the background rates of infection and viral circulation are not part of the calculation of the estimates of effect. The mathematical method first used by Broome and colleagues is correct if three key assumptions are met: </p> <p> <ol id="CD004876-list-0009"> <li> <p>the risk of non‐influenza ILI is the same in vaccinated and non‐vaccinated individuals (a factor called “k” by Broome and colleagues) (<a href="./references#CD004876-bbs2-0367" title="BroomeC , FacklamR , FraserD . Pneumococcal disease after pneumococcal vaccination - an alternative method to estimate the efficacy of pneumococcal vaccine. New England Journal of Medicine1980;303(10):549-52.">Broome 1980</a>); </p> </li> <li> <p>the attack rate in the vaccinated population is low; and</p> </li> <li> <p>the circulating serotypes are similar to those in the selected population within the case‐control studies based on test‐negative design. </p> </li> </ol> </p> <p>All assumptions are unlikely to be fulfilled at the same time, especially in multicentre/multi country surveillance cohorts with a non‐random sampling frame. For example, Cowling and colleagues reported an increased risk of non‐influenza respiratory virus infections associated with receipt of inactivated influenza vaccine. In addition, the OR will give falsely high VE if the attack rate in the vaccinated population is high (<a href="./references#CD004876-bbs2-0369" title="CowlingB , FangV , NishiuraH , Chan K-H, NgS , IpDKM , et al. Increased risk of noninfluenza respiratory virus infections associated with receipt of inactivated influenza vaccine. Clinical Infectious Diseases2012;54(12):1778–83.">Cowling 2012</a>; <a href="./references#CD004876-bbs2-0402" title="OrensteinW , BernierR , DonderoT , HinmanAR , MarksJS , BartKL , et al. Field evaluation of vaccine efficacy. Bulletin of the World Health Organization1985;63(6):1055-68.">Orenstein 1985</a>). Apart from these fundamental design problems, case test‐negative studies are also affected by poor reporting. (See also <a href="./references#CD004876-bbs2-0404" title="PerencevichE . Pondering vexing issues in infection prevention and control. haicontroversies.blogspot.com.au/2015/09/there-is-no-such-thing-as-patient-safety.html#!/ (accessed 22 May 2017).">Perencevich 2013a</a>; <a href="./references#CD004876-bbs2-0405" title="PerencevichEN . How should we calculate influenza vaccine effectiveness?blog.acpinternist.org/2013/02/how-should-we-calculate-influenza_7.html (accessed 22 May 2017).">Perencevich 2013b</a>). </p> </section> <section id="CD004876-sec-0083"> <h3 class="title" id="CD004876-sec-0083">Potential biases in the review process</h3> <p>The publication of our 2006 review sparked a discussion that continues to this day (<a href="./references#CD004876-bbs2-0415" title="RivettiD , JeffersonT , ThomasR , RudinM , RivettiA , Di PietrantonjC , et al. Vaccines for preventing influenza in the elderly. Cochrane Database of Systematic Reviews2006, Issue 3. Art. No: CD004876. [DOI: 10.1002/14651858.CD004876.pub2]">Rivetti 2006</a>). Because we are conscious that (despite the inconclusive evidence) we could have introduced our own biases into the reviewing process, we re‐extracted and reassessed all studies included in this and all other reviews of influenza vaccine studies (259 primary studies, reporting 274 data sets). We worked independently in two teams of two, extracting directly into pre‐set forms with rigid criteria but using the same quality assessment scales used in the original version of the review. As well as assessing quality of study design, we assessed concordance between data presented and conclusions and direction of conclusions (in favour or not of the performance of influenza vaccines). We also looked at the relationship between these variables and study funding and journal of publication. We found that higher‐quality studies were significantly more likely to show concordance between data presented and conclusions (OR 16.35, 95% CI 4.24 to 63.04) and less likely to favour effectiveness of vaccines (0.04, 0.02 to 0.09). Government‐funded studies were less likely to have conclusions favouring the vaccines (0.45, 0.26 to 0.90). A higher mean journal impact factor was associated with complete or partial industry funding compared with government or private funding and no funding (differences between means 5.04). Study size was not associated with concordance, content of take‐home message, funding, or study quality. Higher citation index factor was associated with partial or complete industry funding (<a href="./references#CD004876-bbs2-0397" title="JeffersonT , Di PietrantonjC , DebaliniMG , RivettiA , DemicheliV . Study  quality, concordance, take home message, funding and impact: their relationship in influenza vaccines studies. BMJ2009;338:b354. [DOI: 10.1136/bmj.b354 ]">Jefferson 2009b</a>). </p> <p>We concluded that the general quality of influenza vaccines studies is very low and that publication in prestigious journals is associated with partial or total industry funding. We could not explain this association with study quality, size or study status (registration trials using surrogate outcomes such as antibody titres were not included in the review). </p> </section> <section id="CD004876-sec-0084"> <h3 class="title" id="CD004876-sec-0084">Agreements and disagreements with other studies or reviews</h3> <p>Nichol provides a useful overview of reviews of influenza vaccines in all age groups (<a href="./references#CD004876-bbs2-0401" title="NicholKL . Efficacy and effectiveness of influenza vaccination. Vaccine2008;26:D17-22.">Nichol 2008</a>). For the elderly, she identified our review and a review by <a href="./references#CD004876-bbs2-0339" title="VuT , FarishS , JenkinsM , KellyH . A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community. Vaccine2002;20(13-4):1831-6. ">Vu 2002</a>. Although the point estimates appear approximately similar across the reviews, both Vu and Nichol fail to assess study quality and interpret results accordingly. We have summarised other main reviews identified below. </p> <p>The review <a href="./references#CD004876-bbs2-0366" title="BelongiaEA , SimpsonMD , KingJP , SundaramME , KelleyNS , OsterholmMT , et al. Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies. Lancet Infectious Diseases2016;16(8):942–51.">Belongia 2016</a> includes 56 case test‐negative studies. The authors briefly list five methodological quality criteria which do not appear to have been validated. The authors do not list blinding of assessors to vaccination status, a very well‐known source of bias in case‐control studies. The authors report substantial variation in vaccine effectiveness, but mention none of the limitations of test‐negative designs. </p> <p>The review by <a href="./references#CD004876-bbs2-0370" title="DarvishianM , vanden HeuvelER , BissieloA , CastillaJ , CohenC , EnglundH , et al. Effectiveness of seasonal influenza vaccination in community-dwelling elderly people: an individual participant data meta-analysis of test-negative design case-control studies. Lancet Respiratory Medicine2017;5(3):200-11. [DOI: 10.1016/S2213-2600(17)30043-7]">Darvishian 2017</a> includes data from 4975 elderly who had been included in previous test‐negative studies. The text refers to “individual participant data meta‐analysis”, but the basic problems with test‐negative designs are not addressed, and previous study authors were asked to extract their own study data on provided forms with no methodological quality assessment. The authors conclude that "Influenza vaccination is moderately effective against laboratory‐confirmed influenza in elderly people during epidemic seasons". </p> <p>The review by <a href="./references#CD004876-bbs2-0403" title="OsterholmMT , KelleyNS , SommerA , BelongiaEA . Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infectious Diseases2012;12(1):36-44.">Osterholm 2012</a> included comparative studies with data from the USA and influenza diagnosed by polymerase chain reaction. The authors found variable effectiveness but a lack of evidence in the elderly. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD004876-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/urn:x-wiley:14651858:media:CD004876:CD004876-FIG-01" target="_blank"><b></b></a></p> </div><img alt="Study flow. We identified no new randomised controlled trials for the 2016 update and stabilisation." data-id="CD004876-fig-0001" src="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-FIG-01.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_t/tCD004876-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow. We identified no new randomised controlled trials for the 2016 update and stabilisation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/full#CD004876-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-FIG-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004876-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/urn:x-wiley:14651858:media:CD004876:CD004876-FIG-02" target="_blank"><b></b></a></p> </div><img alt="Relationship between vaccination rate and attack rate" data-id="CD004876-fig-0002" src="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-FIG-02.jpg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_t/tCD004876-FIG-02.jpg" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Relationship between vaccination rate and attack rate</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/full#CD004876-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-FIG-02.jpg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004876-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/urn:x-wiley:14651858:media:CD004876:CD004876-CMP-001.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Influenza vaccines versus placebo: randomised controlled trials ‐ parenteral vaccine, Outcome 1: Influenza" data-id="CD004876-fig-0003" src="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-001.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_t/tCD004876-CMP-001.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1: Influenza vaccines versus placebo: randomised controlled trials ‐ parenteral vaccine, Outcome 1: Influenza </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#CD004876-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-001.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004876-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/urn:x-wiley:14651858:media:CD004876:CD004876-CMP-001.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Influenza vaccines versus placebo: randomised controlled trials ‐ parenteral vaccine, Outcome 2: Influenza‐like illness" data-id="CD004876-fig-0004" src="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-001.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_t/tCD004876-CMP-001.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1: Influenza vaccines versus placebo: randomised controlled trials ‐ parenteral vaccine, Outcome 2: Influenza‐like illness </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#CD004876-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-001.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004876-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/urn:x-wiley:14651858:media:CD004876:CD004876-CMP-001.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Influenza vaccines versus placebo: randomised controlled trials ‐ parenteral vaccine, Outcome 3: Pneumonia" data-id="CD004876-fig-0005" src="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-001.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_t/tCD004876-CMP-001.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1: Influenza vaccines versus placebo: randomised controlled trials ‐ parenteral vaccine, Outcome 3: Pneumonia </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#CD004876-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-001.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004876-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/urn:x-wiley:14651858:media:CD004876:CD004876-CMP-001.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Influenza vaccines versus placebo: randomised controlled trials ‐ parenteral vaccine, Outcome 4: All deaths" data-id="CD004876-fig-0006" src="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-001.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_t/tCD004876-CMP-001.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1: Influenza vaccines versus placebo: randomised controlled trials ‐ parenteral vaccine, Outcome 4: All deaths </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#CD004876-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-001.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004876-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/urn:x-wiley:14651858:media:CD004876:CD004876-CMP-002.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Influenza vaccines versus placebo: randomised controlled trials ‐ parenteral vaccine ‐ adverse events, Outcome 1: General malaise" data-id="CD004876-fig-0007" src="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-002.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_t/tCD004876-CMP-002.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2: Influenza vaccines versus placebo: randomised controlled trials ‐ parenteral vaccine ‐ adverse events, Outcome 1: General malaise </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#CD004876-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-002.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004876-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/urn:x-wiley:14651858:media:CD004876:CD004876-CMP-002.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Influenza vaccines versus placebo: randomised controlled trials ‐ parenteral vaccine ‐ adverse events, Outcome 2: Nausea" data-id="CD004876-fig-0008" src="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-002.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_t/tCD004876-CMP-002.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2: Influenza vaccines versus placebo: randomised controlled trials ‐ parenteral vaccine ‐ adverse events, Outcome 2: Nausea </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#CD004876-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-002.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004876-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/urn:x-wiley:14651858:media:CD004876:CD004876-CMP-002.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Influenza vaccines versus placebo: randomised controlled trials ‐ parenteral vaccine ‐ adverse events, Outcome 3: Upper respiratory tract symptoms" data-id="CD004876-fig-0009" src="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-002.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_t/tCD004876-CMP-002.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2: Influenza vaccines versus placebo: randomised controlled trials ‐ parenteral vaccine ‐ adverse events, Outcome 3: Upper respiratory tract symptoms </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#CD004876-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-002.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004876-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/urn:x-wiley:14651858:media:CD004876:CD004876-CMP-002.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Influenza vaccines versus placebo: randomised controlled trials ‐ parenteral vaccine ‐ adverse events, Outcome 4: Headache" data-id="CD004876-fig-0010" src="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-002.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_t/tCD004876-CMP-002.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2: Influenza vaccines versus placebo: randomised controlled trials ‐ parenteral vaccine ‐ adverse events, Outcome 4: Headache </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#CD004876-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-002.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004876-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/urn:x-wiley:14651858:media:CD004876:CD004876-CMP-002.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Influenza vaccines versus placebo: randomised controlled trials ‐ parenteral vaccine ‐ adverse events, Outcome 5: Fever" data-id="CD004876-fig-0011" src="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-002.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_t/tCD004876-CMP-002.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2: Influenza vaccines versus placebo: randomised controlled trials ‐ parenteral vaccine ‐ adverse events, Outcome 5: Fever </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#CD004876-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-002.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004876-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/urn:x-wiley:14651858:media:CD004876:CD004876-CMP-002.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Influenza vaccines versus placebo: randomised controlled trials ‐ parenteral vaccine ‐ adverse events, Outcome 6: Local tenderness/sore arm" data-id="CD004876-fig-0012" src="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-002.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_t/tCD004876-CMP-002.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2: Influenza vaccines versus placebo: randomised controlled trials ‐ parenteral vaccine ‐ adverse events, Outcome 6: Local tenderness/sore arm </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#CD004876-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-002.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004876-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/urn:x-wiley:14651858:media:CD004876:CD004876-CMP-002.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Influenza vaccines versus placebo: randomised controlled trials ‐ parenteral vaccine ‐ adverse events, Outcome 7: Swelling ‐ erythema ‐ induration" data-id="CD004876-fig-0013" src="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-002.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_t/tCD004876-CMP-002.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.7</div> <div class="figure-caption"> <p>Comparison 2: Influenza vaccines versus placebo: randomised controlled trials ‐ parenteral vaccine ‐ adverse events, Outcome 7: Swelling ‐ erythema ‐ induration </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#CD004876-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-002.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004876-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/urn:x-wiley:14651858:media:CD004876:CD004876-CMP-003.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Influenza vaccines versus placebo: randomised controlled trials ‐ inactivated aerosol vaccine, Outcome 1: Influenza" data-id="CD004876-fig-0014" src="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-003.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_t/tCD004876-CMP-003.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3: Influenza vaccines versus placebo: randomised controlled trials ‐ inactivated aerosol vaccine, Outcome 1: Influenza </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#CD004876-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-003.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004876-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/urn:x-wiley:14651858:media:CD004876:CD004876-CMP-003.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Influenza vaccines versus placebo: randomised controlled trials ‐ inactivated aerosol vaccine, Outcome 2: Influenza‐like illness" data-id="CD004876-fig-0015" src="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-003.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_t/tCD004876-CMP-003.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3: Influenza vaccines versus placebo: randomised controlled trials ‐ inactivated aerosol vaccine, Outcome 2: Influenza‐like illness </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#CD004876-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-003.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004876-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/urn:x-wiley:14651858:media:CD004876:CD004876-CMP-004.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Influenza vaccines versus placebo: randomised controlled trials ‐ live aerosol vaccine, Outcome 1: Influenza" data-id="CD004876-fig-0016" src="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-004.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_t/tCD004876-CMP-004.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4: Influenza vaccines versus placebo: randomised controlled trials ‐ live aerosol vaccine, Outcome 1: Influenza </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#CD004876-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-004.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004876-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/urn:x-wiley:14651858:media:CD004876:CD004876-CMP-005.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Influenza vaccines versus placebo: randomised controlled trials ‐ live aerosol vaccine ‐ adverse events, Outcome 1: General malaise" data-id="CD004876-fig-0017" src="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-005.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_t/tCD004876-CMP-005.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5: Influenza vaccines versus placebo: randomised controlled trials ‐ live aerosol vaccine ‐ adverse events, Outcome 1: General malaise </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#CD004876-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-005.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004876-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/urn:x-wiley:14651858:media:CD004876:CD004876-CMP-005.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Influenza vaccines versus placebo: randomised controlled trials ‐ live aerosol vaccine ‐ adverse events, Outcome 2: Fever" data-id="CD004876-fig-0018" src="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-005.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_t/tCD004876-CMP-005.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.2</div> <div class="figure-caption"> <p>Comparison 5: Influenza vaccines versus placebo: randomised controlled trials ‐ live aerosol vaccine ‐ adverse events, Outcome 2: Fever </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#CD004876-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-005.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004876-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/urn:x-wiley:14651858:media:CD004876:CD004876-CMP-005.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Influenza vaccines versus placebo: randomised controlled trials ‐ live aerosol vaccine ‐ adverse events, Outcome 3: Upper respiratory tract symptoms" data-id="CD004876-fig-0019" src="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-005.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_t/tCD004876-CMP-005.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.3</div> <div class="figure-caption"> <p>Comparison 5: Influenza vaccines versus placebo: randomised controlled trials ‐ live aerosol vaccine ‐ adverse events, Outcome 3: Upper respiratory tract symptoms </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#CD004876-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-005.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004876-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/urn:x-wiley:14651858:media:CD004876:CD004876-CMP-005.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Influenza vaccines versus placebo: randomised controlled trials ‐ live aerosol vaccine ‐ adverse events, Outcome 4: Lower respiratory tract symptoms" data-id="CD004876-fig-0020" src="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-005.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_t/tCD004876-CMP-005.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.4</div> <div class="figure-caption"> <p>Comparison 5: Influenza vaccines versus placebo: randomised controlled trials ‐ live aerosol vaccine ‐ adverse events, Outcome 4: Lower respiratory tract symptoms </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#CD004876-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-005.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004876-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/urn:x-wiley:14651858:media:CD004876:CD004876-CMP-006.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Influenza vaccines versus no vaccination: cohort studies in nursing homes, Outcome 1: Influenza" data-id="CD004876-fig-0021" src="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-006.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_t/tCD004876-CMP-006.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.1</div> <div class="figure-caption"> <p>Comparison 6: Influenza vaccines versus no vaccination: cohort studies in nursing homes, Outcome 1: Influenza </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#CD004876-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-006.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004876-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/urn:x-wiley:14651858:media:CD004876:CD004876-CMP-006.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Influenza vaccines versus no vaccination: cohort studies in nursing homes, Outcome 2: Influenza‐like illness" data-id="CD004876-fig-0022" src="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-006.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_t/tCD004876-CMP-006.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.2</div> <div class="figure-caption"> <p>Comparison 6: Influenza vaccines versus no vaccination: cohort studies in nursing homes, Outcome 2: Influenza‐like illness </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#CD004876-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-006.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004876-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/urn:x-wiley:14651858:media:CD004876:CD004876-CMP-006.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Influenza vaccines versus no vaccination: cohort studies in nursing homes, Outcome 3: Pneumonia" data-id="CD004876-fig-0023" src="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-006.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_t/tCD004876-CMP-006.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.3</div> <div class="figure-caption"> <p>Comparison 6: Influenza vaccines versus no vaccination: cohort studies in nursing homes, Outcome 3: Pneumonia </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#CD004876-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-006.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004876-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/urn:x-wiley:14651858:media:CD004876:CD004876-CMP-006.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Influenza vaccines versus no vaccination: cohort studies in nursing homes, Outcome 4: Hospitalisation for influenza‐like illness or pneumonia" data-id="CD004876-fig-0024" src="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-006.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_t/tCD004876-CMP-006.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.4</div> <div class="figure-caption"> <p>Comparison 6: Influenza vaccines versus no vaccination: cohort studies in nursing homes, Outcome 4: Hospitalisation for influenza‐like illness or pneumonia </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#CD004876-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-006.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004876-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/urn:x-wiley:14651858:media:CD004876:CD004876-CMP-006.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Influenza vaccines versus no vaccination: cohort studies in nursing homes, Outcome 5: Deaths from flu or pneumonia" data-id="CD004876-fig-0025" src="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-006.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_t/tCD004876-CMP-006.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.5</div> <div class="figure-caption"> <p>Comparison 6: Influenza vaccines versus no vaccination: cohort studies in nursing homes, Outcome 5: Deaths from flu or pneumonia </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#CD004876-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-006.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004876-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/urn:x-wiley:14651858:media:CD004876:CD004876-CMP-006.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Influenza vaccines versus no vaccination: cohort studies in nursing homes, Outcome 6: All deaths" data-id="CD004876-fig-0026" src="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-006.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_t/tCD004876-CMP-006.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.6</div> <div class="figure-caption"> <p>Comparison 6: Influenza vaccines versus no vaccination: cohort studies in nursing homes, Outcome 6: All deaths </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#CD004876-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-006.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004876-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/urn:x-wiley:14651858:media:CD004876:CD004876-CMP-006.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Influenza vaccines versus no vaccination: cohort studies in nursing homes, Outcome 7: Influenza cases (clinically defined without clear definition)" data-id="CD004876-fig-0027" src="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-006.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_t/tCD004876-CMP-006.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.7</div> <div class="figure-caption"> <p>Comparison 6: Influenza vaccines versus no vaccination: cohort studies in nursing homes, Outcome 7: Influenza cases (clinically defined without clear definition) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#CD004876-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-006.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004876-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/urn:x-wiley:14651858:media:CD004876:CD004876-CMP-007.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 7: Influenza and pneumococcal vaccines versus no vaccination: case‐control studies in nursing homes, Outcome 1: Influenza‐like illness" data-id="CD004876-fig-0028" src="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-007.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_t/tCD004876-CMP-007.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.1</div> <div class="figure-caption"> <p>Comparison 7: Influenza and pneumococcal vaccines versus no vaccination: case‐control studies in nursing homes, Outcome 1: Influenza‐like illness </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#CD004876-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-007.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004876-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/urn:x-wiley:14651858:media:CD004876:CD004876-CMP-008.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 8: Influenza vaccines versus no vaccination: cohort studies in community‐dwellers, Outcome 1: Influenza" data-id="CD004876-fig-0029" src="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-008.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_t/tCD004876-CMP-008.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.1</div> <div class="figure-caption"> <p>Comparison 8: Influenza vaccines versus no vaccination: cohort studies in community‐dwellers, Outcome 1: Influenza </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#CD004876-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-008.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004876-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/urn:x-wiley:14651858:media:CD004876:CD004876-CMP-008.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 8: Influenza vaccines versus no vaccination: cohort studies in community‐dwellers, Outcome 2: Influenza‐like illness" data-id="CD004876-fig-0030" src="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-008.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_t/tCD004876-CMP-008.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.2</div> <div class="figure-caption"> <p>Comparison 8: Influenza vaccines versus no vaccination: cohort studies in community‐dwellers, Outcome 2: Influenza‐like illness </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#CD004876-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-008.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004876-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/urn:x-wiley:14651858:media:CD004876:CD004876-CMP-008.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 8: Influenza vaccines versus no vaccination: cohort studies in community‐dwellers, Outcome 3: Pneumonia" data-id="CD004876-fig-0031" src="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-008.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_t/tCD004876-CMP-008.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.3</div> <div class="figure-caption"> <p>Comparison 8: Influenza vaccines versus no vaccination: cohort studies in community‐dwellers, Outcome 3: Pneumonia </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#CD004876-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-008.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004876-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/urn:x-wiley:14651858:media:CD004876:CD004876-CMP-008.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 8: Influenza vaccines versus no vaccination: cohort studies in community‐dwellers, Outcome 4: Hospitalisation for flu or pneumonia" data-id="CD004876-fig-0032" src="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-008.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_t/tCD004876-CMP-008.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.4</div> <div class="figure-caption"> <p>Comparison 8: Influenza vaccines versus no vaccination: cohort studies in community‐dwellers, Outcome 4: Hospitalisation for flu or pneumonia </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#CD004876-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-008.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004876-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/urn:x-wiley:14651858:media:CD004876:CD004876-CMP-008.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 8: Influenza vaccines versus no vaccination: cohort studies in community‐dwellers, Outcome 5: Hospitalisation for any respiratory disease" data-id="CD004876-fig-0033" src="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-008.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_t/tCD004876-CMP-008.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.5</div> <div class="figure-caption"> <p>Comparison 8: Influenza vaccines versus no vaccination: cohort studies in community‐dwellers, Outcome 5: Hospitalisation for any respiratory disease </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#CD004876-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-008.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004876-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/urn:x-wiley:14651858:media:CD004876:CD004876-CMP-008.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 8: Influenza vaccines versus no vaccination: cohort studies in community‐dwellers, Outcome 6: Deaths from flu or pneumonia" data-id="CD004876-fig-0034" src="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-008.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_t/tCD004876-CMP-008.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.6</div> <div class="figure-caption"> <p>Comparison 8: Influenza vaccines versus no vaccination: cohort studies in community‐dwellers, Outcome 6: Deaths from flu or pneumonia </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#CD004876-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-008.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004876-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/urn:x-wiley:14651858:media:CD004876:CD004876-CMP-008.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 8: Influenza vaccines versus no vaccination: cohort studies in community‐dwellers, Outcome 7: Deaths from respiratory disease" data-id="CD004876-fig-0035" src="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-008.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_t/tCD004876-CMP-008.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.7</div> <div class="figure-caption"> <p>Comparison 8: Influenza vaccines versus no vaccination: cohort studies in community‐dwellers, Outcome 7: Deaths from respiratory disease </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#CD004876-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-008.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004876-fig-0036"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/urn:x-wiley:14651858:media:CD004876:CD004876-CMP-008.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 8: Influenza vaccines versus no vaccination: cohort studies in community‐dwellers, Outcome 8: All deaths" data-id="CD004876-fig-0036" src="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-008.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_t/tCD004876-CMP-008.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.8</div> <div class="figure-caption"> <p>Comparison 8: Influenza vaccines versus no vaccination: cohort studies in community‐dwellers, Outcome 8: All deaths </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#CD004876-fig-0036">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-008.08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004876-fig-0037"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/urn:x-wiley:14651858:media:CD004876:CD004876-CMP-008.09" target="_blank"><b></b></a></p> </div><img alt="Comparison 8: Influenza vaccines versus no vaccination: cohort studies in community‐dwellers, Outcome 9: Hospitalisation for heart disease" data-id="CD004876-fig-0037" src="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-008.09.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_t/tCD004876-CMP-008.09.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.9</div> <div class="figure-caption"> <p>Comparison 8: Influenza vaccines versus no vaccination: cohort studies in community‐dwellers, Outcome 9: Hospitalisation for heart disease </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#CD004876-fig-0037">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-008.09.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004876-fig-0038"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/urn:x-wiley:14651858:media:CD004876:CD004876-CMP-008.10" target="_blank"><b></b></a></p> </div><img alt="Comparison 8: Influenza vaccines versus no vaccination: cohort studies in community‐dwellers, Outcome 10: Combined outcome: all deaths or severe respiratory illness" data-id="CD004876-fig-0038" src="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-008.10.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_t/tCD004876-CMP-008.10.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.10</div> <div class="figure-caption"> <p>Comparison 8: Influenza vaccines versus no vaccination: cohort studies in community‐dwellers, Outcome 10: Combined outcome: all deaths or severe respiratory illness </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#CD004876-fig-0038">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-008.10.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004876-fig-0039"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/urn:x-wiley:14651858:media:CD004876:CD004876-CMP-009.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 9: Influenza vaccines versus no vaccination: cohort studies in community ‐ adjusted rates, Outcome 1: Hospitalisation for influenza or pneumonia" data-id="CD004876-fig-0039" src="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-009.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_t/tCD004876-CMP-009.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.1</div> <div class="figure-caption"> <p>Comparison 9: Influenza vaccines versus no vaccination: cohort studies in community ‐ adjusted rates, Outcome 1: Hospitalisation for influenza or pneumonia </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#CD004876-fig-0039">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-009.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004876-fig-0040"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/urn:x-wiley:14651858:media:CD004876:CD004876-CMP-009.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 9: Influenza vaccines versus no vaccination: cohort studies in community ‐ adjusted rates, Outcome 2: Hospitalisation for any respiratory disease" data-id="CD004876-fig-0040" src="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-009.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_t/tCD004876-CMP-009.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.2</div> <div class="figure-caption"> <p>Comparison 9: Influenza vaccines versus no vaccination: cohort studies in community ‐ adjusted rates, Outcome 2: Hospitalisation for any respiratory disease </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#CD004876-fig-0040">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-009.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004876-fig-0041"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/urn:x-wiley:14651858:media:CD004876:CD004876-CMP-009.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 9: Influenza vaccines versus no vaccination: cohort studies in community ‐ adjusted rates, Outcome 3: Hospitalisation for heart disease" data-id="CD004876-fig-0041" src="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-009.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_t/tCD004876-CMP-009.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.3</div> <div class="figure-caption"> <p>Comparison 9: Influenza vaccines versus no vaccination: cohort studies in community ‐ adjusted rates, Outcome 3: Hospitalisation for heart disease </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#CD004876-fig-0041">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-009.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004876-fig-0042"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/urn:x-wiley:14651858:media:CD004876:CD004876-CMP-009.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 9: Influenza vaccines versus no vaccination: cohort studies in community ‐ adjusted rates, Outcome 4: All deaths" data-id="CD004876-fig-0042" src="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-009.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_t/tCD004876-CMP-009.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.4</div> <div class="figure-caption"> <p>Comparison 9: Influenza vaccines versus no vaccination: cohort studies in community ‐ adjusted rates, Outcome 4: All deaths </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#CD004876-fig-0042">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-009.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004876-fig-0043"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/urn:x-wiley:14651858:media:CD004876:CD004876-CMP-009.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 9: Influenza vaccines versus no vaccination: cohort studies in community ‐ adjusted rates, Outcome 5: Combined outcome: all deaths or severe respiratory illness" data-id="CD004876-fig-0043" src="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-009.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_t/tCD004876-CMP-009.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.5</div> <div class="figure-caption"> <p>Comparison 9: Influenza vaccines versus no vaccination: cohort studies in community ‐ adjusted rates, Outcome 5: Combined outcome: all deaths or severe respiratory illness </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#CD004876-fig-0043">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-009.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004876-fig-0044"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/urn:x-wiley:14651858:media:CD004876:CD004876-CMP-010.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 10: Influenza vaccines versus no vaccination: cohort studies in community‐dwellers ‐ risk groups, Outcome 1: Influenza" data-id="CD004876-fig-0044" src="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-010.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_t/tCD004876-CMP-010.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.1</div> <div class="figure-caption"> <p>Comparison 10: Influenza vaccines versus no vaccination: cohort studies in community‐dwellers ‐ risk groups, Outcome 1: Influenza </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#CD004876-fig-0044">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-010.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004876-fig-0045"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/urn:x-wiley:14651858:media:CD004876:CD004876-CMP-010.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 10: Influenza vaccines versus no vaccination: cohort studies in community‐dwellers ‐ risk groups, Outcome 2: Pneumonia" data-id="CD004876-fig-0045" src="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-010.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_t/tCD004876-CMP-010.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.2</div> <div class="figure-caption"> <p>Comparison 10: Influenza vaccines versus no vaccination: cohort studies in community‐dwellers ‐ risk groups, Outcome 2: Pneumonia </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#CD004876-fig-0045">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-010.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004876-fig-0046"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/urn:x-wiley:14651858:media:CD004876:CD004876-CMP-010.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 10: Influenza vaccines versus no vaccination: cohort studies in community‐dwellers ‐ risk groups, Outcome 3: Hospitalisation for influenza or pneumonia" data-id="CD004876-fig-0046" src="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-010.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_t/tCD004876-CMP-010.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.3</div> <div class="figure-caption"> <p>Comparison 10: Influenza vaccines versus no vaccination: cohort studies in community‐dwellers ‐ risk groups, Outcome 3: Hospitalisation for influenza or pneumonia </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#CD004876-fig-0046">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-010.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004876-fig-0047"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/urn:x-wiley:14651858:media:CD004876:CD004876-CMP-010.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 10: Influenza vaccines versus no vaccination: cohort studies in community‐dwellers ‐ risk groups, Outcome 4: Hospitalisation for any respiratory disease" data-id="CD004876-fig-0047" src="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-010.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_t/tCD004876-CMP-010.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.4</div> <div class="figure-caption"> <p>Comparison 10: Influenza vaccines versus no vaccination: cohort studies in community‐dwellers ‐ risk groups, Outcome 4: Hospitalisation for any respiratory disease </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#CD004876-fig-0047">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-010.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004876-fig-0048"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/urn:x-wiley:14651858:media:CD004876:CD004876-CMP-010.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 10: Influenza vaccines versus no vaccination: cohort studies in community‐dwellers ‐ risk groups, Outcome 5: Deaths from respiratory disease" data-id="CD004876-fig-0048" src="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-010.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_t/tCD004876-CMP-010.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.5</div> <div class="figure-caption"> <p>Comparison 10: Influenza vaccines versus no vaccination: cohort studies in community‐dwellers ‐ risk groups, Outcome 5: Deaths from respiratory disease </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#CD004876-fig-0048">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-010.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004876-fig-0049"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/urn:x-wiley:14651858:media:CD004876:CD004876-CMP-010.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 10: Influenza vaccines versus no vaccination: cohort studies in community‐dwellers ‐ risk groups, Outcome 6: All deaths" data-id="CD004876-fig-0049" src="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-010.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_t/tCD004876-CMP-010.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.6</div> <div class="figure-caption"> <p>Comparison 10: Influenza vaccines versus no vaccination: cohort studies in community‐dwellers ‐ risk groups, Outcome 6: All deaths </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#CD004876-fig-0049">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-010.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004876-fig-0050"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/urn:x-wiley:14651858:media:CD004876:CD004876-CMP-010.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 10: Influenza vaccines versus no vaccination: cohort studies in community‐dwellers ‐ risk groups, Outcome 7: Hospitalisation for heart disease" data-id="CD004876-fig-0050" src="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-010.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_t/tCD004876-CMP-010.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.7</div> <div class="figure-caption"> <p>Comparison 10: Influenza vaccines versus no vaccination: cohort studies in community‐dwellers ‐ risk groups, Outcome 7: Hospitalisation for heart disease </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#CD004876-fig-0050">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-010.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004876-fig-0051"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/urn:x-wiley:14651858:media:CD004876:CD004876-CMP-010.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 10: Influenza vaccines versus no vaccination: cohort studies in community‐dwellers ‐ risk groups, Outcome 8: Combined outcome: all deaths or severe respiratory illness" data-id="CD004876-fig-0051" src="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-010.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_t/tCD004876-CMP-010.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.8</div> <div class="figure-caption"> <p>Comparison 10: Influenza vaccines versus no vaccination: cohort studies in community‐dwellers ‐ risk groups, Outcome 8: Combined outcome: all deaths or severe respiratory illness </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#CD004876-fig-0051">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-010.08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004876-fig-0052"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/urn:x-wiley:14651858:media:CD004876:CD004876-CMP-011.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 11: Influenza vaccines versus no vaccination: cohort studies in community‐dwellers ‐ no risk groups, Outcome 1: Influenza" data-id="CD004876-fig-0052" src="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-011.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_t/tCD004876-CMP-011.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.1</div> <div class="figure-caption"> <p>Comparison 11: Influenza vaccines versus no vaccination: cohort studies in community‐dwellers ‐ no risk groups, Outcome 1: Influenza </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#CD004876-fig-0052">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-011.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004876-fig-0053"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/urn:x-wiley:14651858:media:CD004876:CD004876-CMP-011.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 11: Influenza vaccines versus no vaccination: cohort studies in community‐dwellers ‐ no risk groups, Outcome 2: Pneumonia" data-id="CD004876-fig-0053" src="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-011.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_t/tCD004876-CMP-011.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.2</div> <div class="figure-caption"> <p>Comparison 11: Influenza vaccines versus no vaccination: cohort studies in community‐dwellers ‐ no risk groups, Outcome 2: Pneumonia </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#CD004876-fig-0053">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-011.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004876-fig-0054"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/urn:x-wiley:14651858:media:CD004876:CD004876-CMP-011.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 11: Influenza vaccines versus no vaccination: cohort studies in community‐dwellers ‐ no risk groups, Outcome 3: Hospitalisation for influenza or pneumonia" data-id="CD004876-fig-0054" src="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-011.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_t/tCD004876-CMP-011.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.3</div> <div class="figure-caption"> <p>Comparison 11: Influenza vaccines versus no vaccination: cohort studies in community‐dwellers ‐ no risk groups, Outcome 3: Hospitalisation for influenza or pneumonia </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#CD004876-fig-0054">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-011.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004876-fig-0055"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/urn:x-wiley:14651858:media:CD004876:CD004876-CMP-011.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 11: Influenza vaccines versus no vaccination: cohort studies in community‐dwellers ‐ no risk groups, Outcome 4: Hospitalisation for any respiratory disease" data-id="CD004876-fig-0055" src="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-011.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_t/tCD004876-CMP-011.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.4</div> <div class="figure-caption"> <p>Comparison 11: Influenza vaccines versus no vaccination: cohort studies in community‐dwellers ‐ no risk groups, Outcome 4: Hospitalisation for any respiratory disease </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#CD004876-fig-0055">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-011.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004876-fig-0056"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/urn:x-wiley:14651858:media:CD004876:CD004876-CMP-011.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 11: Influenza vaccines versus no vaccination: cohort studies in community‐dwellers ‐ no risk groups, Outcome 5: Deaths from respiratory disease" data-id="CD004876-fig-0056" src="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-011.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_t/tCD004876-CMP-011.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.5</div> <div class="figure-caption"> <p>Comparison 11: Influenza vaccines versus no vaccination: cohort studies in community‐dwellers ‐ no risk groups, Outcome 5: Deaths from respiratory disease </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#CD004876-fig-0056">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-011.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004876-fig-0057"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/urn:x-wiley:14651858:media:CD004876:CD004876-CMP-011.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 11: Influenza vaccines versus no vaccination: cohort studies in community‐dwellers ‐ no risk groups, Outcome 6: All deaths" data-id="CD004876-fig-0057" src="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-011.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_t/tCD004876-CMP-011.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.6</div> <div class="figure-caption"> <p>Comparison 11: Influenza vaccines versus no vaccination: cohort studies in community‐dwellers ‐ no risk groups, Outcome 6: All deaths </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#CD004876-fig-0057">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-011.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004876-fig-0058"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/urn:x-wiley:14651858:media:CD004876:CD004876-CMP-011.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 11: Influenza vaccines versus no vaccination: cohort studies in community‐dwellers ‐ no risk groups, Outcome 7: Hospitalisation for heart disease" data-id="CD004876-fig-0058" src="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-011.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_t/tCD004876-CMP-011.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.7</div> <div class="figure-caption"> <p>Comparison 11: Influenza vaccines versus no vaccination: cohort studies in community‐dwellers ‐ no risk groups, Outcome 7: Hospitalisation for heart disease </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#CD004876-fig-0058">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-011.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004876-fig-0059"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/urn:x-wiley:14651858:media:CD004876:CD004876-CMP-011.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 11: Influenza vaccines versus no vaccination: cohort studies in community‐dwellers ‐ no risk groups, Outcome 8: Combined outcome: all deaths or severe respiratory illness" data-id="CD004876-fig-0059" src="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-011.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_t/tCD004876-CMP-011.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.8</div> <div class="figure-caption"> <p>Comparison 11: Influenza vaccines versus no vaccination: cohort studies in community‐dwellers ‐ no risk groups, Outcome 8: Combined outcome: all deaths or severe respiratory illness </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#CD004876-fig-0059">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-011.08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004876-fig-0060"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/urn:x-wiley:14651858:media:CD004876:CD004876-CMP-012.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 12: Influenza and pneumococcal vaccines versus no vaccination: cohort studies in community‐dwellers, Outcome 1: Influenza‐like illness" data-id="CD004876-fig-0060" src="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-012.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_t/tCD004876-CMP-012.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.1</div> <div class="figure-caption"> <p>Comparison 12: Influenza and pneumococcal vaccines versus no vaccination: cohort studies in community‐dwellers, Outcome 1: Influenza‐like illness </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#CD004876-fig-0060">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-012.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004876-fig-0061"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/urn:x-wiley:14651858:media:CD004876:CD004876-CMP-012.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 12: Influenza and pneumococcal vaccines versus no vaccination: cohort studies in community‐dwellers, Outcome 2: Hospitalisation for influenza or pneumonia or respiratory disease" data-id="CD004876-fig-0061" src="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-012.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_t/tCD004876-CMP-012.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.2</div> <div class="figure-caption"> <p>Comparison 12: Influenza and pneumococcal vaccines versus no vaccination: cohort studies in community‐dwellers, Outcome 2: Hospitalisation for influenza or pneumonia or respiratory disease </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#CD004876-fig-0061">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-012.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004876-fig-0062"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/urn:x-wiley:14651858:media:CD004876:CD004876-CMP-012.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 12: Influenza and pneumococcal vaccines versus no vaccination: cohort studies in community‐dwellers, Outcome 3: Deaths from influenza or pneumonia" data-id="CD004876-fig-0062" src="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-012.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_t/tCD004876-CMP-012.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.3</div> <div class="figure-caption"> <p>Comparison 12: Influenza and pneumococcal vaccines versus no vaccination: cohort studies in community‐dwellers, Outcome 3: Deaths from influenza or pneumonia </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#CD004876-fig-0062">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-012.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004876-fig-0063"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/urn:x-wiley:14651858:media:CD004876:CD004876-CMP-012.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 12: Influenza and pneumococcal vaccines versus no vaccination: cohort studies in community‐dwellers, Outcome 4: All deaths" data-id="CD004876-fig-0063" src="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-012.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_t/tCD004876-CMP-012.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.4</div> <div class="figure-caption"> <p>Comparison 12: Influenza and pneumococcal vaccines versus no vaccination: cohort studies in community‐dwellers, Outcome 4: All deaths </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#CD004876-fig-0063">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-012.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004876-fig-0064"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/urn:x-wiley:14651858:media:CD004876:CD004876-CMP-013.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 13: Influenza vaccines with adjuvant versus no vaccination: cohort studies in community‐dwellers, Outcome 1: Influenza‐like illness" data-id="CD004876-fig-0064" src="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-013.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_t/tCD004876-CMP-013.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 13.1</div> <div class="figure-caption"> <p>Comparison 13: Influenza vaccines with adjuvant versus no vaccination: cohort studies in community‐dwellers, Outcome 1: Influenza‐like illness </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#CD004876-fig-0064">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-013.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004876-fig-0065"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/urn:x-wiley:14651858:media:CD004876:CD004876-CMP-013.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 13: Influenza vaccines with adjuvant versus no vaccination: cohort studies in community‐dwellers, Outcome 2: Hospitalisation for influenza or pneumonia or respiratory disease" data-id="CD004876-fig-0065" src="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-013.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_t/tCD004876-CMP-013.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 13.2</div> <div class="figure-caption"> <p>Comparison 13: Influenza vaccines with adjuvant versus no vaccination: cohort studies in community‐dwellers, Outcome 2: Hospitalisation for influenza or pneumonia or respiratory disease </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#CD004876-fig-0065">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-013.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004876-fig-0066"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/urn:x-wiley:14651858:media:CD004876:CD004876-CMP-013.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 13: Influenza vaccines with adjuvant versus no vaccination: cohort studies in community‐dwellers, Outcome 3: All deaths" data-id="CD004876-fig-0066" src="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-013.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_t/tCD004876-CMP-013.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 13.3</div> <div class="figure-caption"> <p>Comparison 13: Influenza vaccines with adjuvant versus no vaccination: cohort studies in community‐dwellers, Outcome 3: All deaths </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#CD004876-fig-0066">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-013.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004876-fig-0067"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/urn:x-wiley:14651858:media:CD004876:CD004876-CMP-014.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 14: Influenza vaccines versus no vaccination: case‐control studies in community, Outcome 1: Hospitalisations for influenza or pneumonia" data-id="CD004876-fig-0067" src="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-014.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_t/tCD004876-CMP-014.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 14.1</div> <div class="figure-caption"> <p>Comparison 14: Influenza vaccines versus no vaccination: case‐control studies in community, Outcome 1: Hospitalisations for influenza or pneumonia </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#CD004876-fig-0067">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-014.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004876-fig-0068"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/urn:x-wiley:14651858:media:CD004876:CD004876-CMP-014.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 14: Influenza vaccines versus no vaccination: case‐control studies in community, Outcome 2: Hospitalisations for any respiratory disease" data-id="CD004876-fig-0068" src="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-014.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_t/tCD004876-CMP-014.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 14.2</div> <div class="figure-caption"> <p>Comparison 14: Influenza vaccines versus no vaccination: case‐control studies in community, Outcome 2: Hospitalisations for any respiratory disease </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#CD004876-fig-0068">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-014.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004876-fig-0069"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/urn:x-wiley:14651858:media:CD004876:CD004876-CMP-014.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 14: Influenza vaccines versus no vaccination: case‐control studies in community, Outcome 3: Deaths from influenza or pneumonia" data-id="CD004876-fig-0069" src="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-014.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_t/tCD004876-CMP-014.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 14.3</div> <div class="figure-caption"> <p>Comparison 14: Influenza vaccines versus no vaccination: case‐control studies in community, Outcome 3: Deaths from influenza or pneumonia </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#CD004876-fig-0069">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-014.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004876-fig-0070"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/urn:x-wiley:14651858:media:CD004876:CD004876-CMP-014.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 14: Influenza vaccines versus no vaccination: case‐control studies in community, Outcome 4: Pneumonia (no better defined)" data-id="CD004876-fig-0070" src="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-014.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_t/tCD004876-CMP-014.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 14.4</div> <div class="figure-caption"> <p>Comparison 14: Influenza vaccines versus no vaccination: case‐control studies in community, Outcome 4: Pneumonia (no better defined) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#CD004876-fig-0070">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-014.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004876-fig-0071"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/urn:x-wiley:14651858:media:CD004876:CD004876-CMP-015.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 15: Influenza vaccines versus no vaccination: case‐control studies in community ‐ adjusted rates, Outcome 1: Hospitalisations for influenza or pneumonia" data-id="CD004876-fig-0071" src="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-015.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_t/tCD004876-CMP-015.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 15.1</div> <div class="figure-caption"> <p>Comparison 15: Influenza vaccines versus no vaccination: case‐control studies in community ‐ adjusted rates, Outcome 1: Hospitalisations for influenza or pneumonia </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#CD004876-fig-0071">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-015.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004876-fig-0072"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/urn:x-wiley:14651858:media:CD004876:CD004876-CMP-015.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 15: Influenza vaccines versus no vaccination: case‐control studies in community ‐ adjusted rates, Outcome 2: Hospitalisations for any respiratory disease" data-id="CD004876-fig-0072" src="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-015.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_t/tCD004876-CMP-015.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 15.2</div> <div class="figure-caption"> <p>Comparison 15: Influenza vaccines versus no vaccination: case‐control studies in community ‐ adjusted rates, Outcome 2: Hospitalisations for any respiratory disease </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#CD004876-fig-0072">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-015.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004876-fig-0073"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/urn:x-wiley:14651858:media:CD004876:CD004876-CMP-015.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 15: Influenza vaccines versus no vaccination: case‐control studies in community ‐ adjusted rates, Outcome 3: Deaths from pneumonia or influenza" data-id="CD004876-fig-0073" src="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-015.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_t/tCD004876-CMP-015.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 15.3</div> <div class="figure-caption"> <p>Comparison 15: Influenza vaccines versus no vaccination: case‐control studies in community ‐ adjusted rates, Outcome 3: Deaths from pneumonia or influenza </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#CD004876-fig-0073">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-015.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004876-fig-0074"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/urn:x-wiley:14651858:media:CD004876:CD004876-CMP-016.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 16: Influenza and pneumococcal vaccines versus no vaccination: case‐control studies in community, Outcome 1: Hospitalisations for influenza or pneumonia" data-id="CD004876-fig-0074" src="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-016.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_t/tCD004876-CMP-016.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.1</div> <div class="figure-caption"> <p>Comparison 16: Influenza and pneumococcal vaccines versus no vaccination: case‐control studies in community, Outcome 1: Hospitalisations for influenza or pneumonia </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#CD004876-fig-0074">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-016.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004876-fig-0075"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/urn:x-wiley:14651858:media:CD004876:CD004876-CMP-017.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 17: Influenza and pneumococcal vaccines versus no vaccination: case‐control studies in community ‐ adjusted rates, Outcome 1: Hospitalisations for influenza or pneumonia" data-id="CD004876-fig-0075" src="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-017.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_t/tCD004876-CMP-017.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 17.1</div> <div class="figure-caption"> <p>Comparison 17: Influenza and pneumococcal vaccines versus no vaccination: case‐control studies in community ‐ adjusted rates, Outcome 1: Hospitalisations for influenza or pneumonia </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#CD004876-fig-0075">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-017.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004876-fig-0076"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/urn:x-wiley:14651858:media:CD004876:CD004876-CMP-018.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 18: Sensitivity analysis: comparison 01: subgroup analysis by study quality, Outcome 1: Influenza‐like illness" data-id="CD004876-fig-0076" src="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-018.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_t/tCD004876-CMP-018.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.1</div> <div class="figure-caption"> <p>Comparison 18: Sensitivity analysis: comparison 01: subgroup analysis by study quality, Outcome 1: Influenza‐like illness </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#CD004876-fig-0076">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/media/CDSR/CD004876/image_n/nCD004876-CMP-018.01.svg" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD004876-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Influenza vaccine compared to placebo for preventing influenza in the elderly</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Influenza vaccine compared to placebo for preventing influenza in the elderly</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people aged over 65 years<br/><b>Setting:</b> community and residential care institutions in the USA and Europe during influenza seasons between 1965 and 2000<br/><b>Intervention:</b> influenza vaccine<br/><b>Comparison:</b> placebo </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with placebo</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with influenza vaccine</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Influenza assessed with: laboratory confirmation</b> </p> <p>Follow‐up was conducted over an influenza season.</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.42<br/>(0.27 to 0.66) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2217<br/>(3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>LOW <sup>2 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>57 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>24 per 1000<br/>(15 to 38) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Influenza‐like illness<br/>assessed with: subjective report</b> </p> <p>Follow‐up was conducted over an influenza season.</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.59<br/>(0.47 to 0.73) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>6894<br/>(4 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/>MODERATE <sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>59 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>35 per 1000<br/>(28 to 43) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pneumonia</b> </p> <p>Follow‐up was conducted over an influenza season.</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>No events occurred in 1 study of 699 people.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>699<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>4 5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Hospitalisations</b> ‐ not reported </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>All deaths</b> </p> <p>Follow‐up was conducted over an influenza season.</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.02<br/>(0.11 to 9.72) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>699<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>4 5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>6 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>6 per 1000<br/>(1 to 55) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Fever</b> </p> <p>Follow‐up was conducted over an influenza season.</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.57<br/>(0.92 to 2.71) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2519<br/>(3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/>MODERATE <sup>6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>16 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>25 per 1000<br/>(15 to 43) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Nausea</b> </p> <p>Follow‐up was conducted over an influenza season.</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.75<br/>(0.74 to 4.12) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>672<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>LOW <sup>6 7</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>24 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>42 per 1000<br/>(18 to 98) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> confidence interval; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate quality:</b> We are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low quality:</b> Our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low quality:</b> We have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Control group risk taken as aggregate of the study control group risks.<br/><sup>2</sup>Downgraded one level due to serious risk of bias. Most of the evidence summarised in the meta‐analysis comes from studies with high or unclear risk of bias for more than one 'Risk of bias' domain.<br/><sup>3</sup>Downgraded due to indirectness. Uncertainty over the definition, testing, and surveillance of influenza in older trials.<br/><sup>4</sup>Downgraded two levels due to very serious imprecision. No events occurred in one study of nearly 700 people. The study was likely underpowered to detect effects on either pneumonia or mortality.<br/><sup>5</sup>Downgraded one level due to serious risk of bias. One study contributing data to this outcome had high risk of selection bias.<br/><sup>6</sup>Downgraded one level due to serious imprecision. Confidence intervals for nausea and fever were wide and include reduction and increase in risk of adverse events.<br/><sup>7</sup>Downgraded one level due to serious risk of bias. One study contributing data to this outcome had unclear risk of selection bias. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Influenza vaccine compared to placebo for preventing influenza in the elderly</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/full#CD004876-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD004876-tbl-0002"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Studies included in the various versions of this review and their impact on our conclusions</span></div> <tbody> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Review version (searches date)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Number of included trials (RCTs/CCTs)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Number of included observational studies</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Estimates of effect (RCTs/CCTs only)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Conclusions (1 to 2 lines from abstract)</b> </p> </th> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Version 1</p> <p>(24 May 2006)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>62<sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Influenza‐like illness</b> </p> <p>LAIV = no data</p> <p>TIV = 41% (95% CI 27% to 53%)</p> <p>IAV = n.s.</p> <p><b>Influenza</b> </p> <p>LAIV = n.s.</p> <p>TIV = 58% (95% CI 34% to 73%)</p> <p>IAV = n.s.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>In long‐term care facilities, where vaccination is most effective against complications, the aims of the vaccination campaign are fulfilled, at least in part. However, according to reliable evidence the usefulness of vaccines in the community is modest. </p> <p>The apparent high effectiveness of the vaccines in preventing death from all causes may reflect a baseline imbalance in health status and other systematic differences in the 2 groups of participants. </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Version 2</p> <p>(20 January 2010)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>66<sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Influenza‐like illness</b> </p> <p>LAIV = no data</p> <p>TIV = 41% (95% CI 27% to 53%)</p> <p>IAV = n.s.</p> <p><b>Influenza</b> </p> <p>LAIV = n.s.</p> <p>TIV = 58% (95% CI 34% to 73%)</p> <p>IAV = n.s.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The available evidence is of poor quality and provides no guidance regarding the safety, efficacy, or effectiveness of influenza vaccines for people aged 65 years or older. To resolve the uncertainty, an adequately powered publicly‐funded randomised, placebo‐controlled trial run over several seasons should be undertaken. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="5"> <div class="table-footnote"> <p><sup>1</sup>These include 49 cohort studies for efficacy/effectiveness (79 data sets); 10 case‐control studies for efficacy/effectiveness (12 data sets); 3 studies (cohorts) for Guillain‐Barré syndrome.<br/><sup>2</sup>For this update, two cohort studies and two case‐control studies were added to the review (all assessing efficacy/effectiveness). </p> <p>Key: CCT = controlled clinical trial; CI = confidence interval; IAV = inactivated aerosol vaccines; LAIV = live attenuated vaccines; n.s. = not significant; RCT = randomised controlled trial; TIV = trivalent inactivated vaccines </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Studies included in the various versions of this review and their impact on our conclusions</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/full#CD004876-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD004876-tbl-0003"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Guillain‐Barré syndrome</span></div> <tbody> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Influenza season</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Vaccine</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Population</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Age</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>RR (95% CI)</b> </p> </th> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD004876-bbs2-0102" title="SchonbergerLB , BregmanDJ , Sullivan-BolyaiJZ , KeenlysideRA , ZieglerDW , RetailliauHF , et al. Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976-1977. American Journal of Epidemiology1979;110(2):105-23. ">Schonberger 1979</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1976 to 1977</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>A/New Jersey/76 or A/New Jersey/76 and A/Victoria/75 swine vaccine</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All the USA population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&gt; 64 years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.2 (3.9 to 7.0)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD004876-bbs2-0053" title="KaplanJE , KatonaP , HurwitzES , SchonbergerLB . Guillain-Barre syndrome in the United States, 1979-1980 and 1980-1981. Lack of an association with influenza vaccination. JAMA1982;248(6):698-700. ">Kaplan 1982</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1979 to 1980</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Inactivated trivalent</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All the USA population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&gt; 18 years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.6 (0.45 to 1.32)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD004876-bbs2-0053" title="KaplanJE , KatonaP , HurwitzES , SchonbergerLB . Guillain-Barre syndrome in the United States, 1979-1980 and 1980-1981. Lack of an association with influenza vaccination. JAMA1982;248(6):698-700. ">Kaplan 1982</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1980 to 1981</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Inactivated trivalent</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All the USA population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&gt; 18 years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.4 (0.80 to 1.76)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD004876-bbs2-0056" title="LaskyT , TerraccianoGJ , MagderL , KoskiCL , BallesterosM , NashD , et al. The Guillain-Barre syndrome and the 1992-1993 and 1993-1994 influenza vaccines. New England Journal of Medicine1998;339(25):1797-802. ">Lasky 1998</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1992 to 1994</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Inactivated trivalent</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21 million</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>&gt; 64 years</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.5 (0.7 to 3.3)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p>Key: CI = confidence interval; RR = risk ratio</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Guillain‐Barré syndrome</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/full#CD004876-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004876-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Influenza vaccines versus placebo: randomised controlled trials ‐ parenteral vaccine</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.1 Influenza <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2217</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.42 [0.27, 0.66]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.1 Outbreak ‐ vaccine matching ‐ community ‐ healthy and ill</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1838</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.41 [0.23, 0.74]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.2 Outbreak ‐ vaccine matching ‐ psychiatric hospital</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>177</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.35 [0.12, 1.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.3 No outbreak ‐ vaccine matching ‐ nursing home ‐ healthy and ill</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>202</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.50 [0.20, 1.25]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.2 Influenza‐like illness <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6894</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.59 [0.47, 0.73]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.1 Outbreak ‐ vaccine matching (circulating strains) ‐ community ‐ healthy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2047</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.57 [0.42, 0.79]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.2 Outbreak ‐ vaccine matching ‐ community ‐ risk groups</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>490</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.49, 1.53]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.3 Outbreak ‐ vaccine matching ‐ nursing home ‐ healthy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4180</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.54 [0.37, 0.80]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.4 Outbreak ‐ vaccine matching ‐ psychiatric hospital</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>177</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.35 [0.13, 0.92]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.3 Pneumonia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3.1 Outbreak ‐ vaccine matching ‐ community ‐ healthy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.4 All deaths <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4.1 Outbreak ‐ vaccine matching ‐ community ‐ healthy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Influenza vaccines versus placebo: randomised controlled trials ‐ parenteral vaccine</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#CD004876-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004876-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Influenza vaccines versus placebo: randomised controlled trials ‐ parenteral vaccine ‐ adverse events</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.1 General malaise <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2560</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.18 [0.87, 1.61]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.2 Nausea <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>672</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.75 [0.74, 4.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.3 Upper respiratory tract symptoms <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>713</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.35 [0.90, 2.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.4 Headache <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2519</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.10 [0.76, 1.58]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.5 Fever <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2519</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.57 [0.92, 2.71]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.6 Local tenderness/sore arm <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2560</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.56 [2.61, 4.87]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.7 Swelling ‐ erythema ‐ induration <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1847</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>8.23 [3.98, 17.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Influenza vaccines versus placebo: randomised controlled trials ‐ parenteral vaccine ‐ adverse events</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#CD004876-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004876-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Influenza vaccines versus placebo: randomised controlled trials ‐ inactivated aerosol vaccine</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.1 Influenza <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>176</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.40, 1.99]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1.1 Outbreak ‐ vaccine matching ‐ psychiatric hospital</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>176</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.40, 1.99]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.2 Influenza‐like illness <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>176</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.84 [0.41, 1.71]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2.1 Outbreak ‐ vaccine matching ‐ psychiatric hospital</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>176</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.84 [0.41, 1.71]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Influenza vaccines versus placebo: randomised controlled trials ‐ inactivated aerosol vaccine</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#CD004876-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004876-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Influenza vaccines versus placebo: randomised controlled trials ‐ live aerosol vaccine</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.1 Influenza <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>220</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.49 [0.21, 1.17]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1.1 No outbreak ‐ vaccine matching ‐ nursing home ‐ healthy and ill</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>220</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.49 [0.21, 1.17]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Influenza vaccines versus placebo: randomised controlled trials ‐ live aerosol vaccine</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#CD004876-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004876-tbl-0008"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Influenza vaccines versus placebo: randomised controlled trials ‐ live aerosol vaccine ‐ adverse events</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.1 General malaise <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.09 [0.18, 53.20]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.2 Fever <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.71 [0.09, 33.24]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.3 Upper respiratory tract symptoms <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.62 [0.42, 6.29]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.4 Lower respiratory tract symptoms <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.91 [0.41, 20.48]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Influenza vaccines versus placebo: randomised controlled trials ‐ live aerosol vaccine ‐ adverse events</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#CD004876-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004876-tbl-0009"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Influenza vaccines versus no vaccination: cohort studies in nursing homes</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.1 Influenza <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1941</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.65 [0.32, 1.29]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1.1 Outbreak ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>658</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.04 [0.43, 2.51]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1.2 Outbreak ‐ vaccine matching absent or unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>592</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.47 [0.22, 1.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1.3 No outbreak ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>691</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.23 [0.05, 1.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1.4 No outbreak ‐ vaccine matching absent or unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.2 Influenza‐like illness <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>26</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>12388</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [0.66, 0.88]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2.1 Outbreak ‐ vaccine matching (circulating strains)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5963</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.77 [0.64, 0.94]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2.2 Outbreak ‐ vaccine matching absent or unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4096</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.80 [0.60, 1.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2.3 No outbreak ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2329</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [0.46, 0.98]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2.4 No outbreak ‐ vaccine matching absent or unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.3 Pneumonia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>10274</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.53 [0.43, 0.66]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.3.1 Outbreak ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4482</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.54 [0.42, 0.70]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.3.2 Outbreak ‐ vaccine matching absent or unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3991</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.68 [0.39, 1.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.3.3 No outbreak ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.3.4 No outbreak ‐ matching absent or unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1801</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.35 [0.18, 0.68]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.4 Hospitalisation for influenza‐like illness or pneumonia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>28032</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.51 [0.32, 0.81]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.4.1 Outbreak ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2027</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.55 [0.36, 0.84]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.4.2 Outbreak ‐ vaccine matching absent or unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3301</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.43, 1.58]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.4.3 No outbreak ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>22704</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.32 [0.14, 0.76]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.4.4 No outbreak ‐ vaccine matching absent or unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.5 Deaths from flu or pneumonia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>32179</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.46 [0.33, 0.63]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.5.1 Outbreak ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6127</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.58 [0.41, 0.83]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.5.2 Outbreak ‐ vaccine matching absent or unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1089</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.34 [0.11, 1.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.5.3 No outbreak ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>23162</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.27 [0.09, 0.87]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.5.4 No outbreak ‐ vaccine matching absent or unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1801</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.30 [0.14, 0.67]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.6 All deaths <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>305</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.40 [0.21, 0.77]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.6.1 Outbreak ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>305</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.40 [0.21, 0.77]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.6.2 Outbreak ‐ vaccine matching absent or unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.6.3 No outbreak ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.6.4 No outbreak ‐ vaccine matching absent or unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.7 Influenza cases (clinically defined without clear definition) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>24238</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.52 [0.27, 1.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.7.1 Outbreak ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>271</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.70 [0.11, 4.56]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.7.2 Outbreak ‐ vaccine matching absent or unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>155</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.23 [0.09, 0.59]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.7.3 No outbreak ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>22462</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.40 [0.35, 0.46]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.7.4 No outbreak ‐ vaccine matching absent or unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1350</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.72 [0.41, 1.28]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Influenza vaccines versus no vaccination: cohort studies in nursing homes</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#CD004876-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004876-tbl-0010"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Influenza and pneumococcal vaccines versus no vaccination: case‐control studies in nursing homes</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7.1 Influenza‐like illness <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1198</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.52 [0.40, 0.68]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1.1 Outbreak ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1198</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.52 [0.40, 0.68]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Influenza and pneumococcal vaccines versus no vaccination: case‐control studies in nursing homes</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#CD004876-tbl-0010">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004876-tbl-0011"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Influenza vaccines versus no vaccination: cohort studies in community‐dwellers</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8.1 Influenza <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>18249</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.19 [0.02, 2.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1.1 Epidemic year ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>427</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.05 [0.01, 0.37]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1.2 Epidemic year ‐ vaccine matching absent or unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1.3 Non‐epidemic year ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>17822</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.50 [0.27, 0.91]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1.4 Non‐epidemic year ‐ vaccine matching absent or unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8.2 Influenza‐like illness <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>9613</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.75 [0.42, 1.33]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2.1 Epidemic year ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2.2 Epidemic year ‐ vaccine matching absent or unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2.3 Non‐epidemic year ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4636</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.08 [0.58, 2.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2.4 Non‐epidemic year ‐ vaccine matching absent or unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>268</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.16, 4.55]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2.5 Epidemic year ‐ vaccine not matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4709</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.44 [0.24, 0.81]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8.3 Pneumonia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>18090</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.88 [0.64, 1.20]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.3.1 Epidemic year ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.3.2 Epidemic year ‐ vaccine matching absent or unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.3.3 Non‐epidemic year ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>17822</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.63, 1.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.3.4 Non‐epidemic year ‐ vaccine matching absent or unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>268</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.00 [0.16, 57.42]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8.4 Hospitalisation for flu or pneumonia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>784643</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.73 [0.62, 0.85]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.4.1 Epidemic year ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>727776</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.74 [0.62, 0.88]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.4.2 Epidemic year ‐ vaccine matching absent or unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.4.3 Non‐epidemic year ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>25532</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.55 [0.37, 0.83]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.4.4 Non‐epidemic year ‐ vaccine matching absent or unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>26626</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.73 [0.54, 0.99]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.4.5 Epidemic year ‐ vaccine not matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4709</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.33, 2.40]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8.5 Hospitalisation for any respiratory disease <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>567299</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.88 [0.54, 1.43]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.5.1 Epidemic year ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>515141</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.78 [0.37, 1.64]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.5.2 Epidemic year ‐ vaccine matching absent or unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.5.3 Non‐epidemic year ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>25532</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.79, 1.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.5.4 Non‐epidemic year ‐ vaccine matching absent or unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>26626</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.16 [1.01, 1.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8.6 Deaths from flu or pneumonia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>163391</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.70, 1.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.6.1 Epidemic year ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>163391</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.70, 1.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.6.2 Epidemic year ‐ vaccine matching absent or unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.6.3 Non‐epidemic year ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.6.4 Non‐epidemic year ‐ vaccine matching absent or unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8.7 Deaths from respiratory disease <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>426668</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.32 [1.25, 1.39]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.7.1 Epidemic year ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>426668</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.32 [1.25, 1.39]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8.8 All deaths <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>409468</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.61 [0.47, 0.80]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.8.1 Epidemic year ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>300332</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.59 [0.50, 0.70]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.8.2 Epidemic year ‐ vaccine matching absent or unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.8.3 Non‐epidemic year ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>104427</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.65 [0.30, 1.39]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.8.4 Non‐epidemic year ‐ vaccine matching absent or unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.8.5 Epidemic year ‐ vaccine not matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4709</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.89 [0.90, 16.89]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8.9 Hospitalisation for heart disease <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>433934</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.67, 1.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.9.1 Epidemic year ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>381776</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.74 [0.56, 0.97]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.9.2 Epidemic year ‐ vaccine matching absent or unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.9.3 Non‐epidemic year ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>25532</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.06 [0.81, 1.38]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.9.4 Non‐epidemic year ‐ vaccine matching absent or unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>26626</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.59 [1.07, 2.36]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8.10 Combined outcome: all deaths or severe respiratory illness <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>290819</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.71 [0.58, 0.85]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.10.1 Epidemic year ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>132365</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.80 [0.42, 1.55]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.10.2 Epidemic year ‐ vaccine matching absent or unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>158454</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.74 [0.69, 0.80]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Influenza vaccines versus no vaccination: cohort studies in community‐dwellers</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#CD004876-tbl-0011">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004876-tbl-0012"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">Influenza vaccines versus no vaccination: cohort studies in community ‐ adjusted rates</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9.1 Hospitalisation for influenza or pneumonia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.73 [0.67, 0.79]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1.1 Epidemic ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.71 [0.65, 0.77]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1.2 Non‐epidemic ‐ vaccine not matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.58, 1.38]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1.3 Epidemic year ‐ vaccine matching absent or unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.68, 0.98]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9.2 Hospitalisation for any respiratory disease <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.78 [0.72, 0.85]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.2.1 Epidemic ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.71 [0.67, 0.74]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.2.2 Non‐epidemic ‐ vaccine not matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.76, 1.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.2.3 Non‐epidemic year ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.84, 1.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9.3 Hospitalisation for heart disease <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [0.70, 0.82]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.3.1 Epidemic year ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.75 [0.70, 0.82]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.3.2 Non‐epidemic ‐ vaccine not matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.80 [0.55, 1.16]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9.4 All deaths <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.53 [0.46, 0.61]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.4.1 Epidemic year ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.47 [0.42, 0.53]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.4.2 Epidemic year ‐ vaccine matching absent or unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.65 [0.57, 0.75]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.4.3 Non‐epidemic year ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [0.60, 0.97]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9.5 Combined outcome: all deaths or severe respiratory illness <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.70 [0.37, 1.34]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.5.1 Epidemic year ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.70 [0.37, 1.34]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">Influenza vaccines versus no vaccination: cohort studies in community ‐ adjusted rates</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#CD004876-tbl-0012">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004876-tbl-0013"> <div class="table-heading"><span class="table-label">Comparison 10.</span> <span class="table-title">Influenza vaccines versus no vaccination: cohort studies in community‐dwellers ‐ risk groups</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10.1 Influenza <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6423</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.40 [0.14, 1.17]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.1.1 Epidemic year ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.1.2 Epidemic year ‐ vaccine matching absent or unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.1.3 Non‐epidemic year ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6423</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.40 [0.14, 1.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.1.4 Non‐epidemic year ‐ vaccine matching absent or unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10.2 Pneumonia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6423</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.22 [0.76, 1.94]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.2.1 Epidemic year ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.2.2 Epidemic year ‐ vaccine matching absent or unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.2.3 Non‐epidemic year ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6423</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.22 [0.76, 1.94]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.2.4 Non‐epidemic year ‐ vaccine matching absent or unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10.3 Hospitalisation for influenza or pneumonia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>45932</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.74 [0.63, 0.86]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.3.1 Epidemic year ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>45932</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.74 [0.63, 0.86]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.3.2 Epidemic year ‐ vaccine matching absent or unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.3.3 Non‐epidemic year ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.3.4 Non‐epidemic year ‐ vaccine matching absent or unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10.4 Hospitalisation for any respiratory disease <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>189004</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.80, 0.92]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.4.1 Epidemic year ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>189004</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.80, 0.92]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.4.2 Epidemic year ‐ vaccine matching absent or unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.4.3 Non‐epidemic year ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.4.4 Non‐epidemic year ‐ vaccine matching absent or unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10.5 Deaths from respiratory disease <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>142464</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.92 [0.86, 0.98]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.5.1 Epidemic year ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>142464</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.92 [0.86, 0.98]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10.6 All deaths <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>68032</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.39 [0.16, 0.97]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.6.1 Epidemic year ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2344</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.13 [0.02, 0.92]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.6.2 Epidemic year ‐ vaccine matching absent or unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.6.3 Non‐epidemic year ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>65688</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.47 [0.17, 1.28]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.6.4 Non‐epidemic year ‐ vaccine matching absent or unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10.7 Hospitalisation for heart disease <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>45932</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.92 [0.83, 1.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.7.1 Epidemic year ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>45932</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.92 [0.83, 1.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.7.2 Epidemic year ‐ vaccine matching absent or unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.7.3 Non‐epidemic year ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.7.4 Non‐epidemic year ‐ vaccine matching absent or unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10.8 Combined outcome: all deaths or severe respiratory illness <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>146248</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.60 [0.49, 0.74]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.8.1 Epidemic year ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>54438</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.54 [0.49, 0.60]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.8.2 Epidemic year ‐ vaccine matching absent or unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>91810</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [0.61, 0.72]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 10.</span> <span class="table-title">Influenza vaccines versus no vaccination: cohort studies in community‐dwellers ‐ risk groups</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#CD004876-tbl-0013">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004876-tbl-0014"> <div class="table-heading"><span class="table-label">Comparison 11.</span> <span class="table-title">Influenza vaccines versus no vaccination: cohort studies in community‐dwellers ‐ no risk groups</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11.1 Influenza <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>11399</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.57 [0.27, 1.17]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.1.1 Epidemic year ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.1.2 Epidemic year ‐ vaccine matching absent or unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.1.3 Non‐epidemic year ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>11399</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.57 [0.27, 1.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.1.4 Non‐epidemic year ‐ vaccine matching absent or unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11.2 Pneumonia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>11399</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.59 [0.37, 0.92]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.2.1 Epidemic year ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.2.2 Epidemic year ‐ vaccine matching absent or unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.2.3 Non‐epidemic year ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>11399</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.59 [0.37, 0.92]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.2.4 Non‐epidemic year ‐ vaccine matching absent or unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11.3 Hospitalisation for influenza or pneumonia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>101619</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.50 [0.40, 0.63]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.3.1 Epidemic year ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>101619</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.50 [0.40, 0.63]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.3.2 Epidemic year ‐ vaccine matching absent or unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.3.3 Non‐epidemic year ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.3.4 Non‐epidemic year ‐ vaccine matching absent or unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11.4 Hospitalisation for any respiratory disease <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>376324</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.84 [0.55, 1.27]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.4.1 Epidemic year ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>376324</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.84 [0.55, 1.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.4.2 Epidemic year ‐ vaccine matching absent or unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.4.3 Non‐epidemic year ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.4.4 Non‐epidemic year ‐ vaccine matching absent or unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11.5 Deaths from respiratory disease <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>281424</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.41 [1.31, 1.53]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.5.1 Epidemic year ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>281424</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.41 [1.31, 1.53]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11.6 All deaths <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>43821</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.65 [0.33, 1.29]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.6.1 Epidemic year ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>7047</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.09 [0.26, 4.49]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.6.2 Epidemic year ‐ vaccine matching absent or unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.6.3 Non‐epidemic year ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>36774</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.59 [0.27, 1.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.6.4 Non‐epidemic year ‐ vaccine matching absent or unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11.7 Hospitalisation for heart disease <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>101619</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.61, 1.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.7.1 Epidemic year ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>101619</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.61, 1.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.7.2 Epidemic year ‐ vaccine matching absent or unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.7.3 Non‐epidemic year ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.7.4 Non‐epidemic year ‐ vaccine matching absent or unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11.8 Combined outcome: all deaths or severe respiratory illness <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>135180</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.62 [0.54, 0.70]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.8.1 Epidemic year ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>68536</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.65 [0.54, 0.78]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.8.2 Epidemic year ‐ vaccine matching absent or unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>66644</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.58 [0.48, 0.71]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 11.</span> <span class="table-title">Influenza vaccines versus no vaccination: cohort studies in community‐dwellers ‐ no risk groups</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#CD004876-tbl-0014">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004876-tbl-0015"> <div class="table-heading"><span class="table-label">Comparison 12.</span> <span class="table-title">Influenza and pneumococcal vaccines versus no vaccination: cohort studies in community‐dwellers</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12.1 Influenza‐like illness <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>374</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.32 [0.16, 0.64]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.1.1 Epidemic year ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.1.2 Epidemic year ‐ vaccine matching absent or unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.1.3 Non‐epidemic year ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>374</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.32 [0.16, 0.64]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12.2 Hospitalisation for influenza or pneumonia or respiratory disease <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>518748</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [0.64, 0.70]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.2.1 Epidemic year ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>518374</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [0.63, 0.71]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.2.2 Epidemic year ‐ vaccine matching absent or unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.2.3 Non‐epidemic year ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>374</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.10, 7.97]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12.3 Deaths from influenza or pneumonia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>259627</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.43 [0.33, 0.57]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.3.1 Epidemic year ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>259627</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.43 [0.33, 0.57]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.3.2 Epidemic year ‐ vaccine matching absent or unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.3.3 Non‐epidemic year ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12.4 All deaths <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>260001</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.44 [0.41, 0.46]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.4.1 Epidemic year ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>259627</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.44 [0.41, 0.46]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.4.2 Epidemic year ‐ vaccine matching absent or unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.4.3 Non‐epidemic year ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>374</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.60 [0.08, 30.65]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 12.</span> <span class="table-title">Influenza and pneumococcal vaccines versus no vaccination: cohort studies in community‐dwellers</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#CD004876-tbl-0015">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004876-tbl-0016"> <div class="table-heading"><span class="table-label">Comparison 13.</span> <span class="table-title">Influenza vaccines with adjuvant versus no vaccination: cohort studies in community‐dwellers</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13.1 Influenza‐like illness <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>498</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.30 [0.16, 0.56]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.1.1 Epidemic year ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>263</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.20 [0.07, 0.54]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.1.2 Epidemic year ‐ vaccine matching absent or unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.1.3 Non‐epidemic year ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>235</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.38 [0.18, 0.82]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13.2 Hospitalisation for influenza or pneumonia or respiratory disease <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>498</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.17 [0.02, 1.28]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.2.1 Epidemic year ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.2.2 Epidemic year ‐ vaccine matching absent or unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.2.3 Non‐epidemic year ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>498</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.17 [0.02, 1.28]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13.3 All deaths <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>235</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.10 [0.10, 43.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.3.1 Epidemic year ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.3.2 Epidemic year ‐ vaccine matching absent or unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.3.3 Non‐epidemic year ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>235</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.10 [0.10, 43.10]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 13.</span> <span class="table-title">Influenza vaccines with adjuvant versus no vaccination: cohort studies in community‐dwellers</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#CD004876-tbl-0016">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004876-tbl-0017"> <div class="table-heading"><span class="table-label">Comparison 14.</span> <span class="table-title">Influenza vaccines versus no vaccination: case‐control studies in community</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14.1 Hospitalisations for influenza or pneumonia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1074</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.69, 1.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.1.1 Outbreak ‐ vaccine matching (circulating strains)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.1.2 Outbreak ‐ vaccine matching absent or unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>825</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.92 [0.69, 1.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.1.3 No outbreak ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>249</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.48, 1.40]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14.2 Hospitalisations for any respiratory disease <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>21378</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.08 [0.95, 1.23]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.2.1 Outbreak ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>20582</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.08 [0.92, 1.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.2.2 No outbreak ‐ not matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>796</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.68, 1.52]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14.3 Deaths from influenza or pneumonia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1092</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.74 [0.53, 1.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.3.1 Outbreak ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1092</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.74 [0.53, 1.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14.4 Pneumonia (no better defined) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>519</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.57, 1.33]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.4.1 Outbreak ‐ partially matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>519</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.57, 1.33]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 14.</span> <span class="table-title">Influenza vaccines versus no vaccination: case‐control studies in community</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#CD004876-tbl-0017">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004876-tbl-0018"> <div class="table-heading"><span class="table-label">Comparison 15.</span> <span class="table-title">Influenza vaccines versus no vaccination: case‐control studies in community ‐ adjusted rates</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15.1 Hospitalisations for influenza or pneumonia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.59 [0.47, 0.74]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.1.1 Epidemic ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.55 [0.36, 0.85]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.1.2 Non‐epidemic ‐ vaccine not matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.1.3 Epidemic year ‐ vaccine matching absent or unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.68 [0.58, 0.79]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.1.4 Non‐epidemic ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.37 [0.16, 0.87]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15.2 Hospitalisations for any respiratory disease <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.71 [0.56, 0.90]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.2.1 Epidemic ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.71 [0.56, 0.90]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.2.2 Non‐epidemic ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.2.3 Non‐epidemic year ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15.3 Deaths from pneumonia or influenza <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.74 [0.60, 0.92]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.3.1 Epidemic year ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [0.60, 0.97]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.3.2 Epidemic year ‐ vaccine matching absent or unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [0.42, 1.07]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 15.</span> <span class="table-title">Influenza vaccines versus no vaccination: case‐control studies in community ‐ adjusted rates</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#CD004876-tbl-0018">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004876-tbl-0019"> <div class="table-heading"><span class="table-label">Comparison 16.</span> <span class="table-title">Influenza and pneumococcal vaccines versus no vaccination: case‐control studies in community</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16.1 Hospitalisations for influenza or pneumonia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6629</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.85, 1.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.1.1 Outbreak ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3617</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.69, 1.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.1.2 No outbreak ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3012</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.80, 1.08]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 16.</span> <span class="table-title">Influenza and pneumococcal vaccines versus no vaccination: case‐control studies in community</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#CD004876-tbl-0019">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004876-tbl-0020"> <div class="table-heading"><span class="table-label">Comparison 17.</span> <span class="table-title">Influenza and pneumococcal vaccines versus no vaccination: case‐control studies in community ‐ adjusted rates</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17.1 Hospitalisations for influenza or pneumonia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.68 [0.54, 0.86]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>17.1.1 Epidemic ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.68 [0.50, 0.93]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>17.1.2 Non‐epidemic ‐ vaccine not matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>17.1.3 Epidemic year ‐ vaccine matching absent or unknown</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>17.1.4 Non‐epidemic ‐ vaccine matching</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.69 [0.49, 0.97]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 17.</span> <span class="table-title">Influenza and pneumococcal vaccines versus no vaccination: case‐control studies in community ‐ adjusted rates</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#CD004876-tbl-0020">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004876-tbl-0021"> <div class="table-heading"><span class="table-label">Comparison 18.</span> <span class="table-title">Sensitivity analysis: comparison 01: subgroup analysis by study quality</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18.1 Influenza‐like illness <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>9211</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.75 [0.65, 0.87]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.1.1 Quality A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4502</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.78 [0.65, 0.94]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.1.2 Quality B</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3854</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.65, 1.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.1.3 Quality C</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>389</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.66 [0.43, 1.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.1.4 Quality D</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>466</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.44 [0.35, 0.57]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 18.</span> <span class="table-title">Sensitivity analysis: comparison 01: subgroup analysis by study quality</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004876.pub4/references#CD004876-tbl-0021">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD004876.pub4&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD004876-note-0006">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD004876-note-0012">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD004876-note-0017">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD004876-note-0011">Français</a> </li> <li class="section-language"> <a class="" href="hr#CD004876-note-0010">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ja#CD004876-note-0016">日本語</a> </li> <li class="section-language"> <a class="" href="ms#CD004876-note-0009">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#CD004876-note-0018">Polski</a> </li> <li class="section-language"> <a class="" href="pt#CD004876-note-0008">Português</a> </li> <li class="section-language"> <a class="" href="ru#CD004876-note-0007">Русский</a> </li> <li class="section-language"> <a class="" href="th#CD004876-note-0015">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD004876-note-0013">简体中文</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD004876-note-0014">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738735355000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738735355000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004876\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004876\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004876\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004876\x2epub4"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004876\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004876\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004876\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004876\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004876\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004876\x2epub4"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004876\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004876\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004876\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004876\x2epub4"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004876\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004876\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004876\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004876\x2epub4"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=1pyM3CVc&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004876.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD004876.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD004876.pub4/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD004876.pub4/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004876.pub4%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740713835387"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD004876.pub4/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740713835391"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD004876.pub4/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918d5ff2d84f936e',t:'MTc0MDcxMzgzNS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 